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Abstract 
Background:  
Hypothyroidism affects between 2% and 5% of the UK population. Reports suggest that up to 15% 
of patients report persistent symptoms despite treatment. Recommendations exist for 
psychosocial and self-management support for patients to address the demands of living with their 
condition and to develop the skills, knowledge, and experience to manage their health. In this study, 
Endocrinologists were asked about the provision of support for patients with hypothyroidism in 
secondary care. Their views, experiences, and perceptions of the barriers and facilitators to the 
implementation of psychosocial and self-management models of care were explored.  
Methods 
Eighteen Consultant Endocrinologists in the UK were recruited via a snowballing sampling 
technique and interviewed. Interviews were analysed using reflexive thematic analysis.  
Findings 
Four overarching themes were identified. In the first theme (‘Walk with them’) participants 
identified that patients with hypothyroidism have diverse needs for psychosocial and self-
management support from the point of diagnosis, but that participants report varied will, skill and 
confidence to meet these needs. The second theme (‘Embedded is best’) encapsulates participants’ 
attempts to explore psychosocial issues and embed components of self-management support into 
their own practice. Difficulties in shifting the focus of the consultation towards self-management 
and subsequent challenges to professional identity as biomedical expert are reported. These were 
perceived to be confounded by debates about non-standard (T3) treatments for hypothyroidism 
and a lack of available support services for referral. The third theme (‘Incorporate and collaborate’) 
presents participants’ views that collaboration is required to address gaps in provision in primary 
and secondary care. Valuable partners include: Patients, Endocrine Nurses, Health Psychologists, 
Pharmacists, Exercise Physiologists, embedded Researchers, and experts in the charitable sector. 
The fourth theme (‘We can’t do this alone’) includes participant-identified barriers to progress and 
highlights a need for change. This includes increases in funding and research, and supportive 
environment which empowers clinicians to place patients at the centre of their care.  
Conclusion 
The findings from this research suggest that patients with hypothyroidism have unmet needs for 
psychosocial and self-management support from the point of diagnosis, and that Endocrinologists 
may to benefit from training, collaboration and support to incorporate non-medical models of care. 
Patients, professional collaborators, and experts in the charitable sector are valuable assets to 
Endocrinology and can contribute to psychosocial and self-management programmes for patients 
and clinician skills training, as well as acting as agents of change to address gaps in provision in 
primary and secondary care.  A whole-systems approach is required to improve outcomes for 
patients with hypothyroidism and the clinicians who manage their care.  
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Chapter 1: Aim, objectives and rationale 
 
Exploring Endocrinologists’ views and experiences of psychosocial and self-management support 
for patients with hypothyroidism 
1.1. Aim and objectives 
 
The aim of this research was to explore Endocrinologists’ views and experiences of psychosocial 
and self-management support for patients with hypothyroidism.  
The objectives of this research were: 
● To examine Endocrinologists’ views about the psychosocial and self-management support 
needs of patients living with hypothyroidism  
● To examine Endocrinologists’ experiences of providing psychosocial and self-management 
support within their own practice 
● To examine whether Endocrinologists refer patients with hypothyroidism for additional 
psychosocial and self-management support  
● To explore perceived barriers and facilitators to the implementation of psychosocial and 
self-management models of care  
An overview of the role of Endocrinologists in the management of hypothyroidism is presented in 
section 2.3. (The Endocrinologists’ Role) and definitions of psychosocial support and self-
management used in this thesis are provided in sections 2.5 (‘Systematic review: Do psychosocial 
interventions improve wellbeing and quality of life in adult patients with thyroid diseases?) and 
section 2.7. (‘Defining psychosocial and self-management support’)  
 
1.2. Research Origins  
 
This research originated when I was volunteering for the British Thyroid Foundation as part of my 
Professional Doctorate in Health Psychology.  
 
My role was to provide evidence-based information and support to people with thyroid diseases 
via telephone and to develop and facilitate a monthly peer support group. During this time, patients 
described unmet psychosocial and self-management support needs, particularly for those with 
hypothyroidism. These ranged from wanting to know more about how to manage their condition, 
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to dealing with mild problems (e.g. cold intolerance, skin complaints, memory problems), to more 
extreme issues (e.g. debilitating fatigue and suicidal thoughts and feelings).  
 
This experience prompted me to carry out my doctoral systematic review into the effectiveness of 
psychosocial interventions for people with thyroid disorders during which, I found that very few 
interventions exist in the published literature for patients with thyroid diseases.  
 
In fulfilment of my doctoral consultancy requirements, I subsequently collaborated with 
Endocrinologists in an NHS thyroid clinic for patients with persistent symptoms and complex needs 
to investigate their experiences of supporting this patient group in secondary care. Initially, I was 
interested in whether Endocrinologists and Health psychologists could collaborate to identify 
approaches and interventions to address the psychosocial and self-management concerns of this 
patient group. However, as I became immersed in this research area through consultancy and wider 
engagement with the participant group, I fostered awareness and sensitivity towards the 
professional and practice issues facing clinicians working this area. As my knowledge and expertise 
widened, and the position of trust between myself as a researcher and the participant group 
developed, I began to explore the management of hypothyroidism from the perspectives of 
participants, and the experiences and worldviews of the professionals became the central focus of 
the research. This progression led to an organic and changing research methodology, influenced by 
the evolving nature of the research question.  
 
During this project, clinicians identified a need for support to meet patients’ psychosocial and self-
management needs but highlighted gaps in their own practice and in wider service provision. To 
examine whether this is a wider need in Endocrinology departments, this qualitative exploration 
was developed to explore the views and experiences of 18 Endocrinologists from a range of 
secondary care settings across the UK. 
 
Throughout the course of this research, my approach and role developed from an initial patient 
facing role to adopting a focus upon professional issues in the management of hypothyroidism.  
 
 
 
 
 
 
 
9 
 
Chapter 2: Introduction and background literature 
 
Exploring Endocrinologists’ views and experiences of psychosocial and self-management support 
for patients with hypothyroidism 
This chapter introduces hypothyroidism as the focus of this research and Endocrinologists as study 
participants. It outlines the history of medical treatments for hypothyroidism and findings from a 
systematic review which highlights a need for additional psychosocial and self-management 
support. The benefits of incorporating psychosocial and self-management models of care into the 
management of long-term conditions are described, as well as the impact of health professionals’ 
attitudes and beliefs about these models upon health outcomes. This chapter builds upon the 
current literature about the beliefs and behavioural components contributing to the management 
of hypothyroidism in primary care (Dew et al, 2018). It describes the wide-ranging biopsychosocial 
support needs of patients with hypothyroidism identified in the literature and provides the 
rationale for exploring Endocrinologists’ views and experiences of psychosocial and self-
management models of support in secondary care. 
 
2.1 Hypothyroidism 
 
Hypothyroidism is a chronic condition affecting between 2% and 5% of the population in the UK 
(Saravanan et al, 2002). Hypothyroidism is a growing problem, which is 10 times more likely in 
females than males (British Thyroid Foundation, 2015; Taylor et al, 2018). Levothyroxine Sodium 
(LT4), a manufactured form of the thyroid hormone thyroxine (T4) is the recommended treatment 
for hypothyroidism and is currently the third most prevalently prescribed drug in the UK (NHS 
Digital, 2017).  
 
There are two main causes of hypothyroidism; autoimmunity (Hashimoto’s disease) and due to a 
side effect of treatment for an overactive thyroid or for thyroid cancer. Together these two types 
account for over 90% of all cases of hypothyroidism in the UK (Okosieme, et al 2016). Rarer causes 
stem from primary hypothyroidism (direct impairment of the thyroid gland function) which may 
result from abnormal fetal development, iodine deficiency, or inflammatory responses to drugs or 
pregnancy. Patients may present with mild biochemical changes (subclinical hypothyroidism) or 
with profound biochemical change (e.g. myxedema coma). Current guidelines for thyroid hormone 
replacement therapy recommend a one size-fits-all testing and treatment approach with synthetic 
LT4 monotherapy (Okosieme et al, 2016; NICE, 2019), an inactive thyroid pre-hormone which is 
known to be converted into the active thyroid hormone triiodothyronine (T3) in the body.  
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2.2. Complexity and persistent symptoms 
 
Evidence exists that between 10-15% of patients with hypothyroidism (Wersinga, 2014; Chaker et 
al, 2017) report persistent symptoms, despite treatment with Levothyroxine (LT4), fuelling debates 
about the efficacy of the current gold standard treatment for hypothyroidism (described in section 
2.4. ‘The history of treatment for hypothyroidism’). Numerous and often debilitating residual 
physical, psychological, and cognitive symptoms, and ongoing social impacts have been reported in 
the literature.  
 
Persistent physical symptoms reported in the literature include; widespread malaise (Mandincova, 
2012); exercise intolerance (e.g. Lankhaar et al 2014); muscular complaints and myalgia (Reuters et 
al, 2012); increased lethargy and fatigue (Van de ven et al, 2012), weight gain (Sanyal & 
Raychaudhuri, 2016); lowered fertility and increased risk of miscarriage or preterm birth (Earl et al, 
2013) and a higher incidence of co-existing autoimmune, inflammatory, and rheumatic diseases in 
patients with autoimmune thyroid diseases (Punzi & Betterle, 2004; Spirkova et al,2015; Fallahi et 
al, 2016). 
 
Self-reported psychological symptoms include: poor general mental health (e.g. Saravanan et al, 
2002), anxiety and depression (e.g. Alsaffar et al, 2016); psychiatric symptoms (Degner et al 2015); 
mood disturbance (Nexø et al, 2015a), and sexual dysfunction (Haider et al, 2016). Studies have 
found that patients treated with levothyroxine (LT4) therapy display significant impairment in 
psychological wellbeing compared to controls of a similar age and sex (Saravanan et al, 2006; 
Saravanan et al, 2002; Paniker et al, 2009; Wekking et al, 2005; In Taylor et al 2019).  
 
The hidden, ambiguous and persistent nature of thyroid disease has been reported to result in 
lasting impacts upon patients’ long-term health related quality of life (e.g. Watt et al, 2006). For 
example, patients with hypothyroidism (and hyperthyroidism prior to treatment to render them 
hypothyroid) have reported poor relationships with others resulting from their symptoms being 
subjective and invisible to others (Nexø et al, 2015a). Other reports of quality of life impacts include: 
impaired body image resulting from visible scars following thyroidectomy (e.g. Sethukumar et al, 
2018) cosmetic eye changes associated with thyroid autoimmune overactivity  (Nexø et al, 2015a; 
Jenkinson & Wickwar; 2016), and increases in body weight accompanying hypothyroidism (e.g. 
Kelderman-Bolk et al, 2015); as well as findings of poor voice recovery after thyroid surgery 
(Pernambuco et al; 2015); and reports of work disability, lowered productivity and loss of income 
(Thilvum et al, 2014, Brandt et al, 2015).  
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Patient reports of persistent physical, psychological symptoms and their impacts have contributed 
to debates regarding the adequacy of the current treatments available (described in section 2.4.  
‘The history of treatment for hypothyroidism’; e.g. Panicker et al, 2009b; Saravanan et al, 2006; 
McAninch &Bianco, 2016) and to recommendations within this thesis to address hypothyroid 
patients’ wellbeing through the implementation of psychosocial support and self-management 
models of care, derived from studies carried out with patients reviewed in  section 2.8. (‘Reviewing 
the psychosocial and self-management support needs of patients with hypothyroidism’). 
 
Despite recommendations made in the literature to address persistent biopsychosocial symptoms 
of hypothyroidism through psychosocial and self-management support; few interventions for this 
patient group are known to exist. Difficulties in defining and addressing issues relating to quality of 
life in this patient group also persist due to the heterogenous definitions and measures of 
psychosocial concern and quality of life throughout the existing literature (see section 2.5. 
‘Systematic review: Do psychosocial interventions improve wellbeing and quality of life in adult 
patients with thyroid diseases?). The many ways that quality of life can be measured has made its 
incorporation into research and systematic review difficult (e.g. Theofilou, 2013)  and a key criticism 
of the existing literature described above includes the use a range of measures which are not 
validated for use with this patient group including the General Health Questionnaire (e.g. Saravanan 
et al, 2002) and the Hospital Anxiety and Depression Scale (e.g. Alsaffar et al, 2016).  
 
2.3. The Endocrinologists’ Role 
 
Endocrinologists assess complex cases of hypothyroidism referred from primary care and see 
patients for whom symptoms of hypothyroidism, or blood test results outside of the normal 
reference range, do not resolve with standard LT4 treatment.  
 
The Endocrinologist role includes identifying the source of unresolved symptoms and treating 
accordingly when the cause is attributed to an endocrine issue; referring patients to other 
specialists to determine other causes or discharging patients back to primary care. They assess 
clinical need in patients requesting additional trials of Liothyronine (LT3) treatment (the active 
thyroid hormone triiodothyronine’) which must be prescribed in secondary care (see section 2.4. 
‘This history of treatment for hypothyroidism’). More recently, due to new government guidelines, 
Endocrinologists are increasingly tasked with reviewing patients who have been using LT3 to 
improve their symptoms, with a view to re-assessment (i.e. to reduce numbers due to cost 
implications). Evidence suggests that this is increasingly problematic for their role in terms of 
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professional autonomy and workload (e.g. BBC News, 2017), and in addressing patient relations 
and reported quality of life (see section 2.4. The history of treatment for hypothyroidism). 
 
Endocrinologists are ideally placed to learn from regarding the reasons for the reports of persistent 
symptoms reported in the literature, and about the provision of psychosocial and self-management 
support known to those working with patients in secondary care. Insights from Endocrinologists 
may help us to learn more about the facilitators and barriers that help or hinder hypothyroid 
patients when managing their symptoms and also about what can empower them to develop the 
knowledge, skills and confidence to manage their health (Hibbard et al 2005) as identified as a need 
in the research literature (see section 2.8. ‘Reviewing the psychosocial and self-management 
support needs of patients with hypothyroidism’). 
 
To date, no published literature exists that describes the ways that Endocrinologists view or manage 
the psychosocial or self-management needs of hypothyroid patients, including a lack of instruction 
within clinical guidelines (e.g. NICE, 2019); and little is known about the existing channels of referral 
or skills development programmes to support Endocrinologists to help this patient group. 
Endocrinologists work closely with other specialities when managing patients with specialist 
endocrine conditions (e.g. pituitary, parathyroid, diabetes, antenatal and adrenal clinics) but clinical 
guidance does not recommend a multi-disciplinary approach for the management of 
hypothyroidism (e.g. NICE, 2019). Whilst this suggests that Endocrinologists occupy an autonomous 
role in the management of hypothyroidism, emerging evidence suggests that Endocrinologists 
currently face difficult challenges in their role, balancing demands for autonomous clinical decision 
making with working within regional prescribing guidelines, leaving them in an unusual position 
between their patients and the healthcare system. These issues are explored further in the 
following section (2.4. The history of treatment for hypothyroidism).  
 
2.4. The history of treatment for hypothyroidism 
 
This section outlines the history of the treatment for hypothyroidism, during which interventions 
to reduce and standardise testing and treatment options for hypothyroidism were introduced, 
resulting in complaints about loss of quality of life from patients and difficulties for clinicians 
treating patients who present with persistent symptoms. 
 
Since the 1970’s, the field of Endocrinology has undergone a series of changes and transformations 
aimed at incorporating new evidence-based practices (EBPs; Bauer et al, 2015) into routine clinical 
usage (see McAninch &Bianco, 2016 for a review). These aimed to standardise and improve the 
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safety of treatment of hypothyroidism through establishing (synthetic) Levothyroxine LT4 thyroid 
hormone monotherapy as standard clinical practice. During this period, the use of traditional 
pharmacologic treatments was phased out due to concerns about dosing and stability (Toft, 1999, 
Taylor et al, 2019). These included unlicensed natural desiccated thyroid preparations (NDT) 
derived from animal sources, and combination therapy with Levothyroxine Sodium (LT4) with 
Liothyronine (a manufactured form of the thyroid hormone triiodothyronine/LT3). Teaching 
regarding the use of natural thyroid hormone preparations (NDT) in medical education ended in 
the mid 1970’s (Thyroid Patient Advocacy Forum).   
 
During this period, a subsection of patients continued to report preference for discouraged 
treatments (Dayan & Paniker 2018) and many began to complain about loss of quality of life 
(Bunevicius et al, 1999). In response, 14 clinical trials were carried out to examine the effectiveness 
of LT4 monotherapy versus LT4/LT3 combination therapy. These trials, along with four systematic 
reviews and meta analyses found no clear benefit of LT4/LT3 combination therapy over 
levothyroxine LT4 monotherapy (Escobar-Morreale et al 2005; Joffe et al 2000; Grozinsky-Glasberg 
et al, 2006; Ma et al 2009; In Taylor et al, 2019). 
 
Subsequent interventions were introduced to reduce ‘unnecessary and costly’ investigative and 
diagnostic blood tests and to establish TSH testing (a single laboratory parameter) as standard 
practice. These interventions targeted the behaviours of new doctors and trainees in medical 
education (e.g. Daucourt et al, 2003), alongside targeting practicing clinicians. For example, a 
systematic review (Zhelev et al, 2016) identified 27 studies of interventions to reduce the volume 
of thyroid tests ordered by GP practices across the UK. Evidence showed that this established a 
broad consensus in clinical practice patterns in the management of primary hypothyroidism (Burch 
et al, 2014). These patterns were consistent with wider drives in medicine to increase clinicians’ 
adherence to guidelines to improve patient outcomes (Pronovost, 2013) and to improve 
implementation of ‘value-based healthcare’ amidst shrinking resources and increasing demand 
(Gray, 2017). 
 
Despite the development of clinical guidelines and efforts to change clinician behaviour, it is 
believed that around 10-15% of patients with hypothyroidism complain of persistent symptoms 
(Chaker et al, 2017; Wiersinga, 2014, Peterson et al, 2018), and thyroid hormone replacement in 
primary care remain suboptimal (Dew et al, 2018). Subsequently, the majority of published national 
guidelines (e.g. European Thyroid Association, British Thyroid Association and American Thyroid 
Association) recognise that a subgroup of patients with hypothyroidism exist with persistent 
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symptoms who may benefit from personalised therapeutic trials of T3, following discussion with 
the patient of the uncertainty, risks and benefits (Okosieme et al, 2017; Taylor et al, 2019).  
Controversy in this area occurred in 2017 when Liothyronine (LT3), the active T3 thyroid 
replacement hormone was included in the NHS England (2019) consultation document ‘Items which 
should not be routinely prescribed in primary care’ leading to many CCGs in the UK issuing a blanket 
ban on the prescribing of medicines perceived to be of ‘low value’, including LT3. This resulted in 
the forceable withdrawal of prescribed LT3 from many patients and restrictions on prescribing 
practice upon clinicians. This was introduced by many CCGs despite significant patient evidence 
being submitted in response to the consultation from patients, patient advocacy groups (e.g. 
National Voices, 2018) and medical groups (e.g. Royal Pharmaceutical Society, 2018) advising 
against this change.  The situation provoked campaigns from patient groups; a subsequent debate 
in the House of Lords in June 2018 and a meeting of key thyroid groups in the House of Commons 
in July 2018 (Hansard Online 21 May 2018) supporting the rights of treated patients with persistent 
symptoms to retain the use of LT3 therapy (British Thyroid Foundation et al, evidence dossier; 2018) 
advocating for improvements in the treatment of hypothyroidism. 
The NHS England consultation process subsequently resulted in the reiteration of the need for 
exemptions from blanket bans of LT3 (liothyronine) for patients treated with LT4 (Levothyroxine) 
with persistent symptoms (Regional Medicines Optimisation Committee, 2018), but concluded that 
trials of LT4/LT3 should not be instigated in primary care, with responsibility and workload 
attributed to the clinical judgement of individual Endocrinologists in secondary care (BBC News, 
2017). More recently however, the new guidelines (NICE 2019) advised against initiation of 
personalised medical trials due to gaps in the evidence whilst recognising that there may be a 
subgroup of patients for whom LT4 therapy may be ineffective.  
Recently, data derived from a study of 797 Clinical Endocrinologists in Italy (Negro et al, 2019) 
showed that nearly 99% of Italian Endocrinologists agree with LT4 monotherapy as the standard 
treatment of choice, but that combination LT4 + LT3 is considered by 43% for LT4-replaced patients 
with  normal TSH reporting persistent symptoms. However in this survey, high percentages of 
respondents reported using alternative LT4 formulations (e.g. liquid solution or soft-gel capsules) 
for patients with specific conditions (interfering drugs, actual or suspected malabsorption, inability 
to take LT4 in the fasting state, unexplained poor biochemical control of hypothyroidism) and 43% 
reported considering these for patients for LT4- treated patients with persistent symptoms. Whilst 
this study suggests that there may be alternative biomedical tools for addressing the problem of 
persistent symptoms of hypothyroidism; these are not currently available through the NHS.  
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In practice, individual CCGs in England currently continue to make local decisions regarding the 
availability and status of LT3 thyroid hormone replacement therapy as the key alternative to LT4 
monotherapy, leaving patients subject to a postcode lottery of provision (Taylor et al, 2019). Many 
patients seek prescriptions privately from Endocrinologists or import LT3 from international 
sources and self-medicate without engagement from NHS healthcare providers, leading to concerns 
about risk and patient safety (Taylor et al, 2019).  
Between 2014 and 2019, published studies have criticised the original research on which the clinical 
guidelines are based (e.g. Wersinga, 2014).  Criticisms include heterogeneity of studies and 
inaccurate administration of LT4 and LT3 during historical trials when scientific knowledge of dosing 
was limited.  In studies where patients preferred LT4 monotherapy to LT3 or LT4/LT3 combination 
therapy, it was found that high doses of LT3 were administered leading patients towards 
overreplacement and symptoms of thyrotoxicosis.  
Whilst criticisms of the research have emerged, and a clearer picture of the scientific ‘knowns’ and 
‘unknowns’ in this area are being mapped (Taylor et al 2019), clinical evidence for personalised 
medical treatment of LT4/LT3 combination therapy and natural thyroid preparations remains weak 
(Hennessey & Espillat, 2018) and clinical guidelines continue to discourage therapeutic trials (NICE, 
2019).  
This situation perpetuates unresolved debates about the necessity, superiority, cost effectiveness 
and potential side effects of the treatment for hypothyroidism throughout the literature (e.g. Toft, 
2002; Toft, 2017; Kalra & Khandelwal, 2011; Hennessey & Espaillat, 2018; Tariq et al, 2018; Dayan 
& Paniker, 2018, Taylor et al, 2019.2) whilst patient reports of persistent symptoms and 
dissatisfaction with treatment persist (see section 2.2. ‘Complexity and persistent symptoms’).  
Criticisms of clinical guidelines call for open minded approaches to prescribing (McAninch &Bianco; 
2016; Toft 2017; Tariq et al 2018,  Hoermann et al 2013, Hoermann et al 2018), and shifts away 
from the recent standardisation of clinician behaviour (Pronovost, 2013; Jonklass et al, 2019). 
Improvements to the research evidence in this area and new paradigms and ways of working are 
now required to address the recent surge in patient complaints about quality of life (Hoermann et 
al, 2017; Toft 2017; Midgley et al, 2019). 
Current controversies and debates regarding the cause and prevalence of persistent symptoms, 
and regarding the need for a personalised versus one-size-fits-all approach to treatment has 
reportedly left some Endocrinologists and General Practitioners feeling stuck between a rock and a 
hard place with the implementation of guidance (Wilkinson, 2018) and concerned about mounting 
pressure upon their role (BBC News, 2017).  
16 
 
Clinicians have described a need for greater flexibility from CCGs who encourage them not to issue 
prescriptions of LT3, despite patient demand and GP contractual obligations (Wilkinson, 2018). A 
significant Increase in the cost of LT3 prescriptions has been attributed as the key driving factor in 
the continued denial of patient choice (Toft, 2017). Dependence upon reductionist diagnostic tests 
and rigid clinical guidelines (Toft, 2017) which negate thyroid patients’ reports of unresolved 
symptoms (National Voices 2017), have been described as diminishing the willingness of GPs and 
Endocrinologists to explore and address the needs of those patients who present outside of the 
‘norm’, particularly those who may require higher levels of LT4 or LT4/LT3 combination therapy or 
alternative LT4 formulations to alleviate their symptoms (Toft, 2017). This is reflected in the findings 
from a study which explored the treatment of hypothyroidism in primary care (Dew et al, 2018; see 
section 2.6. ‘Examining clinicians’ attitudes, beliefs and intentions towards self-management and 
psychosocial care’). This study found that primary care clinicians attributed professional 
responsibility to established clinical guidelines which did not always result in optimum hormone 
replacement. Endocrinologists who are willing to prescribe therapeutic trials of combination 
therapy or increased doses of LT4 have increasingly found their recommendations rejected by GPs 
or CCGs (Toft, 2017).  
 
Some clinicians also question whether persistent symptoms reported by up to 15% of patients with 
hypothyroidism and growing reports of dissatisfaction with treatment may be attributable to non-
thyroidal causes. Particularly, the wider prevalence of medically unexplained symptoms (MUS) in 
the general population, which account for 80% of all GP consultations (NHS Education Scotland, 
2014), has been raised by some Endocrinologists as a possible explanation (Weetman, 2006). 
Others suggest that physical and psychological comorbidities contribute to the over-detection of 
subtle changes in thyroid biochemistry in people presenting with psychological and emotional 
complaints (Bekkering et al, 2019a).  
NHS England (2018) have stated that two thirds of people with a chronic physical health condition 
also have a co-morbid mental health problem, mostly anxiety and depression; and up to 70% of 
people with persistent or ‘medically unexplained symptoms’ also have depression and/or anxiety 
disorders. Hi comorbidity of chronic conditions (e.g. Saravanan et al, 2002) and lower levels of 
psychological well-being have been found in patients treated for hypothyroidism (see section 2.2. 
‘Complexity and persistent symptoms’). However, controversies around the treatment of 
hypothyroidism, make it difficult to determine whether the phenomena of persistent symptoms in 
hypothyroidism results from a failure of standard treatment to resolve symptoms in some patients, 
or whether the large numbers of patients affected by hypothyroidism in the UK (between 2%-5% 
of the overall population; Saravanan et al, 2002) inevitably captures patients with unexplained 
medical symptoms or unresolved symptoms of physical and health comorbidities.   
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The significant evidence submitted by patients to the House of Lords shows that patients believe 
inadequacies in treatment to be the cause of persistent symptoms (BTF evidence dossier, 2018), 
and this is debated extensively in the existing literature with no definitive conclusion (e.g. 
Weetman, 2006; Saravanan et al, 2002; Naxo et al, 2015; McAninch &Bianco, 2016; Taylor et al, 
2019).  
 
Regardless of the cause of patient reported distress, a  joint statement by national clinical leaders 
(Royal Society of Psychiatrists, 2015) stated  that people who are troubled by persistent medical 
symptoms or symptoms inadequately explained by their medical condition are poorly served by 
existing services and state that there is an urgent need to provide them with more integrated 
physical and psychological healthcare to improve their quality of life and reduce costs to the 
National Health Service (NHS) and the wider system.  
 
For health conditions with observed psychological impacts such as hypothyroidism, the World 
Health Organisation (2016) recommend basic training in providing ‘embedded psychosocial 
support’ for all healthcare providers, including training to assess who may need more than basic 
embedded support and what mental health and supportive and services are available to refer to. 
Such services may include psychology or counselling, peer support groups or more commonly, 
online support. The NHS England ‘Implementing the Five Year Forward View for Mental Health’ 
(2016) and ‘NHS Long Term Plan’ (Alderwick & Dixon, 2019) have pledged to expand access and 
referral to NICE-approved IAPT psychosocial  support services (counselling, CBT and 
psychoeducation) for adults with common mental health problems with a focus on long term 
conditions over the next five years. 
  
To conclude, recommendations exist in the literature to widen reductionist biological approaches 
to the management of hypothyroidism (despite clinical guidelines and behavioral interventions  
aiming to reduce personalised medical prescribing) and to incorporate new paradigms and ways of 
working to address reports of persistent symptoms and impaired quality of life in a subgroup of up 
to 15% of hypothyroid patients (see section 2.2. ‘complexity and Persistent Symptoms’).   
 
What is apparent from reviewing the history of clinical treatments for hypothyroidism, however, is 
that little progress seems to have been made in the development of non-biological approaches to 
support patients to manage or improve the symptoms of their condition. 
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2.5 Systematic review: Do psychosocial interventions improve wellbeing and quality of life in 
adult patients with thyroid diseases? 
 
In response to the findings in the previous section, a systematic review of the wider literature was 
conducted (Griffiths, 2017), and submitted as part of the current doctoral programme, to examine 
the existence and efficacy of psychosocial support to address reports of persistent biopsychosocial 
symptoms by patients with hypothyroidism. 
 
The initial search of the literature was expanded beyond studies of patients with hypothyroidism 
to include patients with all thyroid diseases. This was to develop as wide an understanding of the 
available supportive interventions as possible. Secondly, it also aimed to capture interventions for 
thyroid conditions for which the treatment may result in hypothyroidism (for example Graves 
autoimmune thyroid overactivity, or thyroid cancer).  
 
All psychosocial interventions were considered relevant within the scope of this review, and ‘self-
management’ was included as a search term. However, the broad definition of ‘psychosocial 
intervention’ meant that it was difficult to ensure that finite definitions of psychosocial support 
were captured in the search strategy (described in Appendix L: ‘Supporting information from 
systematic review’). This was compounded by the lack of evidence of guidance regarding the 
psychosocial concerns of patients with hypothyroidism in the clinical guidelines (e.g. NICE, 2019) 
and due to an absence of the management of hypothyroidism in the psychology literature.   
 
The British Psychological Society (Guss et al, 2014) define ‘psychosocial interventions’ as a broad 
term used to describe ways to support people to overcome challenges and maintain good mental 
health which may include: adjustment to diagnosis, provision of general and specialist information, 
support with mood, quality of life, maintaining independence, communicating with others, 
maintaining relationships and planning for the future. The techniques involved in providing 
psychosocial support are many and varied and are tailored towards specific issues. These may 
include; targeting psychological symptoms, attitudes toward disease, risk behaviour, or social 
isolation (Deter, 2012) and addressing the condition-specific needs of patient groups based on 
findings from targeted research. For example, in the early stages of dementia, the recommended 
psychosocial interventions include cognitive behaviour therapy, counselling and psychotherapy, 
arts therapies, occupational therapy, family therapy, peer support groups, telephone support, 
stress and anxiety management, occupational therapy, and trauma therapy (Guss et al, 2014) as 
well as psycho-educational therapy for caregivers (e.g. Elvish et al 2013).  
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To overcome the issues regarding lack of clarity regarding the psychosocial concerns and potential 
interventions for patients with thyroid diseases, the search strategy for this review was adapted 
from a similar novel systematic review (Walklet et al, 2016) examining whether psychosocial 
interventions improve quality of life and wellbeing in adults with neuromuscular disorders. After 
identification of this paper, the author was contacted for discussion and the search strategy was 
adapted. For the present review, the terms ‘multidisciplinary’, ‘nutritional’, ‘exercise’ and ‘pacing’ 
were also added to further capture potentially relevant interventions (see Appendix L ‘Supporting 
information from systematic review’) for an overview of the inclusion and exclusion criteria, search 
strategy and list of databases searched).   
 
Despite recommendations in the literature for supportive interventions for patients living with 
hypothyroidism (see section 2.8. ‘Reviewing the psychosocial and self-management support needs 
of patients with hypothyroidism’), the systematic review found that only 8 studies met the eligibility 
criteria for inclusion as a psychosocial intervention for people living with a range of thyroid 
conditions, although the study was limited to English language articles. Additional interventions 
promoting specific nutritional protocols and supplements were considered outside of the scope of 
this review and were therefore excluded.  
Included studies explored condition-specific education including leaflets (Crilly & Esmail, 2005; 
Lincoln et al, 2000); group information sessions (Alsaffar et al, 2016),  mind-body interventions 
alongside traditional pharmacological therapy including Neuro-linguistic technique (Bablis & 
Pollard, 2009) and Neuro-emotional technique (Brown et al, 2015), graded exercise  (Cotovic et al, 
2012; Garces-Ateaga et al, 2013) and yoga (Singh, 2011). Most studies were of weak to moderate 
quality, whilst two higher quality studies found no significant effects of information (a leaflet; Crilly 
& Esmail, 2006) and a mind-body technique (neuro-linguistic technique; Bablis & Pollard, 2009). 
 
It was found that, so far, interventions developed in the UK for patients with thyroid disorders have 
been informational/educational and have focused on brief, paper-based interventions (i.e. ‘a leaflet 
to address thyroxine adherence’; Crilly & Esmail, 2005;  or ‘a leaflet versus single education session 
about thyrotoxicosis’; Lincoln et al, 2000).  These have demonstrated no treatment effect; 
potentially resulting from reducing participants to passive recipients of care and possibly due to 
their failure to explore the illness beliefs, and adherence-related thoughts and feelings, knowledge 
or existing self-management skills of the target patient group.  
 
The systematic review therefore concluded that more research is required is required to improve 
the quality of interventions for this patient group and to increase access to evidence-based support 
which moves beyond the treatment of patients as passive participants in their care. This contrasts 
20 
 
with many other long-term conditions where self-management support promotes the role of 
patients as partners in the care process, for example; arthritis (Lorig, 1982; Lorig & Holman 2003;  
McBain et al, 2018), chronic pain (Tregar, 2014), CFS/ME (Castell et al, 2011; Núñez et al, 2011), 
rheumatology (Dures et al 2016a), and cancer (Polley et al, 2016).  
 
One key omission from this review was that studies focusing on supporting or changing the 
behaviour of health professionals (including trainees) or other participant groups (e.g. caregivers 
and significant others) to address the needs of patients with thyroid diseases were considered out 
of the scope of inclusion. Incidentally, two studies that aimed to change the behaviour of medical 
professionals were found in the literature. One aimed to improve consultants’ knowledge of a rare 
type of thyroid cancer by trialling an online sharing platform (Moss, 2010). The other aimed to 
reduce the amount of blood tests used for the detection of thyroid disease (which were described 
as costly and unnecessary), in line with reviewed US guidelines (Daucourt et al, 2003).  This was 
directly in contrast with patient-centred research and calls from some clinicians to widen the scope 
of reductionist testing and treatment approaches (Toft, 2017; BTF evidence dossier, 2018) and calls 
to increase access to testing to translate patients’ internal experiences into tangible explanations 
and diagnoses (e.g. Nexø et al, 2015a).  No other studies in this area were identified during the 
course of the systematic review.  
 
The present study was therefore developed to address this balance and move the focus of 
investigation towards Endocrinologists’ views about the needs of patients with hypothyroidism 
reported  in the literature and about the apparent gap in intervention provision to improve the 
physical, psychological and social health outcomes of this patient group.  
 
2.6. Examining clinicians’ attitudes, beliefs and intentions towards self-management and 
psychosocial care  
 
For over 30 years, health psychologists have examined the role of patients’ and doctors’ knowledge 
and beliefs about their preference of treatment options, and the impact of these upon health 
outcomes. For example, in Endocrinology, beliefs about self-care have been highlighted as an 
important influence upon metabolic control in patients with diabetes since the 1990s (Bradley, 
1990).  
 
Health professionals’ beliefs about psychosocial and self-management support have been found to 
directly influence health outcomes in patients with persistent symptoms and emotional distress. 
For example, in a study of 4,020 patients with cancer it was found that only 29% of patients who 
were identified by their doctor as ‘psychologically burdened’ were referred to psycho-oncology 
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services for supportive care (Ernst et al, 2018). Similarly, whilst psychological distress attributed to 
persistent fatigue and pain is reported as commonplace amongst rheumatology patients, less than 
a quarter of patients reported being asked about social and emotional issues despite looking to 
rheumatology teams for validation and support (Dures et al, 2017).  
 
A survey of 886 patients and 117 health care professionals in the UK found that only 15% of patients 
with inflammatory arthritis had attended a structured self-management support programme. In 
this survey, health care professionals reported beliefs that they were embedding elements of self‐
management support into consultations, but their patients did not agree, indicating significant 
disparities between doctor and patient beliefs about the delivery of elements of self‐management 
support in routine care (McBain et al, 2018).  
 
Ernst et al, (2018), suggest that a combination of patient beliefs (that they should receive 
psychological support from their doctor rather than a psychologist) doctor beliefs (underestimation 
of the extent of patients’ psychological burden) and the consultation structure (lack of time for 
patients to express their psychological concerns) may act as barriers to referral to psychosocial 
care.  
 
Further research into attitudes and beliefs about self-management support for patients with long 
term conditions (Anderson & Ozakinci, 2019) using the Theory of Planned Behaviour (Ajzen, 1991; 
2002) found that specific beliefs (social norms and perceived control) were more instrumental in 
shaping health professionals’ intentions to implement self-management models of care than the 
personal attitudes of the individual clinicians towards self-management. Healthcare professionals 
were less likely to implement supported self-management if they did not believe that ‘important 
others’ (patients and senior figures) were on-board with the model of care. Wider beliefs about 
cultural and organisational barriers (perceptions about level of control to implement the model) 
were also identified, demonstrating contextual mediators between attitudes and behaviours. This 
study concluded that addressing the social and control beliefs of healthcare professionals may be 
key to improving intention to implement evidence-based models of care (Anderson & Ozakinci, 
2019).  
 
A separate study which explored these issues with rheumatology clinicians showed that clinicians 
cited perceived barriers to psychosocial and self-management models of care to include: a lack of 
time in clinic; difficulties changing the existing pattern and focus of interaction; and concerns about 
exploring social and emotional aspects of living with arthritis. Perceived facilitators included: 
training that balances theory with time to practice skills and receive feedback; access to clinical 
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supervision to gain confidence and develop more advanced techniques; and the perception that 
patients gain a greater sense of control and are better able to take responsibility for their 
treatment, as a consequence of a more collaborative consultation (Dures et al, 2014a).  
 
In response, research which has developed and tested training for rheumatology clinicians to use a 
range of self-management skills (i.e. basic cognitive-behavioural skills and techniques to facilitate a 
collaborative interaction) found that clinicians were able to learn and implement new approaches 
to varying extents, and reported the belief that cognitive behavioural and communication skills to 
facilitate self-management enhanced their practice (Dures et al, 2014b). Additional studies have 
found that when embedded self-management support does occur, it is a significant predictor of 
patients' knowledge, skills, and confidence to self-manage, as opposed to attendance at a 
structured programme (McBain et al, 2018). 
 
Specifically relating to the focus of this thesis, one study has explored the beliefs and behavioural 
components contributing to the management of hypothyroidism in primary care. This study (Dew 
et al, 2018) used the Theory of Planned Behaviour to examine primary care professionals’ attitudes, 
beliefs and behaviours regarding suboptimal thyroid hormone replacement (estimated to be 
between 31%-68% from studies cited).  This study reported dissonance between attitudes and 
beliefs versus behaviours of primary care clinicians (GPs, nurses and pharmacists), elicited during 
qualitative interviews.  
 
Clinicians’ attitudes towards hypothyroidism were that it is an easy condition to manage; and that 
blood tests (rather than reliance on non-specific clinical symptoms) should confirm diagnosis, and 
guide management.  However, despite clinician’s attitudes that hypothyroidism is easy to manage, 
uncertainty existed about the treatment of asymptomatic patients with borderline biochemical 
changes, and gaps in knowledge regarding medicine interactions were identified. Difficulties 
particularly arose for clinicians when patients found information online about treatments 
(combination LT4/LT3 therapy or natural desiccated thyroid extracts/NTD) which did not fit with 
current clinical guidelines. This was problematic because clinicians attributed professional control 
to local guidelines rather than to clinician autonomy or patient reported outcomes. Only one doctor 
reported treating one patient in response to an autonomous patient-doctor agreement. Clinicians 
reported positive attitudes towards to personalised approaches to care, so long as treatment 
remained within normal population reference ranges.  
 
These findings are congruent with arguments found in the literature that dependence upon 
reductionist diagnostic tests and rigid clinical guidelines which negate hypothyroid patients’ reports 
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of unresolved symptoms (National Voices 2017) diminish the willingness of GPs and 
Endocrinologists to explore and address the needs of those patients who present outside of the 
‘norm’ (Toft, 2017; see section 2.4. ‘The history of treatment for hypothyroidism’). 
 
The findings of Dew et al (2018) reflect other findings in the published literature of clinician’s 
attitudes towards self-managing patients. Here varied views have been reported regarding the roles 
that patients should take in their own care. Broadly, clinicians report being more likely to support 
patients’ treatment choices, and to endorse healthful changes in accordance with clinical advice. 
However, clinicians report finding psychosocial and self-management models to be more 
problematic when they consist of patients making independent judgements or independently 
seeking information that may contradict clinical advice (e.g. NHS England, 2015). No studies yet 
exist to explore these findings in regard to patients with thyroid conditions.  
 
2.7. Defining psychosocial and self-management support  
 
The current study explores Endocrinologists’ views and experiences of psychosocial and self-
management models of support and their potential utility (including perceived barriers and 
facilitators) for hypothyroid patients referred to secondary care. It also examines whether 
Endocrinologists currently incorporate elements of psychosocial and self-management care into 
their practice or refer their patients to support services currently unevaluated for their impact on 
the physical, psychological and social health outcomes of patients living with hypothyroidism. 
 
In this research, psychosocial support is considered an applicable area of focus because 
psychosocial models of care are utilised when a situation or health condition impacts the inner 
world of a person (i.e. their thoughts, feelings, and emotions) as well as the external world and 
environment of the person and the relationships they have with this (UNICEF, 2008). The definition 
of psychosocial support used in the context of this thesis is provided in section 2.5 (‘Systematic 
review: Do psychosocial interventions improve wellbeing and quality of life in adult patients with 
thyroid diseases?’). In section 2.8. (‘Reviewing the psychosocial and self-management support 
needs of patients with hypothyroidism’), the need for psychosocial support for hypothyroid 
patients is presented.  
 
Psychosocial models of care address the psychological and social difficulties and community-
identified needs of individuals, their partners, families and caregivers (World Health Organisation). 
They help people to adapt, cope better with distress and suffering and become reconciled to 
everyday life (International Federation of Red Cross and Red Crescent Societies). Psychosocial 
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interventions include psychological therapies (e.g. cognitive behavioural therapy), psychoeducation 
and peer support which can be delivered to individuals or groups (Ruddy et al, 2005). Systematic 
reviews of the literature indicate that psychosocial interventions can improve quality of life and 
well-being in adults with long-term conditions (Rehse & Pukrop, 2003; Steed et al, 2003; Osborn et 
al, 2006).  
 
Self-management support has also been chosen as a focus of investigation due to the utility of the 
model of care to address the key challenges faced by patients when living with chronic illness. 
Definitions of self-management in the literature include; “the individual’s ability to manage the 
symptoms, treatment, physical and psychosocial consequences and lifestyle changes inherent in 
living with a chronic condition” (Barlow et al, 2002); “low intensity intervention that aims to 
encourage awareness of and active patient participation in chronic condition management, 
including physical symptom and emotional management” (NHS Education for Scotland 2014) and 
the development of ‘healthful behaviours’ through behavioural interventions (Lorig & Holman; 
2003). Self-management approaches have been recommended for health problems that last a year 
or longer, impact on a person’s life, and may require ongoing care and support (e.g. NHS Education 
for Scotland) and may therefore be suitable for patients treated for hypothyroidism, with persistent 
symptoms. Self-management support helps patients to develop the skills, knowledge and 
confidence to manage their health (NHS England, 2015).  
 
Research within the self-management paradigm (described in Lorig & Holman, 2003) has 
categorised three sets of challenges that patients face when adjusting to living with chronic illness: 
namely medical, emotional and role management challenges. Medical management refers to 
adjusting to taking medications and adhering to specific treatment regimen. Emotional 
management refers to work required to manage the emotions (e.g. fear and anger) experienced by 
someone with a chronic disease. Role management involves maintaining, changing, and creating 
new meaningful behaviours or life roles. However, traditional patient education and health 
promotion programs have mostly been found to address medical and behavioral issues.  
Research into self-management has identified core self-management skills—problem solving, 
decision making, resource utilisation, the formation of a patient–provider partnership, action 
planning, and self-tailoring (Lorig & Holman, 2003) and similarly, education, managing emotions, 
skills acquisition, self-monitoring, understanding illness, problem solving, goal setting, and action 
planning (Mulligan et al, 2009) as key to improving self-efficacy and helping patients to keep 
‘wellness’ in their foreground perspective (Lorig & Holman, 2003).  Approaches to the provision of 
self-management support include patient education, cognitive-behavioural approaches, health 
coaching, and peer support (NHS Scotland, 2014; NHS England, 2019a) and programmes which 
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incorporate efficiency-enhancing techniques including skills mastery, modeling, reinterpreting 
physiologic symptoms and social persuasion  (Lorig & Holman, 2003).     
Self-management care belongs to a community-focussed family of interventions known as ‘asset-
based health frameworks’ which adopt a different starting place to traditional medical models of 
care (see NESTA, 2020 for an overview). Asset-based frameworks are approaches which begin with 
identifying a community's capacities and encouraging it to help itself (Noble-Jones et al, 2019).  
They focus on patient-perceived problems (Corbin & Strauss, 1988; Lorig & Holman, 2003); foster 
and tap into the resources and capabilities of patients to enhance their health and wellbeing and 
promote resilience and independence (Finnis et al, 2016; Self-Management UK, 2017; Social Care 
Institute for Excellence, 2018). Asset-based frameworks including self-management care promote 
personalised care planning (Coulter et al 2013) which highlights the importance of a collaborative 
patient-provider partnership, combining professional expertise and lay (individual and community) 
experiential knowledge at the centre the creation of health (Von Korff et al, 2002).   
 
Evidence-based self-management programmes aim to activate or empower patients to increase 
their participation in chronic condition management, including physical symptom and emotional 
management and engagement in healthful behaviours (Lorig & Holman; 2003; NHS Education 
Scotland 2014). They have been associated with a reduction in health inequalities, delivery of 
improved outcomes, better quality care and lower costs (e.g. Hibbard & Gilbert 2014; Anderson & 
Ozaninci, 2019; Self-Management UK, 2017). Supported self-management (SSM) is  one of six key 
components of the ‘Personalised Care model’  presented in the NHS Long Term Plan (Alderwick & 
Dixon, 2019) which recommends that health and care professionals tailor their approaches to 
working with people, based on the person’s individual assets, needs and preferences, as well as 
taking account of any inequalities and accessibility barriers, and so working in a personalised way 
based on ‘what matters’ to the person (NHS England, 2019a).  
 
2.8. Reviewing the psychosocial and self-management support needs of patients with 
hypothyroidism 
 
During the literature searching described in this chapter, the need for psychosocial and self-
management support was identified for patients to manage the psychosocial aspects of living with 
hypothyroidism. This was initially described in terms of persistent physical, psychological, and 
cognitive symptoms, and ongoing social impacts in section 2.2. (‘Complexity and persistent 
symptoms’). However, no evidence base for the implementation of psychosocial or self-
management support for people with hypothyroidism was found (see section 2.3. ‘The 
Endocrinologists’ role’) and few interventions were found to exist (section 2.5. ‘Systematic review: 
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Do psychosocial interventions improve wellbeing and quality of life in adult patients with thyroid 
diseases?’). This section, therefore, provides a novel synthesis of recommendations highlighted in 
the literature. It serves to fill the gap left by the absence of pre-existing systematic reviews of 
literature in this area, and by the absence of recommendations to address the psychosocial 
concerns of this patient group in the clinical guidelines (see section 2.3. ‘The Endocrinologists’ 
Role’).  
 
Lorig et al, (2003) highlight that self-management support focuses upon on patient-identified 
concerns and problems, and whilst many concerns are shared across different diseases, behaviours, 
and populations, there are always differences between groups and individuals. They recommend a 
detailed needs assessment for each new topic and group of patients.  This section provides a needs 
assessment for patients with hypothyroidism. In addition, it is the first attempt in the literature to 
relate the needs of patients with hypothyroidism to the components of self-management support 
(Lorig & Holman, 2003, and Mulligan et al, 2009) used to address the challenges of living with  
chronic illness (see section 2.7. ‘Defining Psychosocial and self-management support’). 
 
The following section lists the support needs of patients with hypothyroidism and draws upon the 
components of self-management (Lorig et al, 2003 and Mulligan et al, 2009), to suggest possible 
approaches to meet these needs.  ‘Psychosocial support’ is contained within multiple components, 
for example in information and education, communication skills training and specifically within the 
emotional management component. The recommendations are grouped according to the needs 
found in the literature rather than to potential interventions. Therefore, some duplication exists 
where a specific component of self-management support may be applicable to address more than 
one identified need. The creation of this set of recommendations played a key role in shaping the 
interview topic guide used with participants as described in section 3.9. (‘Data collection. The 
Interview topic guide’). 
 
The literature derived from patients with hypothyroidism recommends that health outcomes may 
be improved if interventions aimed to:  
 
1. Increase patients’ knowledge and understanding of their condition and the consequences of 
suboptimal treatment or over-replacement of thyroid hormones (Brown et al, 2005; Dew et al, 
2017); and provide treatment information and education on issues relating to the impact of the 
disease and treatment on quality of life (Grogan et al, 2016; Banach et al, 2013). Relevant 
components of self-management support (Lorig et al, 2003 and Mulligan et al, 2009) may 
include provision of informational and educational interventions and training for patients to 
find and utilise a range of information and resources.  
27 
 
 
2. Provide psychological support (Perros et al, 2015), on-going listening and responsive 
approaches to treatment and access to counselling to address the impact of hypothyroidism 
(Kirby, 2010); address concerns associated with body image and changed appearance or 
disfigurement (Farid et al, 2005;  Wickwar et al, 2015); this should include support for the 
psychological aspects of weight changes (Kelderman-Bolk et al, 2015; Chaput et al, 2008), and 
cognitive and informational support to realistically manage patients’ expectations of treatment 
(e.g. surgical outcomes for thyroid eye disease associated with an overactive thyroid prior to 
treatment to become hypothyroid; Jenkinson & Wickwar, 2016). Relevant components of self-
management support (Lorig et al, 2003 and Mulligan et al, 2009) may centre around managing 
emotions. 
3. Support patients to cope with poor control over mental and physical states (Naxo et al, 2015); 
develop skills to recognise the ambiguous aspects and symptoms of the disease and understand 
illness symptoms (Banach et al, 2013); provide greater access to blood testing to understand 
and communicate and internal experiences (Naxo et al, 2014); provide continuity of care and 
accessible testing and prescriptions (Dew et al, 2018) referral to multidisciplinary teams to 
manage wide ranging symptoms (Estcourt et al, 2015); and a need for prospective trials using 
intervention strategies known to work in other conditions (Grogan et al, 2016). Relevant 
components of self-management support (Lorig et al, 2003 and Mulligan et al, 2009) may 
include acquiring new illness-related skills to self-monitor and self-manage effectively, and 
promoting understanding of hypothyroidism to support day to day decision making in response 
to changes in symptoms or test results.  
 
4. Develop communication strategies between patients and significant others: including 
addressing attitudes and communication styles of “unsympathetic” or “dismissive” doctors 
(Kalra & Khandewal; 2011) or significant others (Grogan et al, 2016); reducing cognitive 
dissonance in healthcare providers towards the management of hypothyroidism (Dew et al 
2018); support to manage the effects of increased reliance upon relationships with family and 
friends (Naxo et al 2014) and support to negotiate ongoing sickness with employers and co-
workers to reduce disproportionate income and pension losses (Thvilum et al, 2010). Relevant 
components of self-management support (Lorig et al, 2003 and Mulligan et al, 2009) may 
include developing patient–provider partnerships and supporting patients to be actively 
involved in solving problems. 
 
5. Support patients to make healthy behavioural changes to increase resilience and promote 
recovery, including yoga, graded physical activity which include goal setting and targeted 
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nutrition with support from qualified professionals (Singh, 2011; Cutovic et al, 2012; Garces-
Arteaga et al, 2013). Relevant components of self-management support (Lorig et al, 2003 and 
Mulligan et al, 2009) may include action planning to implement short term behavioural changes 
and self-tailoring (i.e. skills to apply knowledge and self-management skills to oneself as 
appropriate).  
 
Following the identification of persistent biological, psychological and social symptoms in some 
patients with hypothyroidism; and the identification of recommendations for the provision of 
psychosocial and self-management models of care, the aims and objectives for this research were 
developed.  
 
The aim of this research was to explore Endocrinologists’ views and experiences of psychosocial 
and self-management support for hypothyroid patients. Specifically, the objectives of this research 
were to; examine Endocrinologists’ views about the psychosocial and self-management support 
needs of hypothyroid patients; examine Endocrinologists’ experiences of providing psychosocial 
and self-management support within their own practice; examine whether Endocrinologists refer 
patients with hypothyroidism for additional psychosocial and self-management support (as of yet 
unreported in the literature); and to explore perceived barriers and facilitators to the 
implementation of psychosocial and self-management models of care. 
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Chapter 3: Methodology and Method 
 
This chapter describes the methodological framework through which this research was developed 
and provides the rationale for the use of the qualitative approach of reflexive thematic analysis. In 
the first part of this chapter, the aim, objectives, and design of this research are described in relation 
to issues regarding the trustworthiness and quality of qualitative research. In the second part of 
this chapter, a description of the method used to carry out this research is provided.  
 
Methodology  
3.1. Rationale for qualitative approach:  Development of researcher’s epistemological and 
theoretical stance 
 
This research adopted a critical realist ontology and qualitative techniques for data collection and 
analysis to explore the views and experiences of participant Endocrinologists.  Initially, this study 
was based on a systematic review and was built upon pragmatist worldviews and methodological 
assumptions that led to the inclusion of quantitative data and analysis in the research design. 
Subsequently, through the development and testing phases of this thesis, the basic assumptions on 
which the research was built were brought into question, leading to a change towards a Big Q, 
qualitative design (Kidder & Fine, 1987). Big Q qualitative research involves working up from the 
data in an inductive way rather than working deductively within pre-existing theoretical 
frameworks (Braun & Clarke, 2016).  
 
This research began with an assumption that the models of care featured in this research (i.e. 
psychosocial and self-management) would be understood, accepted and valued by Endocrinologists 
given the inclusion of supported self-management, particularly of long term conditions, in the NHS 
Long Term Plan (Alderwick & Dixon, 2019). It was formerly a cross sectional, mixed methods study 
with an explanatory sequential design (Wisdom & Creswell, 2013). To meet the research objectives, 
a survey was designed to question Endocrinologists about their attitudes and practices, followed 
by qualitative interviews with a smaller subset of Endocrinologists to provide additional contextual 
insights and experiential accounts.  
 
The original survey required Endocrinologists to complete the ‘Clinician PAM’ (CS-PAM), a validated 
tool which asks questions about clinician attitudes towards the active role of patients in the care 
process (Hibbard et al, 2010) alongside bespoke condition-specific questions as developed in similar 
studies with a quantitative approach (e.g. McBain et al, 2018). The CS-PAM is known to be a 
valuable positivist tool for deriving a ‘score’ or a ‘level’ of strength of endorsement of patient self-
management, and for identifying differences between clinician groups (Rademakers et al, 2015). It 
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also has utility in assessing pre- and post- scores of beliefs regarding the importance of patient 
knowledge and involvement, for example before and following an intervention targeting clinicians 
(NHS England, 2015). 
 
However, in the early stages of research development, The British Thyroid Foundation (a patient-
led thyroid charity) and three Endocrinologists were included as Patient and Public Involvement 
(PPI) contributors’ (Locock et al, 2017)  in the design and testing process. This aimed to help to 
decide which questions were important to be researched as recommended in good practice 
guidelines (e.g. National Institute for Health Research, 2019). One Endocrinologist rejected the 
topic of self-management as unimportant for patients with hypothyroidism and withdrew from the 
process (discussed in Chapter 5.5. ‘Strengths and limitations’). A second suggested a consultancy 
project within their department to adopt a collaborative multidisciplinary approach to ‘shine a light’ 
of the topic to be explored thus demonstrating the importance of the topic to them (discussed in 
section ‘1.2. Research Origins’). A third Endocrinologist highlighted difficulty understanding the 
terminology relating to ‘self-management’ and suggested that their colleagues were also likely to 
struggle with the semantics used from a predominantly health psychology paradigm, particularly in 
the context of hypothyroidism.  
  
After receiving three different responses to the project and the feedback from the third contributor, 
it became apparent that terminology intrinsic to asset-based models of care such as ‘psychosocial’ 
and ‘self-management’ support (e.g. Coulter et al, 2013; NHS England, 2014) were not congruent 
with the semantics and philosophical scientific worldview of participants trained within a medical 
model of care (Lang, 1981). The medical focus upon ‘clinical management’ rather than ‘self-
management’ priorities for patients with hypothyroidism highlights a mismatch between multi-
disciplinary models of health (Davey-Smith et al, 2001).  
 
Communication theory (Lasswell, 1948) proposes that information is transferred via an assumed 
process of shared meaning and a set of common rules and understandings. The assumption of one 
version of reality or knowledge (Braun & Clarke 2013), on which the original research design was 
developed was challenged during the development stage and was subsequently rejected as 
presumptive, prompting a shift away from a realist evaluation of truth towards a qualitative 
examination of knowledge and meaning making.  
 
Additional PPI activity in the form of collaborative consultation was carried out to immerse the 
researcher in the context of participants (see section 3.9. ‘Data collection’ for an overview). As a 
result, additional issues and debates in the field of Endocrinology were identified as salient to 
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participants that were not captured by the initial literature search (which focused primarily on the 
needs of patients). This prompted further literature searching to understand the history and 
debates regarding the treatment of hypothyroidism (described in Chapter 2, section 2.4.; The 
history of treatment for hypothyroidism’). As a result of this additional searching, it became 
apparent that no evidence base or recommendations in the clinical guidelines exist to support 
healthcare professionals to manage the psychosocial concerns of patients with hypothyroidism (see 
section 2.3. ‘The Endocrinologists’ Role’). This new knowledge led to the rejection of the use of pre-
existing quantitative tools and of the inclusion of health psychology models in favour of a qualitative 
research epistemology and design to enable issues of interest and importance to this participant 
group be explored.  
 
Existing research with a similar focus to the current thesis have utilised health psychology models 
to understand or predict patient and clinician behaviour and to further understand the factors 
influencing the management of hypothyroidism. For example, Dew et al (2017) examined patients’ 
beliefs about the treatment of hypothyroidism in general practice. This study used the Health Belief 
Model (HBM; Rosenstock, 1974) to deductively drive the analysis their qualitative data. Using the 
HBM, Dew et al (2017) generated themes about the beliefs of patients with hypothyroidism, 
relating to their ability and readiness to influence the control of their disease. The HBM was 
developed to examine patient health perceptions and behaviours (e.g. to inform interventions) 
rather than clinician views and intentions towards their patients and therefore had no rationale for 
inclusion in the present study.  In a second study, however, Dew et al, (2018) used the Theory of 
Planned Behaviour (TPB; Ajzen, 1991, 2002) to map themes from coded interview data to identify 
the beliefs of primary care health professionals that mediate between an attitude (i.e. that 
hypothyroidism is relatively easy to manage according to clinical guidelines), and the translation of 
that attitude into intended behaviour (e.g. lack of knowledge or time). However, a key limitation of 
the TPB (e.g. Taylor et al, 2006) is that it assumes that behavioural intentions are precursors to 
behaviours. In the current thesis however, the starting point was a lack of definition of intended 
behaviour (i.e. shared understanding of self-management in the context of hypothyroidism or 
existing clinical guidelines towards the management of the psychosocial concerns of patients with 
hypothyroidism) leading to the decision that an initial exploratory approach to the problem was 
required.  
 
In another similar study within endocrinology, McBain et al (2016) used the Theoretical Domains 
Framework (TDF; Atkins et al, 2017) to deductively code qualitative interview data regarding the 
barriers and facilitators healthcare professionals experience when implementing type 2 diabetes 
management guidelines in people with severe mental illness. The TDF was developed from theories 
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relating to behaviour change and implementation science (Michie et al, 2011), from which specific 
constructs were identified and grouped into domains. The development of the framework aimed 
to provide a theory-informed approach to identifying determinants of behaviour and was initially 
developed to identify influences on health professional behaviour relating to implementation of 
evidence-based recommendations (Atkins et al, 2017). Similarly, in the absence of evidence-based 
recommendations in this area, the decision was made to move away from deductive theory-led 
models in favour of an inductive, participant-led approach to capture the ways that 
Endocrinologists view, experience and attribute meaning about this patient group and the potential 
treatment approaches.  
 
This study adopted a critical realist ontology, which proposes a pre-social reality that we can only 
ever partially know through the accounts of social players (Neufield, 1994) and a contextualist 
epistemology which proposes that ‘knowledge’ is socially and contextually influenced (Madill et al, 
2000). This lens was chosen  to encourage Endocrinologists to tell their own stories; and to 
communicate the issues that were important to them, using their own language, knowledge, 
semantics, beliefs, and priorities; as well as to simultaneously examine the issues of interest to the 
researcher. Participants’ views and experiences and perceptions of the perceived barriers and 
facilitators to psychosocial and self-management support were explored, as well as the broader 
social contexts that shape them (e.g. Willig, 1999).  
 
3.2. Quality issues in qualitative research 
Qualitative research has been described as a diverse field encompassing a variety of 
epistemological and ontological standpoints, often representing different procedures and 
standards and embracing different methodologies and epistemologies (Yardley, 2000). Establishing 
the quality and trustworthiness of qualitative research requires the awareness and 
acknowledgement of error (Oakley, 2000; Meyrick, 2006), and a recognition that representations 
of ‘truth and knowledge’ are shaped by the purposes, subjective and cultural perspectives, and 
conversations and activities inherent within research activity (Yardley, 1997). Assuring quality and 
trustworthiness in qualitative research requires consideration of the  validity and utility of research 
for a certain purpose, particular situation and special community of people, as opposed to emphasis 
upon objectivity, reliability, and generalisability inherent to quality frameworks of positivist 
methodology  (Yardley, 2000). 
 
This research was conducted with awareness of good practice recommendations for quality and 
trustworthiness, rigour, and value within qualitative research (Yardley 2000; Meyrick, 2006). These 
principles acknowledge and analyse recognise the influence of the researcher in the production of 
33 
 
knowledge (e.g. their influence upon the research findings), and the influence of participants in the 
development of the topic and data (e.g. through PPI or the  use of open-ended questions interview 
questions) (Yardley, 2015). 
 
Good practice recommendations (Yardley 2000; Meyrick, 2006) begin in the earliest stages of the 
research process, beginning with engagement with pre-existing knowledge relevant to the enquiry 
(in the present study, in the form of literature searching, PPI to include participants and key authors 
in the field and consultancy); to formulating a research question; the selection of appropriate 
methods (which recognise researcher epistemological and theoretical stance) and sampling 
approaches; the choice of appropriate tools for data collection and analysis; and the interpretation 
of findings and presentation of results and conclusions, in which value judgements and 
considerations about the breadth of application and practical utility are made. Yardley (1997; 2015) 
outlines four broad principles for assessing quality in qualitative research which govern the present 
study: sensitivity to context; commitment and rigour; transparency and coherence, and impact and 
importance.  
 
Sensitivity to context  
This research draws upon extensive engagement with theory and previous literature. This includes 
a systematic review and additional literature searching following a collaborative consultancy 
project to fully immerse the researcher into the practice and socio-political context of participants. 
Additional PPI activity including involvement of two Endocrinologists and expert patients from the 
British Thyroid Foundation was conducted to involve them in shaping the methodological approach 
and tools for data collection, to ensure that their values and experiences were included. 
Engagement with authors who have analysed similar topics was also carried out to understand 
existing philosophical approaches, perspectives, models, and tools and to shape choices made 
about approaches used in this study. For example, contact was maintained with authors of key 
papers included in Chapter 2 ‘Introduction and background literature’ (e.g. Dures et al 2014; McBain 
et al, 2018; Dew et al 2018) to achieve ‘vertical generalisation’ (Johnson, 1997), a term used to 
describe the usefulness of the insights gained from the resent research to other contexts with 
similarities (Yardley, 2015).  
 
Commitment and rigour 
This research addresses rigour through attention to sample selection and recruitment, to gain 
unique insights into the views and experiences of the target group. Prolonged engagement with the 
topic was carried out through literature searching and PPI activities (described above) through 
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which the development of the methodological approach was developed (see section 3.2. Rationale 
for qualitative approach: Development of researcher’s epistemological and theoretical stance’). 
This in turn, shaped decisions made about the appropriate tools for sampling, data collection and 
analysis (see section 3 ‘Methodology and Method’) to be selected and studied for use with 
competence.  
 
Transparency and coherence  
The coherence of a study relates to the extent to which it makes sense as a consistent whole, and 
the openness and transparency of the influences which have developed and shaped it (Yardley, 
2015). This research openly describes features that may have influenced the data or interpretations 
(including the rationale for the study in Chapter 1; ‘Aim, objectives and rationale) and researcher 
positionality as a reflexive analysis of how these features could have influenced the conclusions 
reached (see section 3.12. ‘researcher positionality’). 
 
During the data coding phase, reflexive excerpts regarding the researcher’s reactions to and 
assumptions of the data were included; and these are made available in appendix F.  As coding of 
the data was carried out, these were discussed in repeated meetings with the research supervisory 
team to identify themes in data and modify codes to create coherence and consistency.  
 
During the analysis phase, awareness of the assumptions and interests brought by the researcher 
were addressed through inclusion of  ‘disconfirming cases’  (Yardley 2015); this involves seeking 
deviant patterns or cases which do not fit with developing themes to present all the data, not just 
those that fit with researcher interest or viewpoint. Following analysis, a conversation was held via 
telephone to ask one participant for feedback (Silverman, 1993), check for meaning and 
importance, and to check whether findings accurately reflect the wider discourse within 
endocrinology. This was only carried out with one participant due to time constraints (of both the 
researcher and due to the busy schedules of this participant group).   
 
A paper trail linking the raw data to the final report is included in appendix F-K to ensure 
transparency of how the interpretation was derived from the data (Flick 1998, in Yardley 2015, 
p.264). 
   
Impact and importance:  
Evidence of impact is often interpreted as a key indicator of worthwhile research (Yardley, 2015). 
The aim of this research was to explore the ways that Endocrinologists perceive and experience 
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psychosocial and self-management support with regard to patients with hypothyroidism. The 
theoretical and practical implications for this research are addressed in section 5.6. (‘Implications 
for research and practice, and the role for Health Psychology’). This research aimed to elicit 
accounts from a group of clinicians, currently under researched in the literature and to generate 
useful knowledge and important contribution to the wider research conversation about 
psychosocial and self-management support.  
 
 
 3.3.  Selecting thematic analysis as an analytic tool for qualitative data 
 
Thematic analysis was selected in this research as the preferred method with which to interrogate 
verbal data and to identify and describe patterns of shared meaning across the data set (Braun & 
Clarke, 2019a).   
Different approaches to thematic analysis exist throughout the literature. For example, ‘coding 
reliability’ approaches (e.g. Boyatzis 1998) are set within a positivist research philosophy but collect 
and analyse qualitative data, whilst ‘codebook’ approaches to thematic analysis are arguably 
located in a qualitative philosophy but retain some of the structure of the positivist approaches 
(Ritchie and Spencer, 1994; King and Brooks, 2017; Braun & Clarke, 2019a).    
The approach selected in this thesis, reflexive thematic analysis,  is specifically located within a 
qualitative paradigm that centres researcher reflexivity (Braun and Clarke, 2019b). It was chosen as 
the appropriate approach following the journey of paradigm change, and growing awareness of 
differences in values, attributions of importance, and identifying health models between the 
researcher and participants (as described in section 3.2. ‘Rationale for qualitative approach:  
Development of researcher’s epistemological and theoretical stance’), and because research 
exploring Endocrinologists’ views about psychosocial and self-management support for patients 
with hypothyroidism is currently unresearched. Reflective thematic analysis was chosen to enable 
generation of participants’ own stories and paradigms which may not have been previously defined 
by the researcher.  
The flexibility of reflexive thematic analysis to be applied in a descriptive and exploratory way made 
it a suitable choice to meet the aim of  giving a voice (Braun & Clarke 2013) to Endocrinologists 
whom we know little about with regards to this topic area. An experiential variation of reflexive 
thematic analysis (Braun & Clarke, 2013, p.175) was selected based on the ontological assumption 
of a partially  ‘knowable’ world in a way which assumes language to represent the reality of the 
participant (Braun & Clarke 2012). This approach has utility to make actionable recommendations 
of use to practitioners, policy makers, or patients to create impact and importance (Yardley, 2015) 
and to achieve practical, real-world change (Rogers & Rogers, 1997; Yardley 2015). One example 
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from a study with a similar focus was the development and evaluation of a training programme to 
enhance self-management support skills amongst Rheumatology clinicians (Dures et al, 2014b).   
Reflexive thematic analysis was selected over alternative qualitative analytical approaches such as 
grounded theory (Strauss and Corbin, 1998) which is also theoretically flexible, and used within 
different frameworks to answer the different types of research objectives presented in this research 
thesis. Grounded theory was used by Dew et al (2018) with the Theory of Planned Behaviour (TPB) 
to organise themes regarding primary care health professionals’ attitudes and intentions towards 
the treatment of hypothyroidism. However, grounded theory has greater utility to create theory 
about a phenomenon, rather than to generate experiential accounts (Braun & Clarke 2013, p.176) 
as defined as the primary aim of this research.  
Whilst there is a strong online patient voice regarding the causes, symptoms of hypothyroidism and 
preferred treatments, little is known about the views and experiences of those who treat them 
from their own perspectives (as considered in Chapter 2 ‘Introduction and background literature’). 
This research provides an opportunity to examine the views and experiences of Endocrinologists in 
a way that values how they experience and make sense of the world (Braun & Clarke 2013). 
 
Method  
 
3.4.  Design 
This thesis adopted a Big Q, qualitative research paradigm to explore the beliefs, experiences, and 
practices of participants (e.g. Kuhn, 1962; Kidder and Fine, 1987). 
Participants were recruited to participate in semi-structured telephone interviews of 30-45 minutes 
duration.  
Reflexive thematic analysis (Braun & Clarke, 2019a) was used for data analysis, employing an 
experiential orientation (Reicher, 2000). Verbal data was interrogated semantically (descriptively) 
to summarise the data.  
 
3.5.  Ethical approval and conduct 
Full ethical approval for this study was granted by the University of the West of England (UWE) 
ethics committee (UWE REC REF No: HAS.18.10.038) following satisfaction of all conditions relating 
to ‘ethical conduct of research involving human participants’.  
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Further updates and training were provided through the UWE ‘information security toolkit’ as part 
of the Professional Doctorate in Health Psychology ‘Professional Skills’ module to ensure that the 
research remained in accordance with the updated ‘General Data Protection Regulation’ (GDPR) 
which replaced the  ‘Data Protection Act’ (DPA) as the law governing the processing of personal 
data on n 25 May 2018.  
3.6. Sampling and participants 
Participants were 18 Consultant Endocrinologists (3 females, 15 males) from the United Kingdom 
with experience in the treatment of patients with hypothyroidism with persistent symptoms.  
  
A snowballing sampling technique was used to approach Endocrinologists to take part in semi-
structured interviews. To initiate this, the British Thyroid Foundation were approached to 
recommend one Endocrinologist. In turn, they were asked to contact and invite two more and to 
pass on the researcher’s contact details. Following initial contact from those who wanted to take 
part (or after permission was given to contact potential interviewees by previous interviewees), 
potential participants were emailed an information sheet and consent form (included in appendix 
B and C).   
 
During this process, one female Endocrinologist declined to take part (giving ‘being too busy’ as the 
reason), and two additional male Endocrinologists did not respond to the invitation to take part 
from their colleague. Another participant agreed to take part but was unable to schedule an 
interview due to time constraints. Through this method, the intended sample size of between 6-15 
interviews to provide sufficient data for a UK professional doctorate project using thematic analysis 
(Braun & Clarke 2013, adapted in Terry et al, 2017) was exceeded. By the 18th interview, being 
guided by the principle of data saturation, it was judged by the researcher and supervisory team 
that no new data was being generated by participants’ accounts. A paper trial of data coding and 
theme generation can be found in appendix F-K. 
 
Interviews were restricted to English-speaking participants.  However, this did not skew results as 
this research is specific to the views and experiences of Endocrinologists in the UK who are expected 
to communicate with patients in English.  
 
3.7. Information and consent 
Potential participants emailed their intention to take part in response to contact through the 
snowball sampling process. At this point, an information sheet and consent form were sent and 
returned prior to the interview (a copy of these is included in appendix B and C).  Potential 
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participants were informed of the ways in which their data would be used and were directed to a 
contact at UWE for complaints about the research. Potential interview participants were reassured 
that no personal identifiers would be used in the reporting of this research. The interview phase 
involved the collection of names and personal data (i.e. gender, email address and employing 
hospital). However, in the data transcription and coding phase, participants were labelled ‘Doctor 
A’, etc. In the reporting phase, any identifying details (including place of work, or reference to 
publications) were omitted to protect anonymity.   
 
Interview participants were informed on the information sheet that they could withdraw from the 
qualitative study without giving a reason. This was also reiterated in the debrief sheet (included in 
appendix E). Participants were informed that they could withdraw up to two weeks after the 
interview to allow suitable time to ask for further information or questions on the research after 
receiving the debrief. 
 
The data gathered were participant consent forms (paper copies gathered before the interviews), 
and audio recordings of the interviews which were transcribed. Interviews were recorded using a 
digital audio recorder and electronically transcribed using Microsoft Word 10 (.docx). The audio 
recordings were password protected by folder and stored on a password protected UWE drive. 
Once the interviews were transcribed, the Microsoft Word documents were also stored on the 
secure UWE drive.  
 
Paper consent forms were stored in a locked filing cabinet. Hard copies of the anonymised interview 
transcripts were also kept in a locked filing cabinet as a backup of the data but kept separately from 
the consent forms to ensure anonymity. No data was taken out to avoid theft or accidental loss. 
Audio recordings were only accessible to, and transcribed by the doctoral researcher, using 
headphones to avoid anyone else listening. The consent forms and interview transcripts were only 
accessible to the doctoral researcher via access to the locked filing cabinet. No participants 
requested to be withdrawn from the study, but participants were informed that if they wished to 
withdraw within the two weeks, the audio file would be immediately deleted without being 
transcribed. Once all the interviews had been transcribed, the remaining audio files were deleted 
after 3 weeks. Data will be kept securely on the UWE hard drive, and hard copies of consent forms 
and anonymised interview transcripts will be kept securely for 5 years. After this point, they will be 
securely disposed of in accordance with the UWE waste management policy in line with the UWE 
data management policy.  
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3.8. Minimising participant risk  
It was not expected that any risk to participants would occur because of this research, as 
participants were not patients nor a vulnerable group. No deception was involved in this research 
and participants were fully informed of the research aims. Participants were informed of how to 
contact the UWE ethics department if they had any complaints about the research. Contact details 
of a named person at the ‘British Thyroid Foundation’ (BTF) was supplied in case any issues relating 
to practice arose during the research. The BTF were aware of the content of the research and this 
role in it.  To minimise economical risks to participants, telephone interviews were deemed to be 
the most likely option to save time for the qualitative part of this research.  
 
3.9. Data collection  
The Interview topic guide 
A semi-structured topic guide was developed for data collection (see appendix D). This was created 
from the existing literature (see Chapter 2 ‘Introduction and background literature’ for an overview) 
identifying the support needs of hypothyroid patients, and complexities surrounding the treatment 
of persistent symptoms of hypothyroidism; as well as from the components of self-management 
(Lorig et al, 2003; and Mulligan et al, 2009, also used by McBain et al; 2018) also described in 
Chapter 2 (section 2.8. Reviewing the psychosocial and self-management support needs of patients 
with hypothyroidism).  
 
During the design and testing phase, as the epistemological and ontological position developed, 
wider open-ended questions were included to explore participants’ thoughts about the history of 
the treatment for hypothyroidism (see Chapter 2; section 2.4. The history of treatment for 
hypothyroidism). This reflected the developing awareness of the researcher of the practice and 
socio-political contexts of participants gained through engagement with collaborative consultation 
PPI activity (described in sections 3.2 ‘Rationale for qualitative approach’ and 5.5 ‘Strengths and 
limitations’). It also reflected a growing awareness of semantic differences between medical and 
researcher paradigms gained through PPI activity, as discussed in section 3.1. (‘Rationale for 
qualitative approach).    
 
Questions in the topic guide were structured to elicit descriptions of clinical practice, as well as to 
include specific questions about the components of psychosocial and self-management (for 
example about helping patients to manage the emotional aspects of their condition and about 
meeting the informational and educational needs of patients) and also to enable participants to 
talk about the topic area using language from their own medical paradigm. The questionnaire 
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schedule was therefore designed to be open ended and flexible enough to follow information 
salient to both the researcher and participants. The final question asked participants for any 
additional points they would like to add.   
 
In order to review the qualitative interview topic guide for meaning and suitability, experts from 
the British Thyroid Foundation were asked to evaluate whether the questions were appropriate for 
use with Endocrinologists. No changes to the interview schedule were made because of this. 
 
Interview process and reflections on interviews 
Telephone interviews were offered to participants to minimise disruption to their schedules and 
because the geographical spread of participants reached throughout the UK. Interviews were pre-
arranged to take place in a quiet time to enable adequate recording to take place. Participants were 
requested to return consent forms prior to the interview. Participants were given the opportunity 
to ask questions by email or immediately prior to the telephone interview. Participants were 
reminded (as on the information sheet) that they could withdraw from the qualitative study 
without giving a reason and this was re-iterated on the debrief form.   
 
As the participant group were not patients or vulnerable people, it was not considered that they 
were in positions of vulnerability for interviews, however equal importance was given to the 
protection of participants’ rights and confidentiality. Participants tended to partake from their 
offices after completion of clinics (around 2pm).  
 
3.10.  Process of Analysis 
Analysis was completed following the 7-phase analytic process described below, taken from Braun 
& Clarke (2006) and Terry et al (2017). Whilst separate ‘phases’ are described for the analysis of 
reflexive thematic analysis, the stages are iterative and recursive with the researcher moving back 
and forth between the different phases (Terry et al, 2017).  
 
1. Transcription  
The researcher transcribed the interviews during the data collection phase.  
 
2. Reading and familiarisation with data   
This process is the entry point to analysis (Terry et al, 2017) and began during the data collection 
phase. It involved: reading and re-reading the data to become immersed and intimately familiar 
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with its content; taking observational notes of items of potential interest and patterns; starting to 
ask questions about the data; writing notes in transcript margins, and using the highlighting 
function in Microsoft Word 10. During this stage, reflexive awareness was also important (i.e. 
noticing ‘good’ or ‘uncomfortable’ feelings in response to the views and attitudes of some 
participants, see section 3.12. ‘researcher positionality’ below).   
 
3. Complete Coding 
This phase involved systematic and thorough creation of meaningful labels or codes to reduce the 
data and organise it into patterns. It involved working systematically through the entire data set, 
noticing important features within the data and attaching a few words or a phrase to specific 
segments of the dataset of interest, or to those segments that might be relevant to answering the 
research question. Following this, the researcher used ‘cut and paste’ in Microsoft Word 10 to 
collate data segments (codes and relevant data extracts) onto clean pages for later stages of 
analysis. Following this, a list of codes was compiled that identified both patterning and diversity of 
relevant meaning within the dataset.   
 
4. Forming and generating initial ‘candidate’ themes 
This phase involved examining the codes and collated data to identify significant broader patterns 
of salient meaning (potential themes). This involved making choices about what data sets were 
relevant and what was important to say about them. The process involved examining codes (and 
associated data), combining, clustering or collapsing codes together into bigger or more meaningful 
patterns; and identifying features of relationship and similarity across different codes in order to 
cluster them together into a possible theme, and identifying a ‘central organising concept’ or idea 
that underpins the theme (Braun et al, 2015; cited Terry et al, 2017, p. 18). Thematic maps and 
tables were created to facilitate the process of shifting mapping of various patterns (Terry et al, 
2017) and to understand the themes in relation to each other (see appendix G-J). 
 
5. Reviewing and defining candidate themes:  
Here, themes were shaped, refined, and/or rejected. This involved checking that candidate themes 
captured the meaning in the collated, coded data segments, and that within each theme all the 
data extracts were clearly related to the central organising concept (and that diversity of meaning 
around the central organising theme is captured); as well as checking that each individual theme is 
distinctive.  It also involved reviewing whether the candidate themes worked well across the entire 
data set (not just the coded segments) to ensure that nothing had been missed, that to determine 
that the themes told a convincing story of the data, and one that answered the research question.    
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6. Defining and naming themes:  
This stage progressed to an interpretive orientation of the data and centred on ‘telling a story’ 
based on and about the data; and making sense of the patterning and meaning (and diversity of 
meaning). The creation of short theme definitions (a summary of the core idea and meaning of a 
theme) helped determine clarity and scope for each theme (Terry et al, 2017) and helped to define 
whether there was enough depth and detail for each theme to stand alone as a key section of the 
‘analytic story’.   
 
7. Writing up:  
This final phase involved weaving together the analytic narrative and data extracts and 
contextualising the analysis in relation to existing literature (Braun & Clarke, 2013, p 202). 
 
3.11. Researcher positionality 
Research can be defined as ‘a shared space, shaped by both researcher and participants’ (England, 
1994). The Oxford Dictionary (2017) defines ‘positionality’ as “the recognition and declaration of 
one’s own position in a piece of academic work”. This concept is important because in qualitative 
research, the personal values, identities and biases of an individual researcher can may shape the 
way in which they analyse data sets, and the resultant conclusions drawn (Bourke, 2014; Dean et 
al, 2018). Being explicit about our positions in our work allows those who read our work to better 
grasp how we produced the data (Finlay, 2002). 
 
In Section 3 ‘Methodology’ and section 4 ‘Methods’, I have outlined the ways that I have 
approached this research; the epistemological and ontological positions and the shifts that 
occurred through the research development and testing phases of this research. In this section, I 
consider how my interpretation of the social world impacts how I approach my participants, my 
analysis, and the conclusions I draw.  
 
As noted in section 3.2.’ Methodology’ the rationale for this research came from my work with the 
British Thyroid Foundation (BTF), which drew my attention to the ‘problem’ of patients with 
hypothyroidism experiencing persistent symptoms. This led me to carry out a systematic review 
into the existence and effectiveness of psychosocial and self-management interventions to address 
identified need in the literature. However, I found very little in terms of support in this area and I 
embarked on a consultancy project with a Clinical Professor in Endocrinology and their department 
to explore how they addressed these issues in their own practice with a view to informing my own 
work. This resulted in my discovery of issues around patient ‘dissatisfaction’ regarding a lack of 
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access to person-centred medical treatment approaches and debates in the field regarding the 
patient group themselves, the causes of persistent symptoms; and the necessity, safety and cost 
implications of treating them according to the symptoms and lived experiences reported in the 
literature.  
 
I am a 42-year-old British woman, with mixed race heritage. and a mother of two. I have a BSc in 
psychology, an MSc in Health Psychology and I am a Stage 2 Trainee Health Psychologist. My 
research interest primarily focuses on the application of health psychology theories, models and 
tools to issues surrounding health and illness. My identification with the biopsychosocial approach 
(Engel, 1977) has played a role in my focus in multidisciplinary approaches to health which reject 
the mind-body dualism which underpins the treatment approach to many long term conditions and 
advocates for integrated care and integrated care (e.g. Johnson. 2012).  
 
I have experience of supporting people with long term conditions and have worked in NHS and 
charitable sector positions in the areas of CFS/ME (chronic fatigue syndrome), cancer and COPD; 
and finally in a voluntary position with the British Thyroid Foundation. I have helped patients to 
adjust and cope to their illness by providing information, education, and psychosocial support (e.g. 
CBT) and have facilitated health promotion and peer support groups for patients to develop self-
management skills. I initially approached this research from a ‘patient advocate’ position with the 
belief that collaboration between health psychology and medical paradigms (and others) may help 
patients struggling with their thyroid condition to develop the skills and confidence to manage their 
health, and to reduce psychological distress.  
 
Whilst I was not directly an insider-researcher (i.e. a doctor), I collaborated with an endocrinology 
department (in a specialist thyroid clinic) and understood that my skills and experience were valued 
by the doctors I had worked with. My doctoral level training and experience of the patient group 
enabled prolonged engagement with and immersion in the topic area. However, as a doctoral 
trainee, I initially worried that I lacked expertise, particularly around medical terminology and 
procedures and this affected my confidence in the initial interviews, leading to me sticking rigidly 
to my interview topic guide. My position was therefore different to other qualitative research 
where the researcher may be in a position of authority or power over participants. As my 
experience and confidence grew, I became more relaxed and felt reassured by the responses of 
participants to talk to more openly to them about the topic area. This led to more open and 
conversational interviews and enabled me to follow the narratives of participants more freely.  
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After each interview, I wrote notes in a journal to explore the key issues and the way that I felt. I 
recorded the ways that I have brought my own knowledge of health psychology to the 
interpretation of the verbal data of my participants. However, my use of an inductive analytical 
approach aimed to avoid being constrained by pre-defined knowledge and frameworks. In the final 
interpretive stages, however, I have used my knowledge of appropriate areas of health psychology 
to help me to tell a story about the data collected.   
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Chapter 4: Findings  
This chapter presents the analysis of data from 18 Endocrinologists regarding their views and 
experiences of psychosocial and self-management support for people living with hypothyroidism. 
No demographic data relating to participants is presented in this chapter for issues relating to 
confidentiality. The Royal College of Physicians 2018-2019 census of UK Consultants shows that 
there were only 1,089 Endocrinology Consultants across all 1,257 hospitals in the UK. Therefore, all 
identifying data was removed from this study due to the potential for identification. 
Four overarching themes, containing twelve subthemes were identified following examination of 
the data using reflexive thematic analysis. These are presented in the table below alongside the 
thesis objectives. A poster summary of this thesis with an emphasis on the findings can also be 
found in ‘Appendix M: Poster presentation of findings’.   
Thesis objectives and Overarching themes Subthemes 
Endocrinologists’ views about the psychosocial and self-
management support needs of patients living with 
hypothyroidism:  Theme 1: Walk with them 
Patient heterogeneity 
Diverse support needs 
Will, skill, and confidence 
Do Endocrinologists refer patients with hypothyroidism for 
additional psychosocial and self-management support? Theme 2:  
Embedded is best 
What we do 
Professional identity 
Difficulty shifting the focus 
Perceived facilitators to the implementation of psychosocial and 
self-management models of care: Theme 3: Incorporate and 
collaborate 
Patients first 
Seamless care 
Assets and strengths 
Perceived barriers to the implementation of psychosocial and 
self-management models of care: Theme 4: We can’t do this 
alone 
Funding 
Research  
Culture change 
 
 
4.1 Overarching theme 1: Walk with them 
 
In this first theme participants identify that patients with hypothyroidism have diverse needs for 
psychosocial and self-management support and require professionals to ‘walk with them’ from the 
point of diagnosis but that participants report varied will, skill and confidence to meet these needs. 
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Subtheme 1: Patient heterogeneity 
 
Participants identified heterogeneity amongst patients living with hypothyroidism and diversity of 
support needs amongst patients with persistent symptoms. Participants firstly identified that many 
patients suffer with persistent symptoms of hypothyroidism as a result of suboptimal thyroid 
hormone replacement in primary care settings.   
Doctor C: “the reference is rather wide. You might need to treat the dose further and try and get 
the best, or the optimum outcome” 
Doctor N: “I think based on the literature, both overtreatment and undertreatment are common, 
and it is not just in the UK, it's all over the world” 
Two thirds of participants (eleven) also identified that patients may present with additional 
symptom burden resulting from autoimmune thyroid disease as the underlying cause of 
hypothyroidism.  
Doctor R: “I wonder about autoimmunity; rather the chronic inflammation in the gland plays more 
of a role than we really recognise uh and I wonder whether that contributes to the symptoms” 
Doctor F: “the mere fact of having an immune reaction  the inflammation, is that leading to sense 
of unwellness to the release of cytokines (…) cytokines make you feel you know, that you’ve got 
the flu” 
Doctor G: “but majority of them are autoimmune patients (…) whether it's just autoimmunity itself 
or autoimmune hypothyroidism which is causing all these symptoms”  
Seven (nearly half of) participants also raised the additional support needs of patients with 
hypothyroidism as a result of treatment for thyroid cancer. 
Doctor N: “I think especially the people who have got cancer, there are other reasons not to feel 
better” 
Doctor C: “because they've had thyroidectomy surgeries, and a high dose of radioactive iodine 
therapy. It could then yield them completely hypothyroid” 
Doctor R: “the people who have had surgery for thyroid cancer”…”I would let them know to make 
sure that they have enough calcium in their diet and to properly supplement with vitamin D, and 
make sure they get weight-bearing exercise” 
Participants also felt that persistent symptoms of hypothyroidism in some cases are attributable to 
undiagnosed physical co- or multimorbidity:  
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Doctor Q: “some of the symptoms of hypothyroidism are very non-specific so you have things like 
tiredness, brain fog, lethargy which you can have in many other conditions” 
Doctor B: “I would very much want to rule out organic disease” 
Doctor C: “checking for vitamin D deficiency, cortisol levels, other potential causes for fatigue or 
whatever the symptoms might be, they sometimes, they just throw up an answer” 
Participants identified that presentation of persistent symptoms may be a result of patients having 
medically unexplained symptoms (MUS), or conditions that are not adequately explained by current 
scientific knowledge, having been also diagnosed with subclinical hypothyroidism, which may not 
have been the cause of presenting symptoms:  
Doctor P: “people can get those symptoms for a whole variety of health reasons and also a lot of 
psychological and functional reasons that are not due to hypothyroidism” 
Doctor B “some patients who actually their symptoms are not related to the thyroid their 
symptoms are quite vague especially if they only have very mild changes” 
Doctor N: “there'll be patients who might have borderline thyroid dysfunction and were started on 
levothyroxine and for this reason they never felt better” 
Doctor F “we just have to accept that there is a group of people who've got medically unexplained 
symptoms” 
A group of patients who may experience persistent symptoms due to individual responses to 
treatment, for whom standard LT4 treatment may be ineffective were also described. All 
participants agreed that scientific unknowns, and ongoing debates exist regarding the cause and 
prevalence, and regarding management strategies for this group as identified in Chapter 2.4. (‘The 
history of treatment for hypothyroidism). 
Doctor P: “well, there may be something in there, maybe they don't at the tissue level convert T4 
to T3” 
Doctor B: “I would like to think there is a T3 responsive group and there is a non-T3 responsive 
group, if you want to look at it that way”” 
Doctor C: “there might be this individual variation that not everybody on thyroxine might be 
affected to feel that normal” 
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Subtheme 2: Diverse support needs 
Along with diversity of patient subgroups, participants described a diverse range of support needs 
presented by patients in secondary care. These included managing weight gain, mental health 
issues, poor quality of life and cognitive difficulty: 
Doctor L: “A lot of these patients, they complain of weight gain or difficulties maintaining weight” 
Doctor P: “these individuals will generally score higher on anxiety and depression scale”… 
“symptoms of hypothyroidism is fatigue and another is the brain not working properly” 
Doctor O: “ there's that whole underbelly of mental health problems just related to the burden of 
trying to manage a chronic condition all the time and requiring a high level of self-management 
skills which many people don't have” 
Doctor G: “I have patients who've gone back to work, who started back in university, whatever to 
complete their studies or somebody who was very good in music, had stopped feeling the music, 
feeling doubtful” 
Doctor B: “they can't think straight, they can't concentrate, they can't perform well” 
Participants felt that patients require education and expectation management  from the point of 
diagnosis to help them to understand that not all symptoms relating to hypothyroidism can be 
resolved with thyroid hormone replacement therapy (e.g. inflammatory symptoms of 
autoimmunity), and that mild biochemical changes detected in blood tests may not be the 
underlying cause of presenting symptoms. A lack of expectation management was highlighted as a 
particular cause of patient dissatisfaction with treatment.  
Doctor C: “a lot of the time, it is expectations of treatment rather than actual uh the 
medication aren't really working.” 
Doctor A: “I think patients build their hopes up and of course they seek a treatment and the GPs 
will I think listen to that because a significant proportion of them are not knowledgeable about 
thyroid diseases and they will collude with the patient and say "Yes, here’s the answer, here are 
some tablets you'll be fine” 
Doctor O: “I think it is that expectation management early in the condition that is quite important I 
uh I think often people have been struggling with these symptoms for quite a long time and 
they've been consulting for quite a long time. For someone to find something that's abnormal, 
often um that's grasped onto (…)  but probably wrongly, but you then set up a trial that goes on 
49 
 
for months and years ahead” 
Doctor A: “your expectations might be that you'll be back to your normal self-overnight and that's 
not going to happen” 
Doctor C: “the challenges are around how we manage expectations, how a number of people 
being started on thyroxine treatment year on year in the UK and obviously, worldwide 
potentially.” 
Subtheme 3: Will, skill and confidence 
 
When asked about the ways in which participants addressed the psychosocial needs of their 
patients; not all felt that they were equipped to do this in an optimal or structured way. Not all 
participants felt that this was part of their clinical remit, whereas others described this as a central 
part of their role.    
Doctor N: “I feel reasonably confident to identify or probe when I think a patient is struggling” 
Doctor G: “ I wouldn't say that I'll be able to support them adequately because it slightly lies out of 
the clinical remit but what we tend to do is or I tend to do is refer them to their GP and highlight 
these issues that they'll need supportive therapy” 
 Doctor A: “I think I'm not sure the way I do it is optimal but I can describe to you what I do if you 
wish uh but I'm pretty certain that generally both GPs and  Endocrinologists don’t do this well and 
(…) I think that may well explain the dissatisfaction with the care that all these people get” 
Doctor I: “what is relevant is having a proper discussion with them and getting them to 
understand their condition (…) and ruling out other causes for these kinds of issue guidelines and 
that's the most (…)  I don't think I have skills and stuff like that come into play uh I don't think it's 
relevant” 
Doctor A: “I don't think I have the will really to sort of change my professional approach.” 
Doctor O: “I think it's just that we don't have the capacity or the support services, or probably the 
skills, but mainly the time”  
However, the need for psychosocial support was considered key in the healing process amongst 
participants who expressed willingness to engage in addressing patients’ psychosocial needs. 
Doctor G:” I think that's the huge gap what we have not only just with thyroid even with patients 
with any chronic conditions, diabetes as well (…) they should have that support actually 
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psychological support is very important ongoing support because it's not easy to manage these 
conditions day in and day out and not burn out (…) that burnout has to be recognised but I don't 
think we have a service at the moment which can deal with the sort of things that they need 
because it's not only just about one day, it's  about walking with them because this is a lifetime 
condition (…) any chronic conditions they need that ongoing support because there will be times 
when they'll be low, they'll come to a point they would like to give up everything like ‘ I'm not 
bothered anymore’ so those are the times when they just need the support so that they can carry 
on and then take the baton again back in their hand” 
 
4. 2. Overarching theme 2:  Embedded is best 
 
This second theme encapsulates participants’ attempts to explore psychosocial issues and embed 
components of self-management support in their practice but highlights subsequent challenges to 
professional identity. Difficulties in shifting the focus of the consultation are reported and are 
perceived to be fuelled by a battleground around access to LT3 and a lack of available service 
provision. 
Subtheme 1: What we do 
 
Participants described giving patients time, listening to their concerns, and building trust as key 
elements of their role during the consultation with patients.  
Doctor A: “One of the most precious parts of the relationship is trust” 
Doctor C: “trust I think is the other thing because I think if they start trusting what you're saying 
rather than (…) until then because until then they'd been trusting the online blog” 
Listening without judgement to validate patients’ input was considered a valuable start to the 
healing process.  
Doctor F: “You sit down and you go through everything and you do it properly in front of them and 
you don't short-change them with time (…) you listen to everything they say and uh you read 
everything that they've provided. You give them a lot of detailed explanation and you follow that 
up” 
Doctor C: “for most patients, it's just listening to what they're saying that’s an important asset to 
the whole thing (…) they feel like somebody's listening to what they're saying. A lot of the time 
from the patient's point of view and again, I think it's down to the fact that for GPs is just a rushed 
conversation for obvious reasons and they might even just be coming out with a second symptom 
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and the GP might say “that’s fine we'll just prescribe this or I'll do this, that or the other”. The 
patients feel that they're not being listened to, I uh think just the fact that somebody's listened to 
what they're saying and understanding what they're going through I think is an important factor, 
secondly then spending time explaining how thyroid hormones work” 
Participants felt that many patients have fought for their diagnosis and to have their voices heard 
and some emphasised the importance of not being perceived by patients as part of the problem.  
Doctor B: “a lot of people that I see are very angry have fought for a long time trying to get a hold 
of drugs etc. Just giving them the opportunity, listening to them, helping them discuss instead of 
saying, "The answer is no. What is your question?" you know,  It's immensely helpful (…) it’s an 
enormous relief for the oh people that they can actually stop fighting and start healing if you want 
to look at it that way.” 
Doctor D: “most of that is because they feel that there's a battleground out there and uh as I'm 
not a battleground it's not that difficult because actually for the first time, they've got somebody 
that says, "Well, I'm not going to argue with you, I'm not going to say your blood tests are perfect, 
you should feel well." 
Participants described their role in educating patients to support their understanding and to 
increase adherence to treatment.  
Doctor F: “I don't have any graphical slides that I routinely use but I often draw a thyroid gland on 
a piece of paper, and I draw pituitary, gland and I explain the feedback mechanism and how to 
interpret the function test, but there isn't a specific additional tool that I use” 
Doctor J: “I don't really see enormous differences in times between educating doctors and 
educating patients you know if you want people to do the things that you think are in their best 
interests, you have to persuade them and convey to them that this actually truly is in their best 
interests (…)  that means time and a full explanation” 
Doctor A: “I think it's a process of trying to impart good quality information about the condition 
and its treatment and to explain to them (…) what you know my strategy is” 
Some participants described offering trials of LT3 therapy, on its own or in combination with LT4, 
whereas others did not due to safety concerns. Some did not feel that there was sufficient evidence 
to support the use of T3 and highlighted risk to patients as a cause for concern. Those who did, 
emphasised the importance of managing patient expectations through goal setting and action 
planning for patients to understand that this may not be the answer to the symptoms.   
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Doctor K: “I also make it clear to those who are using it that it is a time limited trial of treatment, 
usually six months trial”  
Doctor C: “It's a never ending process if you don't have an agreement right at the beginning”… 
”You could go down you know this route forever. I think what I find is have boundaries, manage 
expectations right at the beginning and have an agreement.” 
Participants described attempts to promote healthful behaviour during consultations but felt that 
there was limited condition-specific evidence for them to draw upon, which reflects findings of the 
systematic review presented in chapter 2.5 (‘Systematic review’). They described more confidence 
when considering medication interactions to increase biological treatment outcomes but less so in 
promoting specific behaviour changes.  
Doctor J: we know that if you combine iron or calcium and vitamin D with thyroxine 
replacement you will dramatically reduce its absorption I think those bits of education 
should be done by all clinicians for all patients” 
Doctor L: “For me it's usually the general lifestyle advice that I give to patients (…) now a lot of 
these patients who come in who are struggling are already doing those things because they've 
worked from first principle and are doing that but I just reiterate the advice really” 
Doctor B: “I’m tempted to just say to the patient, "For whatever you feel gives you more energy, so 
long as it's not going to be harmful, I would strongly be supportive of." Some people, they do a 
little bit of breathing exercise, I'm not sure that's a big thing. A few people engaging in other 
complementary therapies. Some people try meditation or mindfulness. I don't think I can identify 
one specific one. My rough shot at it is it is a more holistic listening and supportive approach” 
Doctor N: “Clearly, the exercise seems to improve or make them feel well, that’s something I tend 
to encourage, but I'm not 100% sure whether there is a study. Do you know of anybody?” 
Subtheme 2: Professional identity 
 
Participants mostly described openness towards approaches in which patients use multiple sources 
of support to address their wellbeing. However, difficulty was highlighted by some participants 
when this included patients requesting or self-sourcing non-standard alternatives to LT4 therapy 
(i.e. T3 or NDT). This was a common area of concern and worry, which introduced doubts about the 
concept of self-management within hypothyroid patient groups. 
Doctor F: ”I think there certainly is a degree of self-management like there is in any condition 
really and lifestyle is part of that. It's different from something like diabetes where you may have 
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to self-manage the dose that you gave. I think dose in a in a lot of these patients, they manage the 
doses themselves depending on how they feel, and that, if anything, makes it more difficult for us 
to assess what their status is because we're not actually really sure what they've been taking and 
how to interpret their results just in light of that” 
Doctor F: “there may be a degree of misinterpretation or misunderstanding by patients who don't 
have the same training as doctors” 
Some clinicians were more open than others to support and monitor patients’ use of non- standard 
treatment choices. Others felt that safety concerns and ‘scientific unknowns’ posed a more 
significant problem for the collaborative doctor-patient relationship, especially for clinicians who 
do not feel confident in the use of T3 or NDT.   
Doctor L: “If they go and buy things  on the internet, then often I have that conversation with them 
that I say, “look, I need you to take what I suggest and what I prescribe or whatever  in 
combination with what your GP prescribes. If you then go and buy things on the Internet, then that 
really makes it difficult for me to manage because I can't help in that situation because I don't 
know what I'm dealing with”” 
Doctor A: ” I'm concerned about the safety of combination treatment and that on this basis I don’t 
recommend it.” 
Doctor G: “the patient would like to try it, but not all the physicians would like to trial it. That 
makes no sense to the physician a because not everybody believes in T3 and NDT. When you don't 
believe there's no point in trying it because I can’t send some of my physician colleagues who do 
not use T3 because they don’t believe in that concept” 
Participants described feeling stuck in the middle between shouldering personal responsibility for 
risk and patient safety, and not wanting to contribute to anger and perceived polarisation between 
patients and the healthcare system. For many, this was a difficult position to be in, due to the 
potential risks of overtreatment with thyroid hormones (particularly T3) which may include atrial 
fibrillation and osteoporosis in the long term. 
Doctor H: “Basically what I say to patients, "If you're taking the desiccated on your own I'm not 
prepared to take any form of clinical responsibility." I'll supervise it, but I won't take clinical 
responsibility if anything goes wrong with that, if you know what I mean.” 
Doctor Q: “the clinician must be happy to initiate T3 and if the clinician is not happy to do that, 
there is nothing  compelling that clinician to do so”…”even if the patient met the criteria in the 
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guidelines for T3 and the clinician wasn't confident or happy to give that prescription, that that 
position is perfectly valid” 
Doctor Q: “I think the average Endocrinologist would feel out of their depth, sometimes to 
prescribe T3, only because they don't have any experience really” 
Doctor K: “If they are prepared to accept those risks then I will say they (…) because they feel so 
much better about that then I'd say you can continue if you accept the risks” 
Doctor D:  “we have to have a few simple ground rules and make sure that you're safe because I 
do say there aren't that many people as an Endocrinologist that are happy to do what I'm doing so 
I'm putting my head above the parapet.” 
Some participants reported that the current situation negatively impacts upon their own job-
related satisfaction. This was particularly true for those who felt in a difficult position as patients’ 
last resort after unsatisfactory attempts to manage hypothyroidism in primary care. They described 
a lonely task of ‘plugging the gaps’ left by scientific unknowns, cost restrictions and unrealistic 
patient expectations regarding the tools available to Endocrinologists to address their symptoms. 
Others however, felt more positive and engaged in moving the situation forward. This was 
particularly true for those working in a specialist thyroid environment who felt supported by 
clinicians with a similar specialist interest, and were actively involved in research in this area. 
Doctor O: “I think probably most of us have a single consultation and it's relatively short and I 
think you often come into it with a bit of trepidation because you kind of know what's coming.” 
Doctor A: “If you're an Endocrinologist and you get a referral from the GP that states all this, your 
heart sinks, okay? It really does, because it's a difficult problem (…) you reflect on your own 
previous experience of how frustrating it is, unrewarding to feel this. I can understand why lot of 
colleagues in the end really feel negative about it” 
Doctor Q: “those of us who have a particular interest in thyroid and in hypothyroidism, we are not 
so concerned and I speak for myself what I suspect is the same for colleagues, we know what to 
expect” 
Doctor B: “I'm reasonably comfortable trying alternative options because at the end of the day, it's 
only a trial of other forms of common replacement that will tell you which group they fall into" 
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Subtheme 3: Difficulty shifting the focus 
Participants felt that many patients arrived at consultations with a fixed agenda of what they want. 
They noted that patients with hypothyroidism were generally an activated patient group but that 
they are vulnerable to misinformation which contributes to rigid beliefs.  
Doctor R: “I think people, because they feel unwell well they'll obviously have been online and they 
may already come to me with very strong views about T3” 
Doctor C: “all they have heard are those stories online how T3 has changed my life.” 
Doctor P: “I mean, again, to be fair to this group of individuals, they've generally been through all 
that themselves before. I think they are an extremely well-read group of people by and large. In 
my opinion, a lot of the stuff they're reading is very inaccurate, biased, and feast on anecdotes 
rather than hard scientific evidence”  
Participants described their role in helping patients to look for other reasons for their symptoms, 
or to correct fixed beliefs that LT3 therapy will be the answer to their persistent symptoms.  
Doctor J: “I don't think patients themselves believe or sometimes considered that there might be 
something else genuinely behind this. I think by the time we see them is often the next massive 
focus on the fact this must be thyroid hormone not working. Whilst that might be the case, it 
might absolutely not be the case. If you're looking under the wrong cushion, you will not find what 
you're looking for.” 
Doctor P: “I think I could I could spend all day with some and it wouldn't make any difference”  
Doctor C: “I always say to patients is that actually by focusing so much on the thyroid, they're 
doing themselves a disservice by taking their eyes off other potential reasons for the symptoms” 
However, participants described difficulty shifting the focus of consultations away from discussions 
about biological treatments (T3 and NDT), particularly when they tried to consider psychosocial 
factors which may be contributing to their overall health and wellbeing status.  
Doctor B: “I do discuss other features that are going on. The patients in general don't want to talk 
about that they say. They want to focus on the biological elements. We all have discussions about 
other stuff that’s going on for them, discover what might be other major stresses in their life, 
financial, bereavement, relationship, that kind of thing. They need to be aware of that and 
continue to discuss those things, continue to encourage them to work on those sides as well as on 
the biological side. That's partly if you like a bit of expectation management there too.” 
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Doctor F: “Patients feel stigmatised by the diagnosis of depression even though medically speaking 
there’s nothing wrong with the diagnosis at all, of course. Equally, medically, unexplained 
symptoms simply mean we don't have an explanation for them it uh doesn't mean to say, "It's all 
in your mind. You're making it up" It just means to say "We don't know why you've got these 
symptoms” 
Doctor P: “again, these individuals have very, very fixed beliefs. If you start saying, actually, I 
think this is more psychological, they don't like that” 
Participants felt that many patients viewed hypothyroidism as an acute condition which is 
responsible for all present symptoms,  and that they held expectations that their symptoms 
should fully reside when they found the correct treatment (which may be T3 or NDT if 
symptoms did not reside with standard T4 treatment).   
Doctor R: “sometimes the consultation could have start in a bad footing because they have one 
thing in mind that they want and if they think that they're not going to get that they get upset, 
pretty quickly” 
Doctor Q: “we're still in an era where people come to you and they want a drug they want a 
treatment and if you cannot offer them a treatment it's assumed you've failed” 
 
Participants identified patient perceptions of distrust and disregard, and an ‘us and them’ divide, 
developed prior to the consultation from previous experiences and from sentiment shared with 
similar others online:  
 
Doctor R: “sometimes they expect a very hostile response which I usually don't give a very hostile 
response, but they might have just had some other health professional so their guard is very much 
up” 
Doctor Q: “there are patients who come with the us versus them idea in their heads and you are 
like the enemy before even you say a word” 
Doctor F: “you're tarnished before you talk” 
Participants described difficulty and dissatisfaction when they could not solve patients’ problems 
with the available tools and treatments. They described a lack of available services to refer patients 
in this situation to, and that many did not feel happy or skilled in the situation of leaving patients 
‘in limbo’.  
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Doctor D: “usually by that point people are already in a healthy diet they’ve looked at ways to 
enhance the diet and exercise to manage the fatigue, they've seen lots of people already” 
Doctor P: “that other explanation may not be a physical explanation and you know lot of people 
they don't want to hear that or the next question is then ‘What can I do to help myself?’  and then 
we have a discussion about the lifestyle they say ‘well I have done all of that that stuff already’ 
and you know it's a very unsatisfying consultation by and large I have to say” 
Doctor O: “people come wanting one thing and they end up feeling that they're not getting it and 
that you had a quite difficult consultation and you don’t feel feel like you've been able to help that 
person very much. It's all very difficult” 
Doctor O: “I think it's always difficult when you can't quite always explain why people feel like they 
do. It becomes quite difficult. I think if you've gotten an explanation, it may not always work, but 
it's often more helpful than when you're saying, "Well, it's not this, but I don't know what it is" I 
think that's quite difficult because you're just leaving that person in a bit of limbo” 
Doctor E: “where I find it more challenging is when people go and their lives are still horrible or 
where we’ve given them a trial of T3 and they’ve got to the edge of what I call their comfort zone 
and we’re between the devil and the deep blue sea and that makes me feel quite unhappy”  
Participants felt they had to be careful not to inflame feelings which could be construed as dismissal 
or disregard. Most participants were committed to trying all they could but felt that patients 
expected them to remain focused on endocrine pathology (also see section 4.3. ‘Assets and 
strengths’).  
Dr Q: “Sometimes we can send to a dietitian or prescribe regular exercise but in doing that 
we have to be careful because it can be misconstrued by the patient again as dismissal” 
Doctor Q: There are still divided opinions, lots of divided opinions but one thing I believe them that 
such a group exists. If you look at the latest guidelines”… “there’s a nod to these patients that yes, 
some patients may still not feel well, some patients may still not feel well but 10 years ago such 
patients were considered unhinged” 
Doctor R: “If they've been dismissed by an Endocrinologist before, they would feel all 
Endocrinologists don't care and they're just there to get them away.” 
Participants who described ‘keeping the door open’ to biological explanations for persistent 
symptoms were more likely to offer therapeutic trials of LT3. These participants felt that validating 
patients’ beliefs about treatments, and ‘turning over all stones’ to eliminate all biological 
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explanations gave them more of a mandate to explore psychosocial issues with patients after 
therapeutic trials.   
Doctor D:  “I feel very relaxed about it. I used to, and I think as Endocrinologists we can be sort of 
somewhat black and white and dogmatic about it, I mean, we've all struggled with that group of 
patients over the years, and none of us know how best to help people”…” Now I sit on the fence 
and say I don’t know but say to the patients, "I'm not here to say you can or cannot have a 
particular treatment”” 
Doctor B: “what people they benefit from is listening and an explanation and keeping the door 
open that there may be a biological explanation. Basically, that actually relaxes people a little bit 
to consider other things because it's like, "If you think I'm mad, I'm not going to have a 
conversation with you," but if I give them the legitimacy which I think is legitimate, that there may 
be a biological reason why they're not feeling well. That helps me engage more with other aspects. 
It gives me a bit more of a mandate to discuss those things.” 
Doctor G: they would like to try something different and see if it works before accepting the fact 
that is not probably all hypothyroidism and this could be something else going on. Then did a little 
bit deeper into their own lives and say, okay, stress, our lifestyle or work could be a contributing 
factor”  
Dr J: “sometimes you can't give the patient an answer (…) this area is a classic example I can look 
under every single cushion turn the room inside out and still not be able to explain to the patients 
at the end of the day why they don't feel right but if at least I say to them "I've looked everywhere 
I can think of looking" patients often appreciate that even if you haven't absolutely solved every 
problem they have” 
 
4.3. Overarching theme 3: Incorporate and collaborate  
 
This third theme (‘Incorporate and collaborate’) presents an overview of participant-perceived 
facilitators of psychosocial and self-management support. It presents participants’ views that asset-
based collaboration is required to address gaps in provision in primary and secondary care. Valuable 
partners include: Patients, Endocrine Nurses, Health Psychologists, Pharmacists, Exercise 
Physiologists, embedded Researchers, and experts in the charitable sector. 
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Subtheme 1: Patients first 
 
Participants held different opinions about the categorisation of hypothyroidism as an acute or 
chronic condition. Those who viewed the condition as chronic were more likely to hold attitudes 
that patients should be involved as partners in their care.  
 
Doctor A: “people that have hypothyroidism and symptoms from it should return to the normal 
state of health after they have been treated”. 
Doctor E: “some people find it very straightforward and don't have any problems and others find it 
much more challenging to manage” 
Participants with a ‘chronic condition perspective’ highlighted the importance of including and 
incorporating patients as respected partners; to solve problem with them and not for them; and 
not to reduce patients to passive recipients of care: 
Doctor A: “ you've got to actually engage the patients in the process of trying to answer this 
question. What is it that you expect? I don't think that they understand it terribly well and I think 
that can be variable within one patient from one time to the next”…” I think the crucial thing 
about it is you've got to get the patients involved right from the start.” 
Doctor B: “I think that increasingly helps people feel that they're not being fobbed off and hidden 
to as well as trying to feel that they're being respected partners and understanding this process” 
Doctor N:” I think it will be helpful to see them and see what are their fears and concerns and 
where they're coming from. I'm not sure just giving a leaflet would alleviate it” 
Doctor Q: “I think the changes are occurring. Five, 10 years ago, anyone who was unwell still on 
thyroxine would be completely dismissed there would be no discussion about it, your TSH is normal 
and that's it but now we recognise that such a group exist and we are beginning to see them and 
trying to understand them.” 
Participants highlighted the growing use of patient reported outcome measures (PROMS) to 
capture patients’ perspectives about clinical treatments for hypothyroidism and reported 
increasing interest in condition-specific PROMS for Clinical Commissioning Groups.  
Doctor H: “we've actually just started doing locally now, because the CCG is clamping down on T3 
is doing some (…) I'll call if you'd like questionnaire, before and after. We've got a (…) we need to 
document a definite clinical improvement whether that be physical or psychological in order to 
continue with T3” 
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Some participants were onboard with PROMS and felt that their use should be widened to 
encapsulate the patient voice in a wider context to understand and address a broader range of 
health outcomes.  
Dr J: “I think that probably the endocrinology with patient-reported measures. I think of the 
patient reported measures at the moment, the big problem we are having in endocrinology is that 
our questionnaires and our patient reported surveys, etc suffer from the lack of specificity if I can 
put it that way. What I mean by that is that the symptoms and sometimes the features that will be 
recorded in those might not just be a feature of having suboptimal replacement, they might be 
capturing other features and things in life as a whole. I think we need general disease-specific 
questionnaires as best as we can, together with quality of life questionnaires. Understanding 
whether somebody could have depression is really important because if they could when you keep 
fiddling with the thyroid hormone, you'll never make them better” 
However, other clinicians reported scepticism about the role that patients should play in reporting 
their own health status and expressed distrust of non-medical biomarkers of health. 
Doctor K: “the problem is that I think people on combination treatment if you ask them to do 
patient-reported outcomes, would report better outcomes if they want to carry on the 
combination treatment. I think it's quite difficult to remove bias from those really. I am always 
very happy to look at them, and I know they’re planning to develop a new tool to support the NICE 
guidance. I keep an open mind should I say, but I don’t use them in my practice.”  
Doctor L: “I think the further development of thyroid-specific questionnaires, just like the THY-Pro 
I'm involved in a project where they're trying to see if we can get the THY-Pro put into an online 
version that then can be used by clinicians in clinics. (…) essentially, I think that is the way forward, 
my,  my colleagues tell me that “I can still predict how they're going to fill this In”, but then that is 
how that patient group feels, so that's what we have to take seriously”. 
Doctor D: “anecdotally, the vast majority of patients seem to feel a lot better on it.” 
Doctor I:” I don't like going on anecdotal evidence from individuals” 
Subtheme 2: Seamless care  
Participants felt that much of the patient dissatisfaction stemmed from suboptimal treatment 
originating in primary care (see section 5.1: ‘Patient heterogeneity’) and highlighted a need to 
engage and support patients from the earliest point. However, participants identified a gap in 
service provision at the interface between primary and secondary care. Participants felt that 
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intervention targeted here may better manage patient expectations and stem the flow to 
secondary care.  
Doctor R: “I think if people are properly counselled at the start that perhaps they wouldn't be so 
disappointed later on if they didn't see any major changes.” 
Doctor O: “I think having something a stage I think between primary care and ourselves would be 
a good idea, I think. It almost feels like sending someone to an Endocrinologist, it's sort of saying, 
"Yes”, and escalating it and confirming it even further whereas if some sort of exploration of (…) I 
think that the biochemistry is important why it might not be the thyroid or what other things we 
might look at. There uh maybe isn't always a disease and perhaps, there are other things like 
coping skills and actually it may come down to managing symptoms and how people do that 
rather than saying we're going to (…) almost like a chronic pain approach” 
Doctor F: “ I think there's an absolute crying need for support for these people and that could be 
GP based. That's where it is. That would stop many of the referrals to hospital which are ill-
equipped to deal with and you get the two  flowing backwards and forwards.” 
Doctor C:”  the other possible way of dealing with this would be to empower, train people, either 
nurses or specific GPs with a special interest in primary care to be able to deal with this within 
primary care within each health area, CCGs or geographical areas” 
Subtheme 3: Assets and strengths  
Participants described limits to the capacity of what they felt they could achieve within 
consultations. They felt that additional skills sets may bring value to meeting the diverse needs of 
patients with hypothyroidism.  
Doctor F: “We don't have in hospitals a sufficiently good and available health psychology service. If 
there's one thing I would like, I'd like to see much more of that available” 
Doctor G: “Having a psychology service attached to chronic disease management will be 
helpful”…”sometimes the patient might attribute all the symptoms to hypothyroidism but in fact 
they don't know what they do, not able to cope with the other life events that are happening and 
there is an overlap there” 
Doctor B: “an Endocrine Nurse role along with a Health Psychologist role here. It's a balance 
between dealing with the organic and the less explained. I'm reasonably comfortable at managing 
the medication, adjusting the medication, discussing the issues. It would be helpful to me, I could 
see more patients, if, for example, there was an Endocrine Nurse who said exactly the same thing 
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but went into it in more detail”…”It's more of a health psychology role to go into the wider aspects 
of their life and how they can get a better outcome overall by addressing other aspects of their 
life.” 
Doctor Q: “I think we should have something like we have in things like chronic fatigue where you 
have a kind of multidisciplinary team which includes lifestyle experts. I think we should have such a 
pathway but that pathway has to be mindful that there may or may not be some endocrine 
pathology. If you have diabetes and you came to me with diabetes and you are still very tired and 
unwell, you know we'll do all the biochemical analysis and things but then I'll send you to my 
diabetes lifestyle group so there's a program which is targeted at patients with type two diabetes 
and within that program you have a Dietitian's inputs, you have an input from a diabetes 
specialist, you have input from an Exercise Physiologist or someone along that line um sometimes 
you even have an input from a kind of motivator or somebody with a psychological background. 
That program is very popular and it's very helpful for patients with diabetes It's not too farfetched 
to think of designing such a program for thyroid problems and  that would help really where you 
have somebody who has the background of the endocrinology, the thyroid pharmacology and then 
you have somebody who's a lifestyle who's looking at the lifestyle aspect and both can work side 
by side. That might be a resource that would help” 
Doctor R: “I often advise patients that going to see a Dietitian may help. Some GPs have access to 
that, others don't. We don't actually even in our clinic, which is large. We don’t have access to a 
dedicated Dietitian, which I think would be useful, but there is no resource for that”. 
Doctor M: “we have some excellent Nurses in our department, and actually, they deliver a 
significant portion of both the hypothyroid and the autoimmune hyperthyroid workload now for 
the nurse-led clinics. 
Doctor J: “clinical service here which is fortunately supported by the fact that there are a lot of 
Research Fellows working the clinics is that as a general role.” 
 
However, some participants felt that this was unlikely to happen due to the size of the problem 
and lack of available resources for the management of hypothyroidism.  
 
Doctor N: “I'm not sure whether all the patients with hypothyroidism who don’t feel well should go 
to multidisciplinary. I think there'll be too many” 
Doctor N: “I don't think the NHS will be able to afford everyone who doesn't feel well, to go to 
multidisciplinary clinic, but I think for special group of patients, yes, it will be useful” 
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Doctor J: “I think Endocrinologists probably don't have the resource for that side of thing” 
Participants felt that is essential to include patient-centred information to overcome issues of 
distrust and disregard and to provide information in line with patient-identified need and 
preference.  
Doctor R: “We’d probably benefit from really good patient information centred around what can 
somebody do for themselves in terms of their own health um and I think it would be particularly 
powerful if it came from patient to patient groups rather than from doctors because I think 
sometimes it's was like distrust (…) I don't know (…) it's just kind of my feeling but you know if we 
had really good patient information that could signpost them to areas so to the kind of things I've 
just been talking about in terms of lifestyle changes, diet changes and managing stress and stress  
at home and about mindfulness maybe or other things and there could be psychological things 
happening that we could never even touch never mind try to treat in an outpatient setting”  
 
Participants highlighted the valuable contribution of the evidence-based charitable sector, 
particularly the British thyroid Foundation and the Pituitary Foundation in providing trustworthy, 
evidence-based information.  
Doctor F: “I emphasise the importance of that as a scientifically-approved organisation which has 
patients' interests at its heart and a very large patient base. I think using them instead of other 
sources of information is important and that people can often get a lot of support from that” 
Doctor R: “I always tell them also that, not everything they find online is reliable and useful. 
There's a lot of fairly dangerous websites, what I consider dangerous websites on there, but I try to 
point them in the direction of recognised national bodies such as the BTF”. 
Doctor N: “I think the patient support groups are really important, and I think on the internet there 
is lots of things which are not true, so people who have stories how life changed just by taking one 
tablet of T3. I think patient support groups like BTF giving accurate and scientific information to 
the patient is really, really important” 
Doctor J: “The Pituitary Foundation, we would very much say, there's very good quality 
information leaflets, materials that are available. They have been published and this though is a 
consequence of many experts and in the patients contributing to them you may find some of this 
information helpful.” 
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4.4. Overarching theme 4: ‘we can’t do this alone’ 
  
This fourth theme includes participant-identified barriers to addressing the psychosocial needs of 
patients with hypothyroidism and supporting them to self-manage and highlights a need for 
change. This includes increases in funding and research, and a supportive environment which 
empowers clinicians to place patients at the centre of their care.  
 
Subtheme 1: Funding   
 
Participants highlighted that uncapped rises of generic medicines in the UK, including of LT3 is a 
primary barrier to clinician prescribing autonomy and patient treatment choice. Most participants 
reported that their local Clinical Commissioning Group has imposed a blanket ban on prescribing of 
T3 due to cost.  
Doctor P: “I think the current pricing is outrageous uh it’s absolutely outrageous” 
Doctor G: “Also, another thing is the prohibitive cost of—especially in T3 and NDT in the UK is 
making it less available for the need patients nobody wants to prescribe it one, it’s not in the 
guidelines, two the costs are so high.” 
Participants felt that this contributed to a stalemate situation where patients were denied trials of 
treatment options and this amplified anger and treatment dissatisfaction amongst patients.  
Doctor B: “There's a point about the anger that's been generated around the cost and therefore, 
the lack of availability, and therefore the lack of experience, has made the situation about a 
hundred times worse than it needed to be because people feel angry and denied. That's an 
important amplifying factor in this problem.” 
Participants felt that the situation in the UK resulted in patients feeling forced to inappropriately 
self-manage by sourcing medication from outside of the UK to avoid feelings of helplessness and 
lack of control.  
Doctor G: “prescribing habits are quite different in the United Kingdom compared to America, it’s 
much more accepted to use NDT than here or in Canada it’s much more accepted to use T3 or NDT 
than the UK. So It’s all about accessibility, availability and it’s physician experience as well” 
Doctor D: “because some of the natural thyroid people buy from here, there and everywhere 
around the world” 
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Doctor E: “people going off to Greece stocking up on T3 pills. It’s about 2 euros a packet in Greece 
and about 300 quid in the UK.” 
Participants felt that the lack of funding and availability perpetuates inequalities in health based on 
socio-economic status.  
Doctor D: “So then patients have to self-fund tests so that they can get the parameters that will 
give us some measures.” 
Doctor O: “I was going to say they're rich (…) he people we tend to see accessing those sorts of 
things are, I would say in general, are probably more high social class, more educated. Now, 
whether that's because they have the skills to go and look and find these things and work out 
ways of obtaining it, that's IT/healthcare savviness that other people don't, I'm not sure. I suspect 
it's probably is. We know that in all sorts of things, people who know their way around the system 
and I guess healthcare professionals, they're highest among those, but people who know their way 
around the system tend to get what they want a bit. That's probably true, not just the healthcare, 
that's quite true with lots of systems” 
Participants felt that funding restrictions also contribute to scepticism and reluctance amongst 
some health practitioners towards the inclusion of the patient voice in research and creates safety 
concerns amongst the scientific community. 
Doctor E: ”if a drug is hard to get and people have to jump through more and more hoops to get it. 
I do worry there's a placebo and a greater placebo effect produced as well. That makes me worry 
and it's something we'll have to all think about that that's one thing that you might see in the 
controlled trials that so far haven't shown a benefit. If there is a placebo effect and you make that 
drug had to get then you’re going to magnify that placebo effect. If people are getting drugs 
abroad or from less reputable sources, you've got a quality control issue there as well, the whole 
thing is a complete dog's dinner” 
Subtheme 2: Research  
In addition to addressing medication pricing and subsequent restrictions upon access to 
treatments, participants highlighted that investment in research is required to address scientific 
unknowns and to move the research conversation underpinning clinical guidelines forward. This 
was felt to be particularly important due to the issues surrounding the use of T3 and NDT casting 
shadow and doubt over patient self-management in this condition. Participants identified a need 
for definitive biomarkers for hypothyroidism, and trials to improve the safety and efficacy of 
treatments.  
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Doctor E: “Certainly I think there is evidence that TSH is not that brilliant of a marker for some 
patients” 
Doctor I: “We certainly need prospective studies but at the moment, I think that the options for 
prescribing T3 are sub-adequate anyway because the half-life is so short” 
 
Doctor P: “T3, I do prescribe. I always prescribe it with a heavy heart. I prescribe it with a heavy 
heart because I'm not perceiving that it's beneficial and because part of me believes that there is a 
theoretical possibility that that could actually be harmful to people in terms of uh the heart and 
bone health. I worry about prescribing it”. 
Doctor N: “I think obviously there is interest in long-acting T3 because some people think that the 
studies haven't benefited because T3 wasn't given in a correct physiological dose” 
Doctor K: “I think the area where there is potentially an issue is subset patients who appear to 
benefit from combination treatment will need liothyronine where I think there isn't a 
consensus about how to manage those patients” 
 
Some participants expressed positivity and hope that the need for research development was 
recognised in the new NICE guidelines and felt that with additional funding and investment progress 
to improve health and wellbeing outcomes for patients was in sight.  
Doctor B: “ I'm very keen that we, in the end, do the right trial to address that question because 
most of the studies that have been done at this point with T3 have not probably been done in the 
right way, and the results have been disappointing. When we are able to replace some closer to 
normal physiology, then we'll be able to sort out the wheat from the chaff a little bit” 
Doctor B: “ We're putting theories together as to why the previous trials have failed. I think there's 
some biological reasons why that could be the case. I'm led to understand that the NICE criteria 
will lead to potentially some funding for some more research in this area. I think that we can sort 
this out” 
Doctor D: “I don't think that unless there's black and white evidence in medical literature, in other 
words, studies, I think  general well-being and how people feel is too nebulous a concept for 
commissioners and prescribers to swallow” 
Doctor G: “Quality of evidence is key to bringing the change” 
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 Subtheme 3: Culture change 
 
Participants highlighted a need for a whole systems approach to remove barriers to patient choice, 
and to support research progress. Participants described issues of concern to them including the 
blocking of treatments which may be crucial for some patients; and the withdrawal of medication 
from others to prove that without it, they become unwell. Participants felt concern at being stuck 
in the middle of being asked to put patients at the centre of their care by some parts of the health 
system directives, whilst being blocked and coerced by others.  
Doctor D: “Sometimes, the NHS systems put barriers in place like GP practices or certain secondary 
care trusts where the biochemistry departments are situated won't do a T3 in a patient or a T4, 
they'll just do a TSH”  
Doctor E: the one thing that's very common and what uh I can't work out why this has not been 
solved yet is the recent T3 crisis is difficult to take, we're seeing a lot of CCGs coming out with 
guidance to deny people T3 and that they're very inflexible and that makes me very angry and 
annoyed” 
Doctor F: “Then I'm asked by the GP would I try to persuade the patient to stop these things. I 
think in those circumstances, obviously, it's wrong.” 
Doctor H:” I know x CCG is different ours do let us prescribe T3, but they need to see really clear 
pre-treatment, post-treatment. In fact, we're having to go back and look at our historic patients 
and actually take them off to prove that there's a definite benefit. They're not happy with just an 
outcome that could say they feel better.” 
Participants in this study identified a will and hope for change and progress towards a medical 
system which empowers and activates patients, supports their choices, and supports their wider 
psychosocial needs. However, Endocrinologists need support to raise patients with hypothyroidism 
up the political agenda and to receive funding, support and autonomy to place patients at the 
centre of their care.  
Doctor C: “ I think one of the issues around this is that thyroid disease or particularly 
hypothyroidism is profiled as relatively low it’s not really as sexy as say cancer or diabetes. For 
commissioners of healthcare as well as deliverers of healthcare of thyroid disease common, is way, 
way down the priority list. You find that thyroxine is third most prescribed drug in the UK. It’s 
staggering that people don’t really take too much notice of it” 
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Doctor D: “It's a battleground, isn't it? Where in some respects the NHS pays lip service to the 
patient being the focus of concern to actually controlling what patients can and cannot have 
through financial means and guidelines. Clearly, there have to be some controls put in, but it's 
been, in my opinion fairly unsympathetic and created more hostility and more battlegrounds.” 
Doctor F: “Let me just emphasise again, I think this is an underfunded and neglected area. I call 
this an embarrassing secret of the NHS because it is the case” 
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Chapter 5: Discussion 
 
This chapter discusses the findings of the analysis presented in Chapter 4 (‘Findings’) in relation to 
the aim and objectives identified in Chapter 1 (‘Aim, objectives, and rationale’) and to existing 
research that has explored similar areas. Implications of these findings to future research and 
practice are considered. 
 
5.1. Endocrinologists views about the psychosocial and self-management support needs of 
patients living with hypothyroidism  
 
In this study, participants highlighted that there are heterogeneous hypothyroid patient subgroups 
with diverse support needs. These include patients with: a new diagnosis; subclinical 
hypothyroidism (see 5.1. subtheme 2); symptoms of thyroid autoimmunity (including thyroid 
autoimmune overactivity, see section 5.3); survivors of thyroid cancer; patients with multi-
morbidity and patients with persistent physical symptoms of unclear origin, or due to potential 
treatment inefficiency.   
 
In Chapter 2.4. (‘The history of treatment for hypothyroidism’), patient heterogeneity was raised as 
one of the limitations of population-level trials of thyroid hormone replacement therapy (Dayan & 
Paniker, 2018). In the wider literature, heterogeneity of patient subgroups has also been attributed 
to modification of effects in varied treatment outcomes (e.g. Kent et al, 2010; Varadhan et al, 2013; 
Gil-Herrera et al, 2014). The current thesis recommends that future research and intervention 
should recognise and appropriately target different subgroups to improve treatment outcomes for 
patients with hypothyroidism.  
 
Symptoms of Hashimoto’s disease: Two thirds of  participants in this study reiterated previous 
research detailing a higher incidence of unresolved symptom burden and co-existing autoimmune 
diseases in patients with hypothyroidism resulting from autoimmune thyroid disease (Punzi & 
Betterle, 2004; Spirkova et al, 2015; Fallahi et al, 2016). A small number, however, did not think 
that autoimmunity plays a role in persistent malaise. This suggests that not all Endocrinologists 
provide education about the residual symptoms of thyroid autoimmunity. Those who did however, 
highlighted a lack of current treatments for Hashimoto’s disease other than LT4 therapy to restore 
thyroid hormone levels.  
Autoimmune thyroid disorders are the most frequent organ-specific autoimmune diseases, 
involving about 5% of world population, Hashimoto’s thyroiditis is the most prevalent (Virili et al 
2018).  Autoimmunity research focuses on the breakdown in immunological self-tolerance and 
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resulting inflammation in creating symptom burden (Figueroa-Vega et al, 2010: Wang et al, 2010; 
Ganesh et al, 2011).  Studies with patients with autoimmune hypothyroidism (Hashimoto’s disease) 
have reported presenting symptoms to include anxiety, negative mood, depression, dry skin, cold 
intolerance, puffy eyes, muscle cramps and fatigue, deep voice, constipation, slow thinking and 
poor memory (Van Zuren et al, 2013). However, little is known as to how much of the persistent 
symptom burden reported in literature regarding hypothyroidism is attributable to the lack of 
available treatment for Hashimoto’s disease.  
 
Research into the interaction of genotype with environmental triggers has led to interest in the role 
of the intestinal microbiota and dysbiosis in thyroid autoimmune disease onset (e.g. Mori et al, 
2012; Virili et al, 2018), and an increased prevalence of celiac disease has been found in patients 
with autoimmune thyroiditis (Lerner et al, 2017). Subsequent interest is growing in research which 
explores whether dietary interventions and specific supplements (particularly selenium) might 
reduce antibody levels and alleviate resulting inflammation; and  result in a decreased dosage of 
LT4  (e.g. Toulis et al, 2010; van Zuuren et al, 2013; Abbot et al, 2019; Wojas et al, 2019).  
 
The findings suggest that condition-specific information and education may be required for people 
with Hashimoto’s disease which may lie outside of the traditional Endocrinology remit and 
highlights a need  for multi-disciplinary paradigms, for example incorporating Dieticians (see section 
5.3., subtheme 3). Self-management support which teaches patients to access and use a range of 
informational resources has been developed for patients with rheumatic autoimmune diseases 
which are also characterised by systemic inflammation leading to target organ dysfunction (e.g. 
Dures et al, 2014a; Dures et al, 2014b; Dures et al, 2016). Future research may consider the 
feasibility of adopting these models of support for patients with autoimmune endocrinology 
conditions.  
 
Thyroid cancer: Nearly half of participants in the current study mentioned the additional symptom 
burden of hypothyroid survivors of thyroid cancer. Whilst not a dominant focus of concern, the 
brief attention given to the subject here is interpreted as important as it reflects wider findings that 
this problem is a largely overlooked by clinicians but of importance to patients.  
 
Thyroid cancer generally has a good prognosis. However studies (e,g, Applewhite et al, 2016) have 
identified that quality of life is similar to that in cancers with worse survival rates and that significant 
unmet informational and psychosocial support need exists in this patient group (e.g. Banach et al, 
2013). Despite this, systematic reviews (Grogan et al, 2016; Parker et al, 2017) have found no 
studies to characterise morbidity or to tailor treatment strategies.  One qualitative study with 
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survivors of thyroid cancer (Smith, 2018) identified a lack of disease-specific information, isolation,  
body image concerns (scars), and concerns about the future (e.g. fertility) to be important amongst 
this patients treated for thyroid cancer. Concerns about stigmatisation resulting from semantics 
relating to the ‘good disease prognosis’; feelings of disregard (i.e. delays in obtaining a diagnosis), 
and worries about subsequent hypothyroidism (lifelong reliance upon medication to achieve 
hormonal health) have also been reported as salient concerns  (Easley et al, 2013; Smith, 2018). 
 
In the present study, some participants felt that hypothyroid survivors of thyroid cancer may have 
condition-specific support needs, including a need for psychological support and for exercise 
intervention to address bone density loss following treatment (e.g. section 4.1; subtheme 1). The 
present study recommends that future investigation is needed to carry out a specific assessment 
to ascertain the psychosocial and self-management support needs in this patient group and 
whether these contribute to reports of treatment dissatisfaction reported in the literature. 
Multidisciplinary interventions (e.g. including by Exercise Physiologists – see section 5.3., subtheme 
3) may also be appropriate for this patient group. 
 
Patients for whom treatment may be ineffective: Participants in this study reiterated findings 
presented in Chapter 2.4. (‘The history of treatment for hypothyroidism’) that there may be a group 
of patients for whom treatment with standard LT4 therapy may be ineffective (e.g. Kalra & 
Khandelwal, 2011; Chaker et al, 2017; Wiersinga, 2014, Peterson et al, 2018, Dayan & Paniker 2018). 
They described investigations to rule out co-multimorbidity in the first instance (see section 5.2; 
Embedded is best). Following this, some but not all participants provide time limited therapeutic 
trials of LT3 or (a smaller number) of NDT thyroid hormone replacement treatment.  
 
However, participants described paradoxical incentives and barriers to this approach including high 
patient demand for personalised or non-standard treatments on one hand and reductionism and 
scientific ‘unknowns’ on the other. This is reflected in the literature, through calls for increased 
attention to patient centred care (e.g. The Health Foundation, 2016) and patient activation 
(Alexander et al, 2012; Hibbard & Gilbert, 2014) set against directives to standardise testing and 
treatments  (e.g. Daucourt et al, 2003; Pronovost, 2013; Toft, 2017; Jonklass et al, 2019; Taylor et 
al, 2019; see Chapter 2.4. The history of treatment for hypothyroidism’ and Chapter 2.5 ‘Systematic 
review’).  
 
In the wider literature, factors at different conceptual levels (e.g. personal, social, financial, 
organisational) have been identified as barriers and enablers to clinicians’ behaviour throughout 
the healthcare system (e.g. Michie et al, 2011). The current research identifies a mismatch between 
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demands and barriers, leaving clinicians ‘stuck between a rock and hard place’ as described in 
Chapter 2.4. (‘The history of treatment for hypothyroidism’ e.g. Toft, 2017; National Voices 2017; 
Pulse Magazine, Sep. 2018; Dayan & Paniker 2018). Participants who offer trials of LT3, described 
doing so despite varied beliefs about efficacy and fear of personal responsibility for risk (see section 
4.2. subtheme 2) but did so to address socio-political (universal) barriers (section 4.2. subtheme 3; 
section 4.4., subtheme 1) which they felt contribute to patients’ sense of helplessness and 
subsequent anger and depression (Seligman 1972; Abramson, Seligman, & Teasdale, 1978). 
 
If patients’ symptoms did not resolve, participants expressed dissatisfaction associated with leaving 
these patients in a state of ‘limbo’ (see section 4.3, subtheme 3) without appropriate support and 
described a lack of service provision for these patients, except referral back to the GP. Participants 
in the current study described managing difficult and emotional interactions with patients in 
response to perceived denial of treatment (section 4.2. subtheme 3), or when treatments failed to 
resolve symptoms. 
Recommendations have been made in the literature for new models of working to address quality 
of life in patients who are dissatisfied with thyroid treatment (Hoermann et al, 2017; Toft 2017; 
Midgley et al, 2019) and to improve healthcare for patients with persistent symptoms (e.g. Joint 
Commissioning Panel for Mental Health, 2017).  Psychosocial interventions based on Seligman’s 
(2011) model of ‘learned optimism’ have been found to promote positive social and psychological 
appraisals and wellbeing and to restore personal control and resilience amongst patients living with 
cancer (e.g. Zollman et al 2017; Seiler & Jenewein, 2019) and may support Endocrinologists to 
address the psychosocial needs of this patient group whilst maintaining validation of patients’ 
illness experiences (see section 5.2., subtheme 3). Recommendations have been also been made 
that all healthcare professionals are provided with training to develop the skills to work effectively 
with patients with persistent or unexplained medical symptoms (e.g. ‘Joint Commissioning Panel 
for Mental Health, 2017) and may address the negative impacts upon their own job satisfaction 
described by some participants in this study (section 5.3. subtheme 2). 
Participants reiterated reports in the literature that the heterogenous patient subgroups described 
above face a range of issues which effect their quality of life including; lethargy and fatigue (Van de 
ven et al, 2012), poor control over weight  (Kelderman-Bolk et al, 2015); anxiety and depression 
(e.g. Alsaffar et al, 2016); poor health related quality of life (e.g. Watt et al, 2006), impairment in 
psychological wellbeing (Saravanan et al, 2006; Saravanan et al, 2002; Paniker et al, 2009; Wekking 
et al, 2005; In Taylor et al 2019). poor general mental health (e.g. Saravanan et al, 2002).  
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Participants recommended that support is needed from the point of diagnosis, particularly for 
newly diagnosed patients and those with subclinical hypothyroidism (for whom findings of slightly 
abnormal biochemistry may or may not be a clear indication of disease). An online leaflet (NHS UK, 
2018) supports this idea. The information tells patients that early diagnosis is essential, stating: “A 
hypothyroid state can change the way the body processes fat. This can cause high 
cholesterol and atherosclerosis (clogging of the arteries), which can potentially lead to serious 
heart-related problems, such as angina and a heart attack”. However, the information sheet 
provides no follow up to support patients with the impact of this information. One study (Smith et 
al, 2018) draws attention to the emotional impact upon patients of learning that they require 
lifelong thyroid hormone replacement medication to maintain their hormonal health but 
emphasises a lack of support in this area.  
 
Participants highlighted that limited condition-management information exists, and that supportive 
information is not routinely offered in primary care. One patient information booklet (American 
Thyroid Association, 2013; p.22) highlights that patients may experience the issues highlighted by 
doctors in this study including;  feelings of disregard during seeking a diagnosis, an emotional 
response to diagnosis, need for expectation management, and feelings regarding the lack of cure, 
lifelong need for management and scientific unknowns. The booklet makes recommendations for 
lifelong commitment to treatment, adherence and good partnership working with doctors. 
However, the current study highlights that early support and a collaborative approach is currently 
lacking for UK patients with hypothyroidism in primary care. In response to the lack of suitable 
information for patients in the UK, the author of this thesis was invited to collaborate with the 
British Thyroid Foundation in 2020 to develop and publish an information leaflet for patients about 
‘Coping with the psychosocial impact of hypothyroidism’ (BTF, Jackson, & Griffiths; 2020).  
 
The benefits of early support perceived by participants in this study reflect calls to identify new 
models of working in primary care (NHS England 2016; Baird et al, 2016). These include delivering 
interventions at the point of prescribing and providing regular reviews to optimise the therapeutic 
outcomes of medications; to prevent waste and subsequent the cost to the NHS (Hazell & Robson, 
2015). Support for this exists in previous research (Dew et al, 2018) which found suboptimal 
treatment of hypothyroidism in primary care despite clinician attitudes that the condition is 
straightforward to treat (Chapter 2.6. Examining clinicians’ attitudes, beliefs and intentions towards 
self-management and psychosocial care). Participants in the present study have highlighted a lack 
of review and suboptimal management in primary care as a primary reason for patient reports of 
treatment dissatisfaction, poor physical and psychological outcomes, risk of non-adherence (e.g. 
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seeking or self-sourcing alternative thyroid hormone replacement therapies) and for increased 
demand upon secondary care.  
 
Despite identifying the diverse support needs of patients with hypothyroidism, participants varied 
in attitudes and perceived confidence and ability to explore psychosocial and self-management 
issues with patients in their own practice. A small number of clinicians reported feeling comfortable 
and happy to probe patients who they thought might be struggling emotionally whilst a minority 
felt that addressing psychosocial issues lay outside of the clinical remit.  
 
This reiterates findings in the wider literature that doctors vary in will and confidence to incorporate 
non-medical models of care. For example, in a survey of 304 doctors and 1,006 patients in the US, 
Jonas et al (2019) reported that only 53% of doctors believed their patients would be interested in 
discussing self-care, compared to 72% of patients. Dures et al (2016) found that only a quarter of 
rheumatology patients reported being asked about social and emotional issues by their clinician.  
In the current research, most participants felt that they primarily lacked time, then skill and support 
to explore patients’ psychosocial and self-management needs. Similarly Jonas et al (2019) reported 
that 78% of physicians reported a lack of time as the top reason they did not discuss self-care with 
their patients,  and also as one of the reasons physicians say they did not personally practice their 
desired amount of their own self-care.  
 
5.2. Endocrinologists’ experiences of providing psychosocial and self-management support within 
their own practice and referring patients with hypothyroidism for psychosocial and self-
management support  
 
Participants described the roles they held in supporting patients with persistent symptoms. These 
included: building a doctor-patient relationship based on trust; listening; validating patients 
experiences; reducing the perceived battleground between patients and the healthcare system; 
ruling out co-morbidity; optimising therapeutic effects of treatment and increasing adherence; 
providing quality information and education; provision of therapeutic trials (but not all clinicians); 
management of expectations through goal setting and action planning; and reiteration of healthful 
behaviours.  
 
Participants described listening to patients’ experiences of their symptoms and trying to 
understand the beliefs that shape patients’ perceptions of the threat to their health. In response, 
participants described addressing inaccurate beliefs and ideas which they felt were often formed 
by information online (see section 4.2. ‘Professional identity’). Participants described carrying out 
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extensive tests to rule out biological co-morbidities and educating patients to form alternative 
explanations for their symptoms (reinterpreting physiologic symptoms; Lorig & Holman, 2003). 
 
The application of theory may support Endocrinologists to work collaboratively by providing 
frameworks to explore and address their patients’ beliefs about hypothyroidism and to tailor 
education to fit individual representations (Baumann, et al, 1989; Petrie et al, 2003). For example, 
in the ‘Common-sense model of self-regulation’ (Leventhal et al, 2003) patients are viewed as 
independent problem-solvers who actively process health information to create understandings 
that guide health-related decisions and behaviour. Training for Endocrinologists in the theory and 
skills of self-management may help them to address the accuracy and coherence of patients’ lay 
beliefs (Moss-Morris et al, 2002; Leventhal et al, 2003); to improve their self-efficacy and 
understand their condition; to avoid ineffective and potentially unsafe self-management 
behaviours (including self-sourcing medications) and to improve their health outcomes (Breland et 
al, 2020).  
 
Whilst participants were generally supportive of patients making decisions to utilise wider 
strategies and complementary approaches to improve their wellbeing, they described challenges 
to their professional identity as the biological expert when patients adopted an active health 
consumer role. Specifically, some participants described their struggle to devolve power to patients  
when they felt that ‘scientific unknowns’ presented potential risks to patients’ health; when they 
felt that patients misinterpreted clinical guidelines, and when patients self-sourced non-standard 
hormone replacement therapies in response to dissatisfaction with reductionist treatment 
approaches. This reflects wider findings that clinicians’ struggle to endorse patient activation when 
they perceive that associated activity contradicts clinical advice (e.g. NHS England, 2015). Some 
described being caught in a ‘battleground’ between paradigms and felt that some patients 
presented with fixed a fixed agenda (i.e. to obtain LT3) and an ‘us and them’ approach to the 
consultation, fuelled in part by engagement with online patient groups (section 4.2, subtheme 3: 
‘Difficulty shifting the focus’). 
 
This phenomenon is argued to reside within an emerging paradigm clash between modern 
subjectivist treatment philosophies and traditional positivist approaches. Newer treatment 
philosophies challenge the concept of professionalism in medicine (e.g. Madden, 2012) through 
increased patient autonomy and treatment responsibility. In contrast, the traditional medical 
model holds a core belief that patients require guidance on medical treatments and that knowledge 
and experience supersede the need for a patient-centred approach (e.g. Rogers et al, 2005). 
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The impact upon the doctor-patient relationship resulting from the clash between activation and 
standardisation is described as a contentious issue throughout modern healthcare (e.g. Madden, 
2012). Within endocrinology, for example, Snow et al (2011) found that patient education to 
increase condition-specific knowledge in patients with Type 1 diabetes led to fraught interactions 
within the healthcare system. This stemmed from patient perceptions that restricting access to 
medications perpetuates power imbalances which impede their ability to self-manage. 
Concurrently, healthcare professionals felt unsure of their patients’ actions and uncomfortable to 
trust their expertise.  
 
Incorporating theoretical approaches, such as ‘Social Identity Theory’ (Tajfel, & Turner, 1979) may 
provide a useful framework through which to further examine conflicts and challenges to 
participants and patients’ identities described here.  Potentially, a reluctance to incorporate 
patient-centred support may be viewed as socially identifying with the ‘profession’ and against the 
‘discrediting’ of science and clinical guidelines. Similarly, identifying with polarised patient groups 
which label Endocrinologists (as knowledgeable or uncaring) may protect patients against perceived 
connotations of being left without answers or labelled with unhelpful terminology including 
‘medically unexplained symptoms’, the impact of which is described by participants in this study 
and elsewhere (e.g. Marks & Hunter, 2015; Joint Commissioning Panel for Mental Health, 2017). 
Incorporating identity theory frameworks into future research and training may provide an 
opportunity for clinicians to identify and challenge assumptions about the nature of professional 
identity within the changing role of the medical profession (e.g. Burford, 2012).  
 
Participants felt that patients were less resistant to having their ideas and treatment beliefs 
challenged when clinicians ‘kept the door open’ to biological explanations for their symptoms. 
However, attempts to shift from a biological focus were often met with anger and upset. This was 
particularly so when participants tried to discuss mental health (e.g. depression) or psychosocial 
(e.g. work stress) issues which may impact upon symptom development or progression; or when 
they tried to refer patients for supportive care (e.g. to a Dietician).  
 
Some participants noted that patients with symptoms of hypothyroidism have traditionally 
experienced dismissal from other health professionals, contributing to ‘us and them’ polarisation. 
This is reiterated in a patient booklet (American Thyroid  Association, 2013; p.22) which recognises 
that many people are diagnosed with hypothyroidism after feeling sick for years or believing or 
being told their symptoms are "all in your head," "just stress," or "a normal part of aging”.  
 
77 
 
Participants therefore felt it important to focus on biological causes of persistent symptoms, and 
worried that a shift in focus away from thyroid biology would be interpreted by patients as 
stigmatisation, invalidation of their illness experience, or that the clinician had somehow failed. 
Participants also resisted ‘moralisation’ (e.g. Brown, 2018) through questioning patients’ health 
behaviours, and highlighted that many patients were well read and activated (although vulnerable 
to misinformation online), and had already tried many approaches to alleviate their symptoms. 
Often, they described feeling stuck to shift the focus of the consultation towards non-medical issues 
in a way which would be acceptable and useful to patients.  These findings support wider findings 
from a study using the ‘Theory of Planned Behaviour’ (Ajzen, 1991; 2002) that  clinicians are less 
likely to implement self-management if they did not believe that ‘important others’ (patients and 
senior figures) are on-board with the model of care (Anderson & Ozakinci, 2019).  
In the literature, overlap can be found with other conditions. For example, debate and anger has 
grown following a clinical trial which concluded that adding cognitive behavioural therapy and 
graded exercise therapy to specialist medical care improved recovery for people with ME/CFS. 
Debates focused on the terminology used in the trial dispute that ‘recovery’ can be achieved 
through non-medical treatments and highlight the implications of these finding upon the organic 
classification of the disease (e.g. Torjesen; 2018). One participant in this study emphasised that any 
potential psychosocial or self-management interventions (section 4.3. Subtheme 3: ‘Assets and 
strengths’) should be mindful of endocrine pathology. This is consistent with recommendations that 
psychosocial interventions should address the ways in which illness has woven itself into the daily 
texture of the patient’s existence rather than to search for alternative causes of symptoms ‘within 
the mind’ (Deary, 2017).   
 
5.3: Perceived facilitators to the implementation of psychosocial and self-management models 
of care  
 
Around half of participants in this study emphasised the need to incorporate patients as respected 
partners in their care; to solve problems with them not for them and to avoid reducing them to 
passive recipients of care. This approach is echoed in the NHS ‘House of Care’ model for long term 
conditions which takes into account the expertise and resources of the people with LTCs and their 
communities (NHS England, 2019a).  Participants  who did not express these views tended to 
perceive hypothyroidism as an acute illness, with symptoms which should resolve with standard 
treatment, and were less likely to engage patients within a co-creative and participative approach 
(e.g. Hardyman et al, 2015; Graffigna & Barello, 2018). However, these participants reported lower 
levels of satisfaction in their interactions with this patient group.  
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In Chapter 2.5 (‘Systematic review’) one-way interventions to provide information to patients 
reported no treatment effect upon health outcomes, for example in increasing adherence to LT4 
(Crilly & Esmail, 2005). This was reiterated by one participant in this study who highlighted that 
more than information-giving is required, and that it is important to engage patients to understand 
what is important to them (their fears, needs and preferences).  
Recommendations in the wider literature have been made to value the role of patients as partners 
and problem solvers particularly when patient illness or treatment expectations are mismatched 
with those of the provider (Young & Flower, 2002), as participants in this study identified in section 
5.1 (‘Subtheme 2: ‘Diverse support needs’). Involving patients in their care is an opportunity to 
narrow polarisation between patients and the medical profession (Young & Flower, 2002) identified 
in section 5.2. (Subtheme 3: ‘Difficulty shifting the focus’) and has been identified as a key strategy 
to reduce feelings of disregard amongst patients, particularly those with persistent or medically 
unexplained symptoms (Houwen et al, 2017).  
 
In primary care however, Dew et al (2018) found that only one GP reported treating a patient with 
hypothyroidism according to a collaborative and autonomous patient-doctor agreement. In the 
present study over half of participants reported being more comfortable than GPs to collaborate 
with patients. However, the conversation around collaboration in this study focused almost 
exclusively on whether or not to support non-standard hormone replacement therapy.  
 
A number of participants raised the issue that using patient reported outcomes measures (PROMS) 
which are informed by the values, attitudes, and perceptions of patients (Dowling et al, 2016) may 
be a way to improve the patient voice in collecting evidence relating to hypothyroidism. Specifically, 
some described using the ‘Thyroid-Related Quality of Life Measure’ (ThyPRO) (Watt et al, 2014) to 
examine quality of life improvements in patients undergoing clinical treatments in their own 
practice, and reported increasing use of this  by Clinical Commissioning Groups (CCGs).  
 
Some participants were sceptical however about the potential for bias within PROMS, as they were 
about anecdotal evidence from patients, which indicates that not all Endocrinologists trust in a 
partnership approach to the management of hypothyroidism. More work is required therefore to 
build collaborative bridges between patients with hypothyroidism and their care providers. Training 
for clinicians in the theory and skills of self-management may include them in the research 
conversation about issues of reliability and validity in the use of PROMS and may decrease 
scepticism. For example, research has found support for the clinical reliability and test-re-test 
validity of the Thy-PRO for use in clinical settings (e.g. Watt et al, 2010).  
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All participants felt that involving patients with hypothyroidism in their own care from the point of 
diagnosis may help to manage patient expectations (see section 5.1. Subtheme 2: ‘Diverse support 
needs’), improve coping skills, and stem the flow of dissatisfied patients backwards and forwards 
between primary and secondary care. In the wider literature the term ‘revolving door’ has been 
used to describe conditions where patients may spend many years seeking help, often getting stuck 
seeing a variety of specialists (Blyth et al, 2004;  Clare et al, 2013). Dew et al (2017) recommended 
that educating patients in primary care regarding the consequences of inadequate thyroid hormone 
replacement may improve long term treatment outcomes for patients with hypothyroidism. 
Participants in the present study felt that this is important to address to remove patients with 
hypothyroidism from the revolving door.  
 
Recommendations have been made for access to patient-centred care that is responsive to 
individual patient preferences, needs and values at the primary-secondary care interface (e.g. 
Sampson et al, 2015) and to engage with patient groups,  and the voluntary and community sectors 
to prevent patients becoming caught in a ‘no-mans land’ between primary and secondary care (NHS 
England 2017).   
 
Recommendations have specifically been made for an increased focus on asset-based models which 
emphasise shared decision making for patients with subclinical hypothyroidism in primary care 
(Cheong, 2019; Jenkins, 2019; Sanday, 2019; Forsyth, 2019; Bekkering et al 2019b). Beyond 
hypothyroidism, it has been found that engaging patients in primary care as ‘assets’ in the planning 
of care is an effective strategy in the management and control of symptoms and secondary 
prevention for patients with chronic health conditions (Dineen-Griffin et al,  2019).  
 
Assets can be described as the collective resources which individuals and communities have at their 
disposal (McLean, 2012). Asset-based approaches begin with identifying a community's capacities 
and encouraging it to help itself (Noble-Jones et al, 2019).  Multi-professional staff and the 
charitable sector are assets that patients might use alongside their own assets to promote capacity, 
connectedness and social capital (NHS Health Scotland, 2011; Noble-Jones et al, 2019).  To enable 
this approach requires health professionals to collaborate, alongside the transformation of the 
health service workforce to work differently (Adkins et al, 2017; NHS Scotland, 2018; Health 
Education England, 2017).   
Participants identified the untapped value of asset-based collaboration with multidisciplinary 
colleagues (Endocrine Nurses, Health Psychologists, Dieticians, embedded Researchers, Exercise 
Physiologists and Pharmacists) and the evidence-based charitable sector to address gaps for 
patients with hypothyroidism in primary and secondary care.  Collaboration is defined as an 
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interactive process that enables people with diverse experience to generate creative solutions to 
mutually defined problems to develop enhanced outcomes (Idol et al, 1995). According to systems 
theory, this is key to improving performance in the healthcare system (Walshe & Rundall, 2001; 
Glanz et al, 2008). 
 
Participants felt that multidisciplinary self-management approaches could help to meet the diverse 
needs of people living with hypothyroidism. Participants talked about approaches used in the care 
of patients with type 2 diabetes which may be adaptable. However, some participants noted that 
the NHS was unlikely to fund such provision. 
 
Multidisciplinary diabetes care teams utilise collaboration between specialists as required, from the 
point of diagnosis and provide care across the primary-secondary care interface which recognises 
the divergent needs of people living with diabetes (Diabetes UK, 2010). The effects of multi-
disciplinary self-management support within this area of endocrinology are recognised worldwide 
(e.g. Hreha & Noce, 2018; Tan et al, 2019).  
 
In the case of thyroid disease, multidisciplinary approaches are included within the National Cancer 
Plan for patients with thyroid cancer. They consist of Oncologists, Radiologists, Pathologists and 
Clinical Nurse Specialists (Mallik, 2006; Hewett, 2007) with support from the evidence-based 
charitable sector (e.g. The Butterfly Thyroid Cancer Trust). However, calls have been made in the 
literature to improve current service provision through incorporating knowledge translation and 
psychosocial support (e.g. Hyun et al, 2016).  
 
Multidisciplinary approaches for patients with thyroid eye disease (TED) have also been 
recommended (Perros et al, 2015) to improve care for people with TED. Endocrine teams are 
required to identify a specialist multidisciplinary thyroid eye clinic in their region and refer all 
patients with moderate or severe TED affecting the patients’ quality of life to this service (Draman 
et al 2017). Research from a health psychology paradigm however (Wickwar et al, 2015) has 
highlighted that development of psychosocial interventions targeting appearance-related cognitive 
processes are yet to be funded and developed to enhance the quality of life outcomes for patients 
with TED undergoing orbital decompression surgery. In 2017, the author of this thesis was invited 
to present at a TEAMeD patient information day, and to provide multidisciplinary team training as 
part of the ‘teaching and training’ requirements for the Professional Doctorate in Health 
Psychology.  
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Participants in this thesis highlighted a need for multidisciplinary approaches for patients with 
hypothyroidism but felt that funding in this area was unlikely. This heterogeneous patient group 
includes survivors of thyroid cancer, and patients who have been treated for TED. It also includes 
(as discussed in 5.1: subtheme 1) patients with high levels of multimorbidity for whom 
multidisciplinary approaches have been recommended in the literature. For example, thyroid 
disease has been found to be a common comorbidity in patients with heart failure and 
multimorbidity (Stewart et al, 2016). Participants also highlighted a lack of training and referral 
services to support communication with patients for whom the cause of symptoms could not yet 
be identified. Calls for health professional training and for multi-disciplinary service provision for 
patients with persistent symptoms have also been made (e.g. ‘Joint Commissioning Panel for 
Mental Health, 2017). 
This thesis therefore recommends that there is a significant rationale to fund research to develop 
and evaluate multi professional self-management interventions for people with hypothyroidism but 
as of yet, no such service exists, despite thyroxine being the third most prevalently prescribed drug 
in the UK (NHS Digital, 2017).   
 
Participants highlighted that important expertise could be provided by Endocrine Nurses, Health 
Psychologists, Dieticians, Exercise Physiologists, and embedded Researchers to improve outcomes 
for patients with hypothyroidism. Recommendations have also been made in the literature for 
pharmacists to play a key role in delivering medical and behavioural modification interventions (e.g. 
Jonklaas & Kane, 2017), although it has been found that Pharmacists may play a more substantive 
role if they had access to the medical notes of patients to support the optimisation of thyroid 
treatment outcomes in primary care (Dew et al, 2018).  
 
Participants also highlighted the essential role of the British Thyroid Foundation and the Pituitary 
Foundation in providing trustworthy evidence-based information and support for patients (see 
section 5.5 ‘Endocrinologists’ views and experiences of referring patients for psychosocial and self-
management support’) and for helping to combat inaccurate or misleading online messaging.  
 
Research has found that when patients perceive a lack of condition-specific informational or other 
support they seek identification with others who have experienced the same condition to provide 
shared understanding, positive role models and to obtain information about coping  (Smith et al, 
2018). This is the case for survivors of thyroid cancer (e.g. Easley et al, 2013; Smith et al, 2018) and 
has been identified by participants in this study for patients with hypothyroidism who commonly 
experience loss of social support,  including loss of work and problematic relationships with others 
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(Thilvum et al, 2014, Brandt et al, 2015; Naxo et al, 2015, see 2.2. ‘Complexity and persistent 
symptoms’).    
 
However, when individuals without the right knowledge or experience support others and facilitate 
peer interventions, it has been found to exacerbate the original problems through the provision of 
unproven or incorrect advice (e.g. Department for Education, 2017). Participants in the present 
study, however have highlighted the positive value of support from expert peers which is not 
available from friends and family (Matthews 2000; Coyne & Borbasi 2007; Clarke et al, 2011) and 
support recommendations for commissioning which views evidence-based peer support as 
essential to the future of the NHS, (including NHS England’s ‘Five Year Forward View’ in 2014; and 
a joint NESTA and National Voices review, 2015).  
 
Self-management support for patients with hypothyroidism should therefore incorporate and 
support the charitable sector to provide key elements of self-management support. These may 
include resource utilisation, modelling and self-tailoring (Lorig & Holman, 2003) to increase 
patients’ knowledge and understanding of their condition and the consequences of suboptimal 
treatment or over-replacement of thyroid hormones (Brown et al, 2005; Dew et al, 2017) and to 
provide education on issues relating to the impact of the disease and treatment on quality of life 
(Grogan et al, 2016; Banach et al, 2013).  
 
5.4: Perceived barriers to the implementation of psychosocial and self-management models of 
care  
 
In Chapter 2.7. (‘Defining Psychosocial and self-management support’) it was highlighted that 
investment into the ‘Personalised Care model’ including self-management support, is included the 
‘NHS Long Term Plan’ (Alderwick & Dixon, 2019). Programmes which activate and empower 
patients have been associated with a reduction in health inequalities, delivery of improved 
outcomes, better quality care and lower costs (e.g. Lorig & Holman; 2003; Hibbard & Gilbert 2014; 
NHS Education Scotland 2014; Self-Management UK, 2017; Anderson & Ozaninci, 2019). Within this 
model, self-management training can help health care professionals to work with ‘what matters’ to 
people, based on their individual assets, needs and preferences, as well as to take account 
inequalities and accessibility barriers (Dures et al, 2014.2; NHS England, 2019a).  
 
Paradoxically (see section 5.1. Subtheme 1), participants in this study identified uncapped rises of 
the cost of LT3 and restrictive practices from CCGs as limiting patient treatment choice and clinician 
prescribing autonomy and promoting reductionist, directive approaches. They described 
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restrictions to NHS services based on cost as creating health inequalities (access to private 
appointments and self-sourced treatments become based on socioeconomic status and internet-
savviness) and research bias (reporting in the THY-Pro). Some participants felt that standardisation 
of treatments diminishes clinician experience (of using non-standard therapies) and undermines 
patient safety (patients source medication from abroad and self-medicate without support from 
clinicians). This reflects wider criticisms and concerns about rising costs of and the uncertain future 
of generic medications in the UK (House of Commons, 2018), which effect a wider range of patients 
with chronic illnesses beyond those with hypothyroidism.   
 
Call are therefore made within this research that echo others (e.g. Ewbank et al, 2018) to address 
the rising costs of medicines in the UK, and to provide resources to include patients with 
hypothyroidism within the ‘House of Care’ in which clinicians are supported by organisational and 
clinical processes  and commissioning to put patients at the centre of care (NHS England, 2019a; 
see section 5.3: subtheme 1).  
 
Participants expressed hope resulting from new NICE recommendations (2019) for trials to examine 
LT4 – LT3 combination therapy for people with persistent hypothyroidism symptoms, and in the 
effectiveness of LT4 for people under 65 with symptomatic subclinical hypothyroidism. The present 
study highlights the importance of these investigations and calls upon the NIHR for funding to 
address ‘scientific unknowns’ which perpetuate ambiguity in the management of hypothyroidism 
and present barriers (particularly clinician attitudinal and behavioural barriers) to the development 
and endorsement of psychosocial and self-management models of care.  
 
In addition, participants have identified a need for investment in research to trial a new long-lasting 
LT3 preparation to address current safety concerns relating to patient treatment choice and to 
develop quality biomarkers to support diagnosis. A subgroup of participants also highlighted the 
need to embed a wider range of wellbeing and patient-reported measures into the research 
conversation to capture a wider range of wellbeing outcomes and incorporate the patient voice 
(section 4.3; subtheme 1).     
 
This thesis recommends that research should move beyond limited informational interventions 
which reduce patients to passive recipients of care (see Chapter 2.5. ‘Systematic review’) to 
incorporate self-management approaches used in other treatment areas  which orientate patients 
as partners in the care process, for example in; arthritis (Lorig, 1982; Lorig & Holman 2003;  McBain 
et al, 2018), chronic pain (Traegar, 2014), CFS/ME (Castell et al, 2011; Núñez, 2011), rheumatology 
(Dures et al 2016), and cancer (Polley et al, 2016).  
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Multidisciplinary research is also required to improve the weak quality of physical interventions 
(also reported in Chapter 2.5: ‘Systematic review’) to support physical recovery from 
hypothyroidism (Singh, 2011; Cotovic et al, 2012; Garces-Ateaga et al, 2013) within the research 
literature. Nutritional and dietary self-management interventions (e.g. Wang et al, 2018; NICE, 
2019; e.g. Abbot et al, 2019) should be recognised as a growing area of interest for patients, 
particularly for the management of autoimmune thyroid disease, to potentially reduce need for 
surgical thyroidectomy, and  for survivors of thyroid cancer.   
 
However, participants’ accounts and interpretations in this section recommend that caution must 
be given to ensure that future interventions are developed as complimentary rather than primary 
therapies and that their delivery must remain mindful of endocrine pathology.  Elsewhere it has 
been emphasised that asset-based approaches are not a replacement for investment in service 
improvement, or for addressing the structural causes of health inequalities (Glasgow Centre for 
Population Health, 2012; Noble-Jones et al, 2019). Participants in this study highlighted that work 
is required to engage patients in the process to determine what issues are of importance for them. 
This may be conducted through the charitable sector to address issues of patient distrust in the 
healthcare system raised in this study. 
 
Most participants in this research identified as motivated to adopt personalised models of care and 
a self-management paradigm where the needs of the patient are viewed as a starting point for 
exploration and development of new solutions (Reid et al 2005). However, numerous extrinsic 
barriers between ideals and practice were identified which have reflected descriptions of 
Endocrinologists as ‘stuck between a rock and a hard place’ regarding the treatment of patients 
with hypothyroidism (see section 5.1; subtheme 1).   
 
The challenge of integrating clinical care that is consistent with scientific evidence yet gives room 
to patients’ personal contexts and emotions and empowers them to manage their health (see 
section 4.2. subtheme 2) has similarly resulted in findings of dissonance through the literature (e.g. 
Butalid et al, 2014). This highlights the importance of addressing social norms and control factors 
which mediate health professionals’ intentions to implement self-management models of care 
(Dures et al, 2014.1; Ernst et al, 2018; Anderson & Ozakinci, 2019). For example, clinicians 
reportedly cite a lack of referral options as one of the top three barriers to acceptance and use of 
diabetes self-management support (Mulvaney, 2009; Peyrot et al 2009).  
 
Restrictions upon autonomy and competence were identified by participants in this study, and the 
subsequent impact upon relationships with patients. Some argue this highlights the potential threat 
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of disruption posed by asset-based models of working to the status quo within modern medicine 
and public health (e.g. Hopkins & Rippon, 2015). Specialist and reductive approaches are cautious 
and risk averse and directives to adopt new ways of working may be met with a lack of support 
from different healthcare paradigms, leaving clinicians stuck in the middle stuck and in fear of risk 
and blame (Telegraph, 2014).   
 
Theoretical frameworks such as Self-determination theory (SDT) (Ryan & Deci, 2000; Deci & Ryan, 
2012; Ryan & Deci 2017) identify that such a mismatch in intrinsic and extrinsic sources of 
motivation may result in a detrimental impact on clinician wellness.   A small number of participants 
described their experiences of supporting patients with hypothyroidism in terms including 
‘trepidation’, ‘dissatisfying’ and ‘heartsink’ suggesting a degree of helplessness and burnout in the 
lack of perceived progress. Burnout has been defined  as  a  state  of  exhaustion  and cynicism 
about ones’ capacity to make a difference  (Maslach et al, 1996;  Schaufeli et al, 2009) resulting in 
apathy, fatigue, anxiety,  low job satisfaction and withdrawal behaviour; negative attitudes towards 
self and others and  belief ones work related gaols can and have not been achieved (Bakker  & 
Demerouti,  2007; Adebayo, 2011).  
 
Other participants described positivity and hope for the future. These clinicians were more likely to 
report ‘task identity’ in offering therapeutic trials of non-standard medications to patients, 
engagement in research and guideline development, and were more likely to be supported by 
researchers and specialist Endocrine Nurses within their thyroid clinics. Task identity is described 
as job characteristics that stimulate personal growth and enable employees to maximise use of 
their talent and ability (Hackman et al, 1975) protecting healthcare staff against diminished 
motivation and burnout (Bajwa, et al , 2010; Adebayo, 2011). The findings of this research highlight 
the importance of addressing the mismatch and between clinicians’ motivations and professional 
values and the realities of practice (Agarwal et al, 2020) and providing them with the necessary 
resources to move forward.  
 
British Medical Association (BMA, 2020) suggests that change is required to improve care for 
patients but also for the working lives and wellbeing of doctors in the NHS, including the promotion 
of learning and time for reflective practice. The review carried out in Chapter 2.5 (‘Systematic 
review’) recommends that this includes training in the theory and skills of self-management 
support. However, system change is also required to address the funding deficit, to empower 
doctors and NHS staff to work together across traditional organisational divides and to create a 
culture that promotes innovation and development that is not rooted in blame (BMA 2020).  The 
findings of this thesis therefore reiterate that integration of psychosocial and self-management 
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support within health care delivery requires a whole system approach, not just negotiation 
between patients and healthcare providers (Weckowicz 1989; Rogers et al, 2005; Alexander et al, 
2012).   
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5.5. Strengths and limitations  
 
Strengths  
 
The strength of this research stems from the commitment to quality and rigour embedded at all 
stages, and through incorporation of best practice frameworks for the design, conduct and analysis 
of qualitative research (e.g. Meyrick, 2006; Yardley, 2000; Braun & Clarke, 2006). These processes 
are described in section 3.2. ‘Quality issues in qualitative research’.  
 
Methodological limitations 
 
This research has generated accounts and experiential descriptions (Braun & Clarke, 2006, p. 174) 
of the views and experiences of participant Endocrinologists. It did not examine the latent content 
of data which would have also been possible using reflexive thematic analysis (Braun & Clarke, 
2006) to interrogate the assumptions, ideas and discourses that may underlie and shape the spoken 
narratives of individual professional attitudes (e.g. Evans & Lewis, 2018).  
 
Future qualitative research using different methodologies may add depth of understanding to this 
subject area. For example, Madden (2012) used a discursive approach to explore the challenges of 
the shifting modern healthcare terrain upon the identities of general practitioners and patients, 
and upon the shifting practitioner-patient relationship. Discourse analysis was used to explore the 
paradoxes and paradigm clashes between treatment philosophies, issues of professionalism and 
the standardisation of treatments, power relationships and debates around dominance and 
subordination.  
However, the findings from the current research also identify participants’ broad accounts of the 
medical paradigm and the perceived challenges to role and identity of incorporating components 
of psychosocial and self-management support. These issues were first identified in Chapter 3.1. 
(‘Rationale for qualitative approach:  Development of researcher’s epistemological and theoretical 
stance’) through the perceived level of importance assigned to the research topic by different PPI 
contributors, and the different levels to which they felt that this research was relevant to the clinical 
remit. It was identified again in the same section when one PPI contributor highlighted that 
Endocrinologists were likely to struggle with healthcare semantics from a Health psychology 
paradigm.   
These differences in ‘knowledge’ between the Health Psychology paradigm and medical 
participants, were used to shape the selection of the current research ontology and epistemology 
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which has aimed to conduct a broad exploration of the accounts of Endocrinologists’ at a level 
which targets and values the partially ‘knowable’ with a view to applying this knowledge to make a 
difference or bring about change.   
 
Sampling limitations and risk of bias   
The use of a snowball sampling method sought to improve recruitment of Endocrinologists who 
may be considered a ‘hard to reach’ group based on their employment status and time constraints.  
During the planning stages of this research, PPI contributors were included to establish the quality 
and trustworthiness of the research, with reference to sensitivity to context, commitment and 
rigour, transparency and coherence. However, as highlighted in section 3.1. (‘Rationale for 
qualitative approach:  Development of researcher’s epistemological and theoretical stance’) one 
Endocrinologist rejected the research importance of persistent symptoms in hypothyroidism and 
withdrew from the project. Whilst this view was unsupported by two other Endocrinologists, this 
experience shaped the recruitment strategy which then attempted to raise the profile of and 
recruitment to the study by asking Endocrinologists (rather than the researcher, a doctoral student) 
to invite other Endocrinologists who may be agreeable to the research cause to participate.  
This method was successful at increasing participation and the appropriate sample size for a UK 
professional doctorate project using thematic analysis (6-15 interviews; Braun & Clarke 2013, 
adapted in Terry et al, 2017) was exceeded.  However, this sampling technique may have biased 
recruitment towards inclusion of people with similar interests, particularly those who professionally 
identify through developing research and practice in this topic area (e.g. Parker et al, 2019). To 
minimise this, participants were asked to consider colleagues who both supported and opposed 
their views, based on knowledge of polarisation identified through extensive engagement with the 
literature. The resulting data does demonstrate differences in accounts regarding practice (e.g. a 
wider range of views regarding LT3 and NDT hormone replacement treatments) but this may still 
not be representative of Endocrinologists as a whole. The aim of this research, however was not to 
provide generalisable or representative findings, which may be valued within positive research; 
rather to give novel accounts and insights from Endocrinologists with a particular interest and 
expertise in the management of complex hypothyroidism, regarding non-medical models of 
support for this patient group.  
 
Further research may address these limitations  through adoption a of pragmatist approach to take 
what is presented here and test out themes on a larger scale,  to look for wider patterns of 
agreement and divergence in the Endocrinologist population (e.g. through a mixed methods 
survey). However, caution in this approach is advised as Endocrinologists in this research were not 
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fluent in language relating to the theory and skills underpinning the facilitation of self-management 
and this approach may require the provision of appropriate definitions or may be suitable to 
evaluate attitudes post-skills based training.  
 
Interpretive and reflexive considerations  
 
Health service research often focuses on generation of theory or to test the use of existing models 
in novel situations.  For example (Dew et al, 2018) using grounded theory to explore data and 
generate theory regarding patients’ and clinicians’ attitudes towards the medical management of 
hypothyroidism in primary care. 
 
The aim of this research however was to provide a starting point; to provide experiential accounts 
of the views and experiences of participants and of the social and political contexts in which they 
are situated. However, the findings from this research were interpreted in this discussion section 
by a trainee Health Psychologist with extensive engagement with the background literature 
regarding the medical treatment of hypothyroidism as well as with the health psychology literature. 
Therefore, whilst this research did not aim to generate theory or to apply deductive tools as a 
theoretical lens (Braun & Clarke 2006), this experiential research is not completely free of 
researcher interpretation.  
Jacobson & Mustafa (2019) highlight the central role the researcher holds in generating and 
analysing data (Leibing & McLean, 2007; McLean, 2007).  They highlight the multitude of factors 
which impact the way that research is approached, interacted with, and interpreted. These include 
the way that we see and interpret the world; our background, experiences, social identity, 
motivations for conducting research and our social position in comparison to that of our 
participants. They note that not only are there power relations to be examined, but that researchers 
are often outsiders without first-hand understanding of the unique social experiences.  
Throughout this research, I have aimed to be reflexive about my own position to allow those who 
read it to better grasp how I produced the data (Finlay, 2002). In Chapter 1.2. ‘Research Origins and 
Rationale’ an overview of the starting point and rational for this research was presented. In Chapter 
3.1 (‘Rationale for qualitative approach: Development of researcher’s epistemological and 
theoretical stance), reflexive examination took place, detailing the factors and experiences which 
shaped this research. The ways in which I have worked to ensure quality in this research were 
described in section 3.2. (‘Quality issues in qualitative research), and the rationale for selection of 
analytic tool in 3.3.  (‘Selecting thematic analysis as an analytic tool for qualitative data’). 
Consideration of researcher positionality was provided in Chapter 3.11. (‘Researcher positionality). 
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5.6. Implications for research and practice, and the role for Health Psychology 
 
Implications for research 
 
This research has highlighted Endocrinologists’ views and experiences of psychosocial and self-
management support in the context of patients with hypothyroidism in secondary care. It has found 
that Endocrinologists perceive patients with hypothyroidism as a heterogenous patient group with 
diverse support needs. It also found that Endocrinologists themselves have varied views, 
experiences, interests, levels of expertise and confidence, and perceived levels of support to 
address and manage the psychosocial concerns of their patients. Whilst a range of psychosocial 
concerns have been identified in the literature developed with patients with hypothyroidism, 
Endocrinologists are in a unique position whereby no current guidelines exist to guide them to 
support patients with this aspect of their care.        
 
This thesis has made several recommendations for research, which are summarised in Table 1, 
below. Specifically, it recommends that a chronic (rather than acute) condition perspective is 
adopted in the management of hypothyroidism. Its also endorses the replacement of reductionist 
testing and treatment approaches (with patients as passive recipients of information) with asset-
based, patient-centred models of care.  
 
Table 1: Summary of recommendations for research 
• Target heterogenous groups of patients with hypothyroidism to identity different concerns, needs and 
symptom clusters (e.g. the role of inflammation in persistent symptoms of Hashimoto’s disease, the lack of 
information for patients with thyroid cancer)  
• Widen the scope of research and intervention (e.g. to include epigenetics, nutrition, and physical activity) 
• Address potential LT4 resistance, trial long lasting T3 
• Involve patients and stakeholders from the outset to ask what is important to patients (beliefs, values, 
expectations)  
• Co-produce and evaluate resources and interventions 
• Include and support the charitable sector to build bridges between patients and the medical system 
• Collaborate. Include Health psychologists, Endocrinologists, Exercise Physiologists, Physiologists, 
Pharmacists, Specialist Nurses in multi professional approaches 
• Incorporate theory and exploratory frameworks. Include Communication theory (Lasswell, 1948) to 
develop shared meanings and understandings of the issues for patients and professionals;  Social identity 
theory (Tajfel, & Turner, 1979) to examine conflicts and challenges to participants and patients’ identities;  
and the ‘Common-sense model of self-regulation’ (Leventhal et al, 2003)  to view patients as independent 
problem-solvers who actively process health information to create understandings that guide health-
related decisions and behaviour. 
• Embed PROMS and wellbeing measures validated for this patient group to measure quality of life (e.g. the 
ThyPRO, Watt et al, 2014) 
• Review existing self-management interventions available to patients (e.g. self-management: Allegrante et 
al, 2019) 
• Assess feasibility of adapting existing models/interventions (e.g. diabetes, cancer, TED) 
• Create guidelines (e.g. NICE review) for addressing the psychosocial concerns of patients with 
hypothyroidism and to support self-management 
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To move the research conversation forward, Health Psychologists may play a role in supporting 
Endocrinologists and multi-professional teams to engage patients, particularly through the 
charitable sector, to identify the research questions that are important to them. In doing so, it is 
key to remain mindful of the diversity within this patient group. After identifying the psychosocial 
concerns of patients, a collaborative approach is required to co-produce and evaluate interventions 
to address these concerns and to support patients to develop the skills, confidence and experience 
to manage their health. An exploration of the feasibility of adapting existing self-management 
interventions from similar conditions for use with patients with hypothyroidism is required.   
 
The areas identified in this thesis as important to patients through searching the patient-centred 
literature and interviewing Endocrinologists are summarised in Table 2 below.  The development 
and evaluation of interventions to address these needs may support the creation of guidelines for 
professionals providing psychosocial care to patients with hypothyroidism.  
 
Table 2:  Suggested interventions to design and evaluate with patients 
• Provide specific education targeted at patient subgroups (e.g. patients with Hashimoto’s disease and 
thyroid cancer) 
• Develop training for patients to find and utilise a range of information and resources  
• Provide psychosocial support to address perceptions of disregard, responses to diagnosis and lifelong 
medication, managing emotions, adaptation to changed appearance (e.g. weight management, surgical 
scars), and to provide treatment expectation management and relationship support 
• Promote positive social and psychological appraisals and wellbeing, promote personal control and 
resilience 
• Develop communication strategies between patients and significant others (health professionals, family 
and friends and workplaces) 
• Develop self-management interventions to promote recovery (e.g. adapt to changes in the ways that the 
body processes fat, adopt appropriate exercise for patients with symptoms of autoimmunity and patients 
with thyroid cancer) 
• Address polarisation/build bridges between patients and the medical system particularly seen in online 
forums (e.g. through co-production) 
• Retain a biological focus/remain mindful of endocrine pathology and ensure interventions work alongside, 
rather than replace optimal medical treatment 
 
 
Implications for practice 
 
To promote the inclusion of psychosocial and self-management support in the management of 
hypothyroidism, this thesis recommends that it is important to address the ‘healthcare 
battleground’ discussed in Chapter 4 (‘Findings’).  To do so, interventions to support clinicians, as 
well as to bring about change at organisational and socio-political levels are required.  Health 
Psychologists may play an important role in providing research and evaluation, teaching and 
training, and consultancy to support the implementation of change to embed the evidence-based 
recommendations which result from the research streams described above.  
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The interventions which may support Endocrinologists to explore and address the psychosocial 
concerns of patients with hypothyroidism as identified in this thesis are summarised in Table 3 
below. Specifically, the recommendation is made to develop and evaluate training for 
Endocrinologists in the theory and skills of psychosocial and self-management support. The 
outcomes of these training programmes may be used to develop NICE guidelines in this area.  
 
Table 3: Interventions to support Endocrinologists to develop psychosocial and self-management support in practice 
• Address attitudinal/behavioural variation towards patients’ psychosocial needs (e.g. development of 
guidelines) 
• Incorporate theory, e.g. Theory of Planned behaviour (Ajzen, 1991; 2002) to increase intention to 
implement psychosocial and self-management models of care (target perceptions) 
• Support understanding of self-management theory and skill (avoid concerns about moralisation with shift 
away focus from ‘lifestyle’) 
• Promote incorporation of psychosocial/self-management support whilst maintaining biological focus and 
validation of illness experience (skills training) 
• Include support for difficult/emotional communication (e.g. unavailability of treatments, unresolved 
symptoms, self-medicating) 
• Provide support for discussing mental health and psychosocial issues 
• Support Endocrinologists to explore and address patients’ lay beliefs (self-efficacy, understanding) 
• Incorporate theory e.g. Self-determination theory (SDT) (Ryan & Deci, 2000; Deci & Ryan, 2012; Ryan & 
Deci 2017) to address mismatch in intrinsic and extrinsic motivation which may impact on clinician 
wellness and job satisfaction  
• Reduce scepticism about PROMS (e.g. training, co-production) 
• Provide opportunity to collaborate with other specialisms 
• All healthcare clinicians offered training wo work with MUS 
• Training also to be provided in primary care (NICE guidelines; medication reviews) to reduce flow to 
secondary care 
 
The findings of this research also highlight the importance of addressing the wider barriers and 
facilitators to the adoption of self-management and psychosocial support. Health Psychologists 
may contribute useful skills in this area by applying the science and technology of ‘Implementation 
Science’ to improve the translation of evidence-based research into practice (e.g. Michie et al, 
2011).  
 
Implementation science is concerned with the translation of research into healthcare practice and 
policy, and the ways in which behaviour change is facilitated in multi-level systems (Michie & 
Johnston, 2017). The implementation of psychosocial and self-management support may be 
supported by drawing upon theoretically driven behavioural frameworks such as the ‘Theoretical 
Domains Framework’ which recognise and target social and environmental (as well as cognitive, 
affective) influences on health professional behaviour (Atkins et al, 2017). 
 
The findings of this thesis have identified a range of organisational (healthcare) level factors which 
may be addressed to examine their influence on the adoption of psychosocial and self-management 
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support for patients with hypothyroidism in secondary care.  These are summarised in Table 4 
below.  
 
Table 4: Recommended organisational (healthcare) changes to promote implementation of psychosocial and self-
management support for patients with hypothyroidism 
• Offer reviews and psychosocial/self-management support from diagnosis in primary care 
• Develop referral pathways for patients with hypothyroidism 
• Incorporate patients and multi-disciplinary professionals as assets in care planning and control of 
symptoms  
• Support and fund the charitable sector to build bridges and trust and to create unified, expert messaging 
• Value patient-centred care with patient needs, preferences and values at the centre 
• Highlight and address paradoxical barriers and incentives to patient centred care and activation 
• Address the mismatch between promoting new healthcare paradigms and the realities of practice 
(reductionism/risk-aversion)  
• Promote task identity (creativity, personal growth, engagement and use of talent) to prevent against 
diminished motivation and burnout amongst clinicians and promote clinician wellbeing, (i.e. promote skills 
and confidence, update research) 
• Reduce fear of blame and promote positivity and hope 
 
Similarly, this thesis has identified a range of socio-political level factors which may be addressed 
to examine their influence on the adoption of psychosocial and self-management support for 
patients with hypothyroidism in secondary care.  These are summarised in Table 5 below. Health 
Psychologists and multi-professional colleagues, as well as patients and the charitable sector should 
work alongside commissioners and policy makers as agents of change (Garratt, 2017) to reduce the 
gaps of health and well-being, care and quality, and funding and efficiency as set out in the Five 
Year Forward View (NHS England, 2016). 
 
Table 5: Recommended socio-political changes to promote implementation of psychosocial and self-management 
support for patients with hypothyroidism 
• Address struggle to devolve ‘power’ to patients (address scientific unknowns, potential risks) 
• Reduce boundaries between organisation/specialism divides 
• Address dismissal and disregard of patient concerns in healthcare system  
• Recognise the value of asset-based models 
• Recognise threat of asset-based models to the healthcare/public health status quo 
• Incorporate implementation science and knowledge mobilisation to implement the ‘personalised care 
model’ in the NHS Long Term Plan (2019) 
• Address uncapped rises in generic medicines in the UK 
• Address health inequalities and patient safety/harms created by cost-based restrictions to services 
• Provide resources and funding to further the research conversation and promote patients choice/clinician 
autonomy 
• Raise hypothyroidism on the political agenda (levothyroxine is the third highest prescribed drug in the UK; 
NHS Digital, 2017) 
• Psychosocial and self-management support within healthcare requires a whole system collaborative 
approach to improve performance and develop enhanced outcomes 
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5.7. Conclusion 
 
This research has created novel findings that patients with hypothyroidism have unmet needs for 
information and  support from the point of diagnosis, but that Endocrinologists perceive a lack of 
time, training, service provision and support to facilitate psychosocial and self-management models 
of care.  
 
Patients, Health Psychologists, Endocrine Nurses, Dieticians, Pharmacists, and experts in the 
charitable sector are valuable assets to Endocrinology and may contribute to self-management 
programmes and clinician skills training to address gaps in provision for those in need. Self-
management support should not be provided in place of medical treatment or service 
improvement, and the needs of those for whom standard treatment may be ineffective should be 
addressed.  
 
Addressing the cost of treatments (specifically, unregulated rises in generic medications), funding 
quality research (e.g. trials of long-acting LT3 targeting specific hypothyroid patient subgroups, 
alongside interventions to address patient-identified psychosocial concerns), building bridges 
between patients and the healthcare system (through co-production and inclusion of the charitable 
sector) and increasing innovation and autonomy in healthcare may reduce barriers to the 
implementation of psychosocial and self-management models of care. The value of asset-based 
models of working to meet the changing demands upon healthcare should be recognised, alongside 
the threat that they may pose to the socio-political status-quo. NHS staff need to be supported in 
a culture which promotes creativity and innovation and reduces burnout and fear blame, especially 
those caught in the middle of opposing healthcare paradigms.   
 
The findings presented in this thesis recommend areas of change at all levels of the healthcare 
system to improve outcomes for patients with hypothyroidism and for the clinicians treating them. 
A whole-systems approach is needed to support Endocrinologists to place patients with 
hypothyroidism at the centre of their care. 
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Appendix B: Participant information sheet 
 
 
 
Participant information sheet for semi-structured Interview 
Invitation 
The study you are being invited to take part in is part of a professional doctorate in health 
psychology at the University of the West of England and is supported by the British Thyroid 
Foundation. 
This semi-structured questionnaire asks about your views on the management of hypothyroidism; 
the involvement of patients in decisions around their care, and the things that may affect the ways 
that hypothyroidism is managed. 
What is the project’s purpose? 
Despite the known efficacy of treatment for hypothyroidism, unknown numbers of patients report 
residual physical, psychological, cognitive, and social symptoms. Recommendations in the research 
literature carried out with hypothyroid patients include a need for psychosocial and self-
management models of care to be developed to improve health-related outcomes. This is 
supported by the NHS Five Year Forward View which acknowledges the need to support people to 
manage their health and care.  
Little is published about the provision of supportive models of care for people with thyroid 
disorders in secondary care, or the tools and techniques currently being used by Endocrinologists 
with their patients. This semi-structured interview aims to learn more about your views on the 
medical care you provide to people living with hypothyroidism; and about the available approaches 
to the management of their condition. 
Why have I been chosen? 
A survey has previously been sent to all Endocrinologists who are members and associates of the 
British Thyroid Foundation. All survey recipients have been invited to take part in semi-structured 
interviews as we would really appreciate your views on this topic. A smaller number of 
Endocrinologists have been directly invited to take part by other participants via a snowballing 
sampling technique.  
What will happen if I agree to take part? 
You will be asked to take part in a semi-structured interview lasting between 30 and 45 minutes. 
This is likely to be on the telephone depending on where you are in the UK.  
What are the possible benefits of taking part? 
It is hoped that this research will bring new insights into the management of hypothyroidism, which 
currently effects between 2% to 5% of people living in the UK. This research may help to underpin 
the future development of psychosocial and supportive interventions for patients living with 
hypothyroidism.  
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Will my taking part in this research be kept confidential? 
All information that we collect about you in this research will be kept strictly confidential.  
The interviews will be audio recorded and transcribed using Microsoft Word. Interview transcripts 
will be anonymised and stored online, protected by passwords and other relevant security 
processes in line with the University of the West of England data management protocol. Once 
interviews have been transcribed and analysed, audio recordings will be securely destroyed in line 
with the University of the West of England data management protocol.  
Hard copies of consent forms and interview transcripts will also be stored securely and only 
accessible to the research team.  Reporting of interview data will be done in an anonymised way 
and no identifying such as name or employing institutions data will be reported. 
Data collected may be shared in an anonymised form to allow reuse by the research team and other 
third parties. These anonymised data will not allow any individuals or their institutions to be 
identified or identifiable. 
Can I choose to withdraw from the study? 
You may choose to withdraw from the study without giving a reason. You are free to withdraw from 
the study up to two weeks after the interview which will give you additional time to ask further 
questions about the research after receiving the debrief at the end of the interview. If you choose 
to withdraw, the audio recording of your interview will be securely destroyed without being 
analysed.  
Who has ethically reviewed this research and who can I contact if I have any concerns?  
This project has been ethically approved by the University of the West of England Research Ethics 
Committee. If you have any queries or complaints about this study, you may contact 
researchethics@uwe.ac.uk or Tel: +44 (0)117 32 81170. If you have any concerns regarding the 
needs of your patients as a result of this project, please contact the British Thyroid Foundation on 
01423 810093 for support and guidance.  
Who can I contact for more information? 
For more information, please contact the corresponding researcher: 
Michelle.griffiths@live.uwe.ac.uk 
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Appendix C: Consent form 
                                     
Corresponding researcher: Michelle Griffiths 
Department of Health Psychology 
Contact details: Michelle.Griffiths@live.uwe.ac.uk 
Primary Researcher status: Stage 2 Trainee Health Psychologist 
UWE ethics contact: researchethics@uwe.ac.uk 
 
Participant Consent Form: Qualitative Interview 
Study Title: Exploring psychosocial and self-management support for hypothyroidism: A mixed-
methods study in the UK 
Purpose of the study: To explore your views on the management of hypothyroidism; the 
involvement of patients in decisions around their care, and the factors impacting the ways that 
hypothyroidism is managed in secondary care. 
Please initial statement 
1. I confirm that I have read and understand the information sheet for the above study.  
2. I am aware of the corresponding researcher and UWE ethics department contacted  
details to ask any additional questions I may have.  
3. I understand that my participation is voluntary and that I am free to withdraw for 2  
weeks after the interview without giving any reason, and without any consequences or  
penalty. 
4. I am aware that any data collected about me will be stored securely and that no  
individual identifying information will be reported.  
5. I have considered any potential risks associated with taking part in this research.  
6. I understand that data collected during this study may be looked at by designated  
individuals from the University of the West of England. I give permission for the  
researcher’s supervisory research team to access my data for the purposes of this study. 
7. I understand who will have access to personal data provided, how that data will  
  be stored and what will happen to the data at the end of the project. 
8. I understand how this research will be written up and published 
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9. I understand this project has been reviewed by, and received ethics clearance  
through, the University of the West of England Research Ethics Committee.  
10. I agree to anonymised data collected in this study to be shared with other researchers  
to be used in other research studies.  
11. I agree for data collected in this study to be anonymised and shared with other  
researchers, to be used in other research studies. 
12. I agree to take part I this study. 
13. I agree for my contact details to be kept in a secure and encrypted database for the  
purpose of contacting me about follow ups to this research. I understand this does not  
oblige me to participate further.  
   
 
 
  
  
 dd / mm / yyyy 
  
  
  
Name of Participant  
 Date 
 
 Signature 
 
 
 
 
  
  
 dd / mm / yyyy 
  
  
  
Name of person taking consent Date 
  
 Signature 
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Appendix D: Semi-structured interview topic guide 
 
Introduction:  
 
Thank you for agreeing to take part in this interview. We are conducting this study to help us 
understand how hypothyroidism is managed in secondary care, and to learn about opportunities 
to support patients with hypothyroid symptoms. Some of the questions may appear to be quite 
similar or obvious to answer but we are trying to understand the topic from a variety of perspectives 
so bear with me, take your time and answer as frankly as possible. Are you happy to get started? 
 
1. (Managing expectations) how many of your hypothyroid patients struggle with symptoms 
that are difficult to resolve, despite returning to normal population reference ranges?  
 
2. Population characteristics: Are there distinct subgroups of people with hypothyroidism 
(such as those who have been treated for cancer, or those with autoimmune thyroid 
diseases) who are more likely to experience residual symptoms?  
 
3. Why do you think there are patients who appear to remain ’dissatisfied’ with their 
treatment? What percentage do you believe this to be? 
 
4. How do you feel when patients remain dissatisfied with their hypothyroid symptoms and 
treatment?  
 
5. (Should we better manage patient’s expectations to expect residual symptoms as with 
other medical conditions?) 
 
6. Medical management: Are clinical guidelines and available treatments sufficient to meet 
the needs of all hypothyroid patients?   
 
7. Psychological management: Do you feel able to help your patients to manage the 
emotions and stresses in relation to hypothyroidism and its treatment?  
 
8. Do you feel able to identify hypothyroid patients who may need further psychological and 
emotional support? 
9. What other services are available to support your patients to manage the emotional 
impact of hypothyroidism? 
 
10. Behavioural management: What patient skills or lifestyle changes do you think have the 
greatest impact on health outcomes for hypothyroidism?  
 
11. How confident to you feel to address these and to collaborate with patients to work 
towards healthy goals? 
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12. Do you feel able to meet the informational and educational needs of your patients (for 
example to implications of over or under replacement? dietary advice, fatigue 
management)?  
 
13. What tools and resources are available to you to inform and educate your patients about 
managing their condition? 
  
14. Do you think it is important for patients to self-monitor their hypothyroidism? Do you 
teach patients the meaning of their blood test results? 
 
15. Do you refer patients to other specialisms for residual symptoms? Examples? (sex 
hormones, vitamin deficiencies, cardiac, rheumatology, hepatology  
 
16. Do you think that additional skill sets, or multi-professional approaches are required to 
support Endocrinologists to help hypothyroid patients to manage their condition? 
 
17. Do you think that changes will occur in the future regarding the ways that hypothyroidism 
and its treatment are managed? 
 
18. Thank you for answering my questions… is there anything else that you think is important 
to note in this subject area?  
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Appendix E:  Debrief form 
 
 
 
 
Interview debrief form: 
 
Exploring the views of Endocrinologists towards psychosocial and self-management support for 
hypothyroid patients: A mixed methods study in the UK.   
 
Further details of the research 
 
The research you just participated in was part of a study to examine the views of Endocrinologists 
towards psychosocial and self-management models of care for hypothyroid patients; to enquire 
whether embedded or structured psychosocial and self-management support for hypothyroid 
patients exists in secondary care that is currently unreported in the literature and to explore the 
barriers and facilitators to the provision of a psychosocial and self-management model of care. 
 
The rationale for this study is outlined below: 
 
Hypothyroidism is a costly and growing problem currently affecting between 2% and 5% of the 
population in the UK, and Levothyroxine is currently the third most prevalently prescribed drug in 
the UK.  Despite the known efficacy of treatment for hypothyroidism, unknown numbers of people 
report continued symptoms, loss of daily role function and impaired employment; and numerous, 
often debilitating residual physical, psychological, cognitive, and social symptoms have been 
reported in the literature.  
 
Research carried out with people with thyroid disorders recommends the development of 
psychosocial and self-management models of care to improve health and quality of life outcomes 
for 
hypothyroid patients.  
 
In the published literature of clinician’s attitudes towards ‘patient activation’ (providing patients 
with the knowledge, skills and confidence to manage their own health), varied views have been 
reported regarding the roles that patients should take in their own care. Broadly, clinicians are more 
likely to support patients to make behaviour and lifestyle changes in accordance with clinical advice. 
However, clinicians have found supporting self-management to be more problematic when it 
consists of patients making independent judgements or independently seeking information or 
treatments that may contradict clinical advice. 
 
The aim of this research was to explore your experiences of the barriers and facilitators to providing 
psychosocial and self-management models of care to hypothyroid patients in secondary care so 
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that we can learn more about the opportunities to develop interventions based on the 
recommendations in the patient literature.  
Further information 
There is a possibility that the current research findings may be published in a scientific journal to 
aid general greater understanding of managing hypothyroidism. 
If you decide you would like to withdraw from this research, you can do so up until two weeks 
from today. 
To withdraw from the study or for further information please contact: 
Michelle.Griffiths@live.uwe.ac.uk 
If any of the topics discussed today have caused any you any concern or you would simply like to 
access further support, please contact the British Thyroid Foundation on 01423 810093. 
Thank you for taking part.  
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Appendix F: Interview coding  
Interviewer: The first question is whether you think that 
hypothyroidism is a chronic condition in terms of monitoring 
or management, or whether it's likely that symptoms will go 
on when peoples’ blood test return to the population 
reference range? 
 
Interviewee 2: So (…) I think in a sub percentage maybe 
around 10% to 15% appear to have persisting symptoms 
despite returning to the reference range. 
Interviewer: Do you think that there is a particular subgroup 
of people such as those who've been treated for cancer or 
those with autoimmune thyroid diseases who are more likely 
to experience these residual symptoms? 
 
Interviewee 2: I don't know that but from what I can see (…) 
it's less likely to be the people treated for cancer and more 
likely to be people who are treated for mild hypothyroidism. 
Interviewer: Right okay uh this is a really open question bear 
with me,  why do you think there are patients who remain 
dissatisfied with their treatment? 
 
Interviewee 2: It's likely to be a mixture (…) sorry 
[unintelligible 00:01:39] in the background (…) of two things 
probably one is some patients who actually their symptoms 
are not related to the thyroid, their symptoms are quite vague 
especially if they only have very mild changes those might be 
the group that you'd expect would not really respond very 
well to changes in therapy but might respond to a more 
holistic approach. The second group, which I have an 
emerging theory about would be those in whom they um 
seem to benefit more from having a combination of T4 and 
T3 and are therefore somehow sensitive to being replaced 
with thyroxine on its own o I would like to think there is a T3 
responsive group and there is a non-T3 responsive group, if 
you want to look at it that way. 
 
Interviewer: Yeah ok so how do you feel when patients 
remain dissatisfied with their hypothyroid symptoms and 
treatments? I think people are vary, vary much in their 
practice, so the responses have been quite different to this 
. 
Interviewee 2: Some people find it very frustrating and 
depressing but because we have a clinic in which we do offer 
them alternatives, I think that's much easier to deal with than 
doctors who don't really have that option. I'm reasonably 
comfortable with those patients, we treat them fairly 
regularly and comfortable trying alternative options because 
at the end of the day, it's only a trial of other forms of 
common replacement that will tell you which group they fall 
into. 
 
 
 
 
Belief in biomedical reason for ongoing symptoms  
 
 
 
Those with mild hypothyroidism may be more 
symptomatic.  
Interesting that did not identify cancer – cancer salient 
to me due to proof Doc placement where I saw this was 
an issue… why not here? Thyroid cancer predominantly 
dealt with in oncology… Doctor I says they see a lot of 
patients treated for thyroid cancer… also did not 
identify. Contradicts my assumptions.  
 
 
 
Mild vague symptoms may not be thyroid. One group. 
Holistic approach may be better than changes in thyroid 
medication for this group.  
 
 
 
 
 
Less frustrating for doctors when they have the option 
of trialing personalised medicines.  
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Interviewer: Do you think we should manage patients' 
expectations earlier as to the efficacy of T4 treatment? Do 
you think nationally, there's a problem with patient 
expectation? 
 
Interviewee 2: I actually don't know the answer to that one. 
I'm very keen that we, in the end, do the right trial to address 
that question because most of the studies that have been 
done at this point with T3 have not probably been done in the 
right way and the results have been disappointing. When we 
are able to replace some closer to normal physiology, then 
we'll be able to sort out the wheat from the chaff a little bit 
then answer your question because we certainly have some 
patients who are delighted and they say they're pretty much 
tback to normal but There are other people where it's really 
only 20% or 30% and they go "Well, do you know what?"  and 
then other people that you wish you'd be more cautious 
about your expectation management I think generally 
correct, you have to be careful about their expectations, 
especially those people who are not profoundly hypothyroid 
at the beginning where it started from a mild position but 
there's certainly a percentage who've had significant benefit. 
Interviewer: Great okay. Onto a different strain of questions 
now (…) Do you feel able to help your patients to manage the 
emotions and stresses in relation to their hypothyroidism and 
its treatment? 
 
Interviewee 2: Well, only to a very limited extent. I do discuss 
other features that are going on. The patients, in general, 
don't want to talk about that, they say they want to focus on 
the biological elements. We all have discussions about other 
stuff that’s going on for them, discover what might be other 
major stresses in their life, financial, bereavement, 
relationship, that kind of thing. They need to be aware of that 
and continue to discuss those things, continue to encourage 
them to work on those sides as well as on the biological side. 
That's partly if you like a bit of expectation management 
there too. I really don't think in the time I have available that 
I can do the best. What I think I can do is something we've 
discussed, is to help legitimise more holistic approaches when 
people are very biologically focused I’ll say, "Right, that's fine. 
I will deal with the biology, but I think it'll help you to have a 
wider approach to your therapies, alternative therapies, 
complementary therapies, holistic approaches, that kind of 
thing which I can't provide." 
 
Interviewer: Do you know of any other services or places that 
you can refer your patients to help them with this aspect of 
the condition or this aspect of holistic approach? 
 
Interviewee 2: There's a simple answer to that question, 
Michelle. 
 
 
 
Belief that clinical trials are not sufficient quality. 
 
 
 
 
Manage expectations of the mildly hypothyroid group 
who may not benefit from lone or combination 
treatment.  
Belief that there are different patient group and some 
benefit from combination treatment.  
 
 
Limited ability to address psychological impact. 
 
Patients reluctant to discuss emotions and want to 
focus on biological aspects. Encourage patients to work 
on this (link to expectation management and interview 
1; want a fix without having patient input). 
Lack of time for holistic approach but does try to ask 
about what’s going on in patient’s life. Interview 1 did 
‘not have the will’ to change to this approach.  
 
Belief in legitimising holistic integrative approaches to 
therapies.  
 
 
 
 
Does not believe that these patients have a psychiatric 
reason for persistent symptoms (link to T.Watt, debates 
about biological/psychological causes old; need to 
move forward to improve patient experience). This dr 
tries to promote a holistic approach but uses ‘belief’. 
Interview 1 wants to make them feel listened to but 
does not have such belief or willing to trial personalised 
medicines approach.  
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Interviewer: [laughs] Yes I see. 
 
Interviewee 2: There is a liaison psychiatry service who will 
help diagnose psychiatric disease you know significant 
depression but in my experience, very few of these people 
have a diagnosable psychiatric disease. 
 
Interviewer: So then what skills or lifestyle changes do you 
think have the greatest impact on the health outcomes for 
the patients that you see? what lifestyle changes may 
patients who've been successful have brought into the 
management plan with them? 
 
Interviewee 2: I'm not sure if I can be very specific about that. 
I certainly think and it is not quite the answer to the question, 
but it really helps them to be sympathetic anyway. A lot of 
people that I see are very angry have fought for a long time 
trying to get a hold of drugs etc. just giving them the 
opportunity, listening to them, helping them discuss instead 
of saying, "The answer is no. What is your question?" It's 
immensely helpful. It's an enormous relief for people that 
they can actually stop fighting and start healing if you want to 
look at it that way. 
 
Interviewer: Fantastic. 
 
Interviewee 2: An acknowledgment of listening is very 
important listening to all aspects and not belittling small ones 
unless [unintelligible 00:08:54]. Listening support is 
definitely helpful. More specific than that, I don't think I can 
narrow it down. I’m tempted to just say to the patient, "I’m 
for whatever you feel gives you more energy, so long as it's 
not going to be harmful, I would strongly be supportive of." 
Some people, they do a little bit of breathing exercise i'm not 
sure that's a big thing, a few people engaging in other 
complementary therapies. Some people try meditation or 
mindfulness I don't think I can identify one specific one, my 
rough shot at it is it is a more holistic listening and supportive 
approach. 
 
Interviewer: The next few questions have been covered by 
that. I might just tell you what they are and see if there's 
anything you want to add to that last response. The next 
questions really were about how confident you feel to 
collaborate with your patients to work towards healthy 
lifestyle goals. What you've described as your communication 
style and your approach actually shows your collaboration 
style. We'll move on— 
 
Interviewee 2: I'm certainly willing to do that and to do it in a 
collaborative way rather than a confrontational way. I would 
 
Sympathetic approach (listening, discussing, not just 
saying ‘no’) to improve outcomes. Patients can stop 
fighting and start healing (promote holistic approaches 
alongside not instead of medical treatment). KEY POINT 
link to psycho-oncology and integrative medicine. 
Complimentary not alternative. 
 
 
Being believed, listened to and not belittled. Not having 
to fight to be heard or to try options that might improve 
your biological health are more important than a 
particular complimentary therapy (e.g. meditation) 
when you are still fighting for your health.  
 
 
 
 
 
 
 
 
 
Collaboration not confrontation.   
Need for a practitioner to support collaboration with 
patients and practitioner in the service (link to 
interview 1: get patients involved from outset to see 
what they want and need). 
 
 
Listening, validating, ‘keeping the door open’ ro a 
biological explanation (link to interview 1; people hope 
for a biological explanation to avoid labels of ‘blackout’ 
feeling). Patients less likely to engage if they feel you 
are saying it is all in their head (link to backlash against 
ME PACE study - exercise or CBT helps recovery from ME 
- patients felt it doubts biological basis of disease or 
symptoms). Will engage more about lifestyle or 
complimentary approaches if validate their experience.  
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certainly be helped if I had a practitioner who is better at it 
than me that work in the service. 
 
Interviewer: Similarly, do you feel able to meet the 
informational and educational needs of your patients? I guess 
they come in with lots of different questions around fatigue 
management, dietary advice, implications of under or over 
replacement. Do you feel that you have the time and the 
ability to work with patients for these informational needs? 
 
Interviewee 2: Again, I think the answer is partial in the sense 
that what people they benefit from is listening and an 
explanation and keeping the door open that there may be a 
biological explanation. Basically, that actually relaxes people 
a little bit to consider other things because it's like, "If you 
think I'm mad, I'm not going to have a conversation with you," 
but if I give them the legitimacy which I think is legitimate, 
that there may be a biological reason why they're not feeling 
well. That helps me engage more with other aspects. It gives 
me a bit more of a mandate to discuss those things. 
 
Interviewer: Yes. Now i'm looking at some of the tools and 
resources that are available to you to inform and educate 
your patients about managing their condition. One could be 
showing them their test results or the DEXA scan, what 
resources do you feel that you do have or maybe don't have 
to help people to learn more about their condition? 
 
Interviewee 2: Yes. I very much want my patients to feel I'm 
being transparent and that there's no smoke and  mirrors 
happening here. That's particularly the case when what I'm 
trying to discuss is the risks of over replacement. It's so 
important to me that it is collaborative. Things like the DEXA 
scan is an illustration of what might be, the thinning of their 
bones, and it's potentially a side effect. The blood test results 
are showing that graphically with green and red areas 
showing what the normal range is begins to help people 
understand how farther away they are from the rest of the 
population. I find those tools to be helpful and also the fact 
that you've explained them from the computer suggest that 
it's not an edited version you know what I mean you're seeing 
what I am seeing. I think that increasingly helps people feel 
that they're not being fobbed off and hidden to as well as 
trying to feel that they're being respected partners and 
understanding this process. 
 
Interviewer: Thank you. This is great. Do you refer patients to 
other specialisms for unexplained residual symptoms? Um 
examples, vitamin deficiencies, cardiac, rheumatology, 
CFSME you know where do you commonly refer to outside of 
your office for this particular group? 
 
 
Clarity (no smoke and mirrors), collaboration, 
transparence; helps with open trusting relationship to 
discuss issues like over-replacement. Trust of doctor 
(interview 1 - trust is not offering open choice of 
medication but sticking to your medical knowledge and 
beliefs). Different interpretations of trust. Trust me im 
the expert versus collaborative trust.  
 
Education e.g. of scans, graphs 
 
Not being fobbed off. Patients as respected partners in 
collaborative process. Fostering patient understanding 
of the process.  
 
 
 
 
 
 
 
 
 
 
 
Does not see this patient group  as CFS/ME (opposite to 
interview 1). 
Knowledge of CFS criteria and differences with this 
patient group.  
 
 
Reluctance to attribute to lifestyle or unexplained 
symptoms.  
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Interviewee 2: And the answer to that question is that I rarely 
refer unless if it's a symptom that is very persistent and I want 
to make sure I'm not missing biology there. We don't really 
have, as far as I'm aware, a well-established CFS service. I'm 
not sure to what extent they will entertain these people. They 
are different from CFS in the sense that the CFS patients, well, 
they manifest differently. The thing is fatigue, they can't get 
out of bed and they're lucky if they get out of bed one day. 
For most of the thyroid patients, it's more they’re not 
themselves, they can't think straight, they can't concentrate, 
they can't perform well, but very few of them, I don't think 
anybody, is bed bound. The little bit I've done with CFS, there 
was quite a few people who are pretty much bed bound 
actually. These people do get up but they find it difficult to 
function at the level they want to function at.They find it 
difficult to do their jobs, or if they do their job, they come 
home and they're exhausted and lie down but they’re not you 
know,  I'm feeling that probably many of them would not 
qualify as having CFS by CFS criteria. I haven't at the moment 
found somewhere else. If somebody had a particular 
symptom, let's say, for argument's sake, diarrhea or 
something like that that I thought well like  "Well, this doesn't 
really fit," or particularly abnormal blood test that I wouldn't 
expect I would very much want to rule out organic disease I 
don't want to miss the fact that someone's got an underlying 
cancer or something like that that I am not understanding. I 
don't think you can discuss the kind of issues we're talking 
about now unless you're very confident that you're not 
missing another diagnosis. 
 
Interviewer: Given that lack of referral pathway, do you think 
there are additional skill sets or multi-professional 
approaches that would support endocrinologists to help their 
hypothyroid patients to manage their conditions? 
 
Interviewee 2: Yes, very much so. People talk about an 
Endocrine Nurse role along with a Health Psychologist role 
here. It's a balance between dealing with the organic and the 
less explained. I'm reasonably comfortable at managing the 
medication, adjusting the medication, discussing the issues. It 
would be helpful to me, I could see more patients, if, for 
example, there was an endocrine nurse who said exactly the 
same thing but went into it in more detail. I think we could 
benefit more people if there was a health psychologist who 
could deal with the wider issues that are not obviously 
endocrinology, if you like. An endocrine nurse experienced in 
this area could discuss the benefits and the risks and how we 
do the dosing and how we're going to think about testing it, 
what tests we're going to do, and all that kind of thing as well 
as I could and spend more time with people. It's more of a 
health psychology role to go into the wider aspects of their 
life and how they can get a better outcome overall by 
addressing other aspects of their life. 
 
Interviewer: Final question. I think we're just about making it 
to three o'clock. Do you think the changes will occur in the 
future regarding the ways that hypothyroidism and its 
treatments are managed? 
 
 
Need for a specialist nurse or Health Psychologist role 
in the service. More detail in educating patients and 
managing the ‘less explained’ aspects. Risks and 
benefits, informed discussion. More time for the 
patient allowing the doctor to see more patients. Nurse 
to spend more time discussing tests and treatments and 
health psychology for health 
improvement/emotional/social (less endocrinology) 
aspects.  
 
 
 
 
 
 
 
 
 
 
 
 
Hope for change in the future: alternative forms of 
therapy, recognition of those who do not respond to 
therapy and to design better clinical trials.  
Critical of the existing clinical trials 
Hopeful that we ‘can sort out’ the dissatisfaction of 
patients (still focusing on the issue of T4/T3 
combination therapy) 
Hope for slow release T3 to ‘get a significant proportion 
of people better’.  
 
 
New theories about treating those with mild disease (it 
might make things worse due to DI02 enzymes 
increasing T4 ratio) 
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Interviewee 2: Well, number one, I very much hope so. 
Actually, two days ago, the draft NICE criteria came out. They 
do very clearly leave the door open that there are some 
dissatisfied individuals and they acknowledged this and they 
acknowledged that some may need alternative forms of 
therapy. There is a meeting coming up which is a joint 
meeting between the American, European, and British 
thyroid associations, it's going to happen in London, to look 
at the new science around this. Particularly, the idea is to get 
a consensus together and to design better trials. 
Interviewer: Excellent. 
Interviewee 2: There are theories as to why the previous 
trials have failed. I think there's some biological reasons why 
that could be the case. I'm led to understand that the NICE 
criteria will lead to potentially some funding for some more 
research in this area. I think that we can sort this out. 
Increasingly, the view that a slow release T3 would be very 
helpful both in terms of getting the level right and in terms of 
being able to monitor very accurately. I'm not sure that it is 
essential for the patients, but it's much easier to know that 
you've restored the natural level ls which is what you dont get 
with the current dosing. I'm fairly optimistic that if we go in 
those directions, developing a slow release T3, then treating 
people in a proper RCT with the right outcomes with slow 
release T3, I think we'll get a significant proportion of people 
better. There was a biological reason why thyroxine actually 
makes people with mild hypothyroidism worse because of 
the deactivation of their own hormones but we've yet to 
prove that in humans. 
 
Interviewer: The deactivation of their own hormonal 
function, you mean for people with— 
Interviewee 2: The enzyme that activates T4 to T3, the 
deiodinase enzyme, and there is quite good evidence that T4 
actually inhibits that enzyme. When you take T4 alone, you 
get a disproportionately high level of T4 in your blood in terms 
of the T4 to T3 ratio. What that may be doing is it still feeds 
back to the pituitary, so the pituitary says, "That's fine." If 
there's evidence that the pituitary enzyme is not inhibited, 
there is the enzyme in the periphery in the rest of your body 
is inhibited so it's eventually the more you take of the 
thyroxine, the less you're getting because less of it is 
converted. 
Interviewer: Interesting. 
Interviewee 2: It's a natural way of protecting the tissue from 
too much thyroid hormones because they don't expect-- 
Biologically, we weren’t developed to eat thyroxine. This may 
be an explanation but it remains to be proven. 
Interviewer: Fantastic. Okay, so thank you for answering my 
questions. Is there anything else that you feel is important to 
note in this subject, or area, or that I may have missed out or 
not, or misrepresented or anything? 
Interviewee 2: There's a point about the anger that's been 
generated around the cost, and therefore, the lack of 
availability, and therefore, the lack of experience, has made 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The cost of T3 has led to a lack of availability and a lack 
of clinician experience and resulting in anger that did 
not need to be the case. People have felt denied.  
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the situation about a hundred times worse than it needed to 
be because people feel angry and denied. That's an important 
amplifying factor in this problem. 
Interviewer: Possibly what we need to keep in mind if a slow 
release T3 is developed that we somehow keep it affordable 
to the UK [laughs] 
Interviewee 2: 100%, absolutely. There's no point if we can't 
do that, yes. 
Interviewer: Wonderful. Okay. Well, thank you. Thank you so 
much for taking time part. 
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Appendix G: Collating codes by Interview (example excerpt)  
 
Generated in interviews 1-5 
 
General attitude towards condition:  
Heterogeneity of thyroid subgroups: 
Reasons for persistent symptoms: 
How Endocrinologists feel 
Psychosocial interventions  
Trust/belief in scientific literature  
Expectations: 
Referrals 
Need for a multidisciplinary approach?  
Anticipated Changes to treatment 
Engaging in changed practice (sees results) but need to have a will to change practice 
Trust in doctor and patient (empowerment)  
Other thoughts 
Open Vs closed door medicine  
Experiences/competency of doctor  
Cause of patient stress/distress (role of medicine in this) 
 
 
 interview 1a 
 
Focus on persistent 
symptoms and link 
with unexplained 
symptoms. Patients 
wanting treatment 
so that symptoms 
cannot be 
attributed to being 
‘all in their mind’ to 
avoid the threat of 
this. Dangerous role 
of social 
media/influence of 
‘others’  
 
General attitude 
towards condition:  
should be simple, 
symptoms should 
subside 
Unexplained 
symptoms 
Looking for physical 
causes  
Don’t want it to be 
seen as all in the 
mind 
Interview 2b 
 
Reasons for 
persistent 
symptoms: 
Those treated 
for mild 
hypothyroidis
m (problem is 
not the 
thyroid; some 
other cause); 
vague 
symptoms 
(more like 
chronic 
fatigue)  
 
Belief that in 
come cases, 
treatment is 
sub-optimal as 
some patients 
require T4/T3 
combination 
therapy  
 
“listening and 
an explanation 
and keeping 
the door open 
Interview 3c 
 
General attitude 
towards 
condition:  
Requires 
management and 
adjustments and 
monitoring, 
manipulation 
within wider 
reference range 
 
the treatment is 
quite long it 
requires constant 
and regular 
monitoring dose 
adjustment and so 
on as well as 
clinical evaluation. 
I think again the 
vast majority of 
patients are fine 
when the thyroid 
function is within 
the reference 
range 
 
Heterogeneity of 
thyroid 
subgroups: 
Interview 4d 
 
General attitude 
towards 
condition:  
Micro managed at 
GP level, dogma in 
medicine, 
battleground 
 
Heterogeneity of 
thyroid 
subgroups: 
Permanent 
hypothyroidism 
(thyroid removed, 
RAI for cancer; 
progressive 
autoimmune 
thyroiditis) 
Transient cases 
where thyroid can 
recover 
 
Reasons for 
persistent 
symptoms:  
Symptoms at best 
are  vague and 
non-specific 
Interview 5e 
 
General attitude:  
Dissatisfied patients are up 
to 15% but when consider 
this is the third most 
prescribed drug in the UK, 
this is a very large group 
 
Heterogeneity of thyroid 
subgroups: 
Heterogeneity between 
those who find it difficult to 
manage and those who do 
not 
Autoimmunity leads to 
higher 
dissatisfaction/continued 
symptoms. Autoimmunity 
increases severity. WE don’t 
know why that is. 
Genetic polymorphisms 
 
 
Reasons for persistent 
symptoms: 
Genetic polymorphisms 
Do not feel better because 
not the thyroid 
Lack of tissue level 
biomarker 
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Need for diagnosis 
drives belief that 
thyroid is cause of 
symptoms 
Euphoria (weight 
loss) when thyroid 
hormone taken to 
excess 
Risk of 
excess/unlicensed 
treatment 
(morbidity/long 
term health 
outcomes) 
 
Heterogeneity of 
thyroid subgroups: 
Autoimmunity has 
more symptoms (in 
literature and does 
not question this)  
Role of 
inflammation 
 
Reasons for 
persistent 
symptoms 
Unexplained 
symptoms with 
normal 
biochemistry (wider 
patient group in 
literature) 
Not due to 
suboptimal thyroid 
hormone 
replacement 
(combination T4/T3 
not effective) 
Patient group is a 
tiny fraction 
(nowhere near the 
15%) 
‘Expressed 
dissatisfaction’ 
rather than 
persistent 
symptoms 
Over 
investigation/diagn
osis (about 50%) 
and treatment of 
normal/subclinical 
patients at GP level  
Thyroid is not the 
cause of the 
symptoms in some 
that there may 
be a biological 
explanation”. 
Most would 
not meet CFS 
criteria (from 
professional 
experience in 
this area), 
manifests 
differently 
(lack of 
functioning 
versus 
bedbound) 
 
 
Psychosocial 
interventions: 
Those treated 
for mild 
hypothyroidis
m (problem is 
not the 
thyroid; some 
other cause); 
vague 
symptoms 
(more like 
chronic 
fatigue) may 
respond more 
to a holistic 
approach: 
support, 
promote 
approaches to 
help feel 
better (if not 
harmful)  
“What I think I 
can do is 
something 
we've 
discussed, is to 
help legitimize 
more holistic 
approaches 
when people 
are very 
biologically 
focused. I'd 
say, "Right, 
that's fine. I 
will deal with 
the biology, 
but I think it'll 
help you to 
have a wider 
approach to 
Some have 
residual thyroid 
function, some 
have reliance on 
thyroid 
replacement. 
People with 
cancer have had 
parathyroid 
removal, high 
doses of 
radioactive iodine 
Autoimmunity 
creeps up over a 
long time (over 
years) 
Thyroid 
supplementation 
versus complete 
replacement   
 
 
 
How 
Endocrinologists 
feel 
Systematic, clear, 
boundaried 
 
Reasons for 
persistent 
symptoms 
Threshold for 
treating too low 
(GP level, treating 
people with 
fatigue/symptoms 
with only mild 
changes in 
biochemistry) 
which then leads 
us to the 
questions as to A, 
"Is it because the 
thyroid hormone 
isn't working?" B, 
"Is it because the 
symptom was 
never related to 
the thyroid in the 
first place?" 
Because 
subclinical 
hypothyroidism is 
so common, this 
was just an 
incidental finding. 
Thyroid can 
become the focus 
of all symptoms in 
people with 
hypothyroidism 
Patients ‘micro-
managed in 
primary care’ 
(being made to 
change doses 
based on blood 
tests). A source of 
frustration for 
patients. 
Cost of T3 stops 
individual trials  
Trials were never 
done 
systematically 
NHS barriers 
(tests for T3) to 
help monitor 
condition Patient 
have to fund) 
 
Other thoughts 
Lots of patients 
source medication 
and fund trials 
privately, they are 
the more 
educated and 
affluent 
Anecdotally, the 
vast majority of 
patients seem to 
feel a lot better 
on it. 
(link to Taylors 
epidemiology 
paper) 
 
Changes in 
treatment: 
Endocrinologists 
do not se most 
people with 
hypothyroidism 
unless there is a 
problem (me does 
this lead to an 
underrepresentati
on of persistent 
symptoms in the 
hypothyroid 
population?) 
 
Overreliance on TSH as 
biomarker (link to Toft 
paper) 
Many patients have tried 
everything they can to feel 
better 
How Endocrinologists feel 
 
Trust/belief in scientific 
literature: 
So um the question is how 
much of it because we've 
got it wrong, and it's a 
misclassification and how 
much of it is because some 
people are more susceptible 
to the risk of the symptoms. 
I don’t think that we know 
the answer to that. 
 
Science showed that T4 
could convert to T3 and 
that people preferred T4  
Limitations of research 
papers underpinning 
clinical guidelines (rationale 
for doctors keeping an open 
mind). Wrong dosing of 
combination therapy so 
that people reported no 
change or became 
thyrotoxic. Clinician 
knowledge and critical 
awareness of the research - 
open mind.  
 
 If they were there wouldn't 
be people going off to 
Greece stocking up on T3 
pills. It’s about 2 euros a 
packet in Greece and about  
quid 300 in the UK. 
 
Patients going to Greece to 
self source medication; due 
to the cost crisis in the UK. 
Patient demand (threat; 
benefits versus costs of self 
sourcing remains despite 
CCG rules). Cost as primary 
barrier. 
 
How Endocrinologists feel 
he one thing that's very 
common and what uh I can't 
work out why this has not 
been solved yet is the recent 
T3 crisis is difficult to take, 
we're seeing a lot of CCGs 
coming out with guidance to 
deny people T3 and that 
they're very inflexible and 
that makes me very angry 
and annoyed. 
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with mild 
hypothyroid 
changes 
GPs ‘collude’ with 
hopeful patients  
GPs not 
knowledgeable 
about thyroid 
GPs raise 
expectations 
‘They raise the 
expectations about 
we have found 
something physical 
and explained  
your 
therapies, 
alternative 
therapies, 
complementa
ry therapies, 
holistic 
approaches, 
that kind of 
thing, which I 
can't provide." 
in my 
experience, 
very few of 
these people 
have a 
diagnosable 
psychiatric 
disease.   
Sympathy, 
empathy, 
awareness of 
struggle to get 
to be seen 
Being 
supportive 
and non 
confrontation
al 
Listening, 
explaining 
Keeping the 
‘door open’ 
(link to 
biological 
causes 
Need 
Endocrinology 
nurse to 
spend more 
time, educate 
address 
adherence, 
medication 
adjustments 
etc 
 
Lack of tissue-
level biomarker 
Reliance on 
symptoms which 
are like many 
other problems 
GPs 
overstretched, 
need quick 
answers for 
complex fatigue 
presentations 
Stress 
Lifestyle 
Medications 
Other 
autoimmune 
conditions 
Liver disease 
CFS/ME 
Diabetes 
Diet 
Sleep 
Anemia 
Work stress 
Somatic impact of 
stress 
Expectations of 
treatment (over 
expectation) for 
some group 
Normalisation of 
TSH to population 
level (not 
individual level)  
Open to low T3 in 
blood or ‘tissue 
hypothyroidism’ 
explanation 
How 
Endocrinologists 
feel 
Very relaxed 
about it (happy to 
use personalised 
approach as 
experience has 
developed) 
Happy to sit on 
the fence and tell 
patients we do 
not know. Can be 
black and white 
an dogmatic or 
open 
More confident as 
experience in 
using additional 
treatments grows 
 
We have all 
struggled with 
these patients 
over te years 
(changed 
approach from 
dogma/gatekeepe
r/black and white 
to open minded 
and supportive 
and sees 
anecdotal 
evidence) 
 
Engaging in 
changed practice  
 I am very open 
and honest, and 
tell people I used 
to be very 
negative. Now I sit 
on the fence and 
don't know, but 
say to the 
patients, "I'm  
 
Um where I find it more 
challenging is when people 
go and their lives are still 
horrible  
 
Clinician sad when cannot 
help patients (trials did not 
work or at edge of comfort 
zone with T3). Link to other 
clinician description of  
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Appendix H: Collating Codes across data set (example excerpt) 
Endocrinologists views about psychosocial and self-management interventions  
 
Candidate theme 3: Psychosocial interventions/ embedded within practice 
 
 
Interview 1a Interview 2b Interview 3c Interview 4d Interview 5e Interview 6f 
(not always 
well 
appreciated 
by patients, 
not experts in 
mental 
health/fatigu
e); 
 
Gp for 
depression or 
CFS 
investigation 
(not expert in 
these but 
suggest to 
patients) 
Patients not 
amenable to 
this 
suggestion. 
Don't like 
being told ‘all 
in head’, 
threat 
 
 
works well 
when 
embedded in 
practice; 
time, being 
clear about 
intensions 
and 
treatments, 
 
Give them 
time 
Tell them not 
alone, 
common 
problem 
Explain 
investigation 
Look for 
other 
conditions  
More than 
one 
consultation 
to investigate 
before 
 Belief in holistic 
approaches  
Need 
biopsychosocial 
approach and 
multi disciplinary 
approach (Dr, 
Endocrine nurse, 
health 
psychologist 
 
Those treated for 
mild 
hypothyroidism 
(problem is not 
the thyroid; some 
other cause); 
vague symptoms 
(more like chronic 
fatigue) may 
respond more to a 
holistic approach: 
support, promote 
approaches to 
help feel better (if 
not harmful)  
“What I think I can 
do is something 
we've discussed, is 
to help legitimise 
more holistic 
approaches when 
people are very 
biologically 
focused. I'd say, 
"Right, that's fine. I 
will deal with the 
biology, but I think 
it'll help you to 
have a wider 
approach to your 
therapies, 
alternative 
therapies, 
complementary 
therapies, holistic 
approaches, that 
kind of thing, 
which I can't 
provide." 
in my experience, 
very few of these 
people have a 
diagnosable 
psychiatric 
disease.   
Endocrinologists 
have more time to 
educate patients  
(need 40/50 mins) 
about thyroid and 
hormones (link to 
BTF online 
education and 
patient 
information 
events; low uptake 
of physical events? 
online more 
utilised?). GPs 
have less time for 
exploration.  
 
Time is the key  
Form trust 
Collaboration 
Listening to what 
they are saying 
Understanding 
what they are 
going through 
looking for other 
causes (patients 
on board even if 
coming for T3).  
Education  
individualised 
exploratory 
approach (beyond 
individualised 
medicines 
approach) 
Expectations 
Action planning 
(how the next few 
months will work)  
Goal setting & 
action planning 
(for 
emotional/psycho
logical 
management)  
Boundaries 
Validate; explain 
interplay between 
stress and body 
response,  
feeling like 
someone is 
listening 
its not what you 
say but the way 
that you say it 
Medication 
adherence: It's not 
what you say but 
how you say it 
Partnership and 
structure (ensure 
trials are structured 
with ground rules, 
not ‘willy nilly’ link 
to interview 1 when 
says patients are like 
them in medical 
school; without 
experience/knowled
ge following tests 
rigidly and not 
having experience) 
Need to allow 
therapeutic trials 
before focus on 
psychosocial 
interventions  think 
if they undergo a 
therapeutic trial and 
they feel better, 
then they're often 
more capable of 
dealing with other 
aspects of their life 
because they're not 
feeling quite so tired 
and run down. I've 
seen quite a number 
of patients, again it's 
only anecdotal who 
come in and then 
they bounce in 
having slumped in 
Managing risk, 
educating and 
informing, informed 
choice (clinician role 
)  decision making 
(patient role).  
Not being the 
battleground  
unless there's black 
and white evidence 
in medical literature, 
in other words, 
studies, I think  
general well-being 
and how people feel 
is too nebulous a 
concept for 
commissioners and 
prescribers to 
swallow. 
 
It's only when it 
becomes more 
challenging do they 
end up on our 
doorstep and usually 
by that point people 
are already in a 
healthy diet they’ve 
looked at ways to 
enhance the diet and 
exercise to manage 
the fatigue, they've 
seen lots of people 
already. I think we get 
a different group than 
the GP if that makes 
sense, but in our case 
we often find  people 
have already been 
through most things. 
Lots of quackery out 
there and companies 
happy to make money 
from patients  
 
Good to have 
connection with other 
patients (link to 
interview 1 where 
other patients seen as 
problematic) 
 
 
 
 
Patients with 
complex or 
unexplained 
symptoms need 
time, not quick fix 
prescriptions.  
 
 
There is a gap in NHS 
service and 
provision 
particularly for 
people with ongoing 
fatigue. There is a 
need for good health 
psychology service 
to help patients. 
Currently can only 
refer back to the GP 
(link to revolving 
door literature and 
heartsink quote 
from other interview 
 
Signposting role 
(British Thyroid 
Foundation is safe 
and trusted, 
evidence-based) . 
Referral to dietician, 
provide information 
on keeping 
physically active.  
Lack of support 
services in hospitals. 
Key monitoring role, 
and seeing patient 
more than once.  
 
Doctor patient 
interaction is 
important , time 
listening not fobbing 
patients off and 
‘rushing them out’. 
This is the success of 
‘rogue practitioners’ 
they give patients 
time and make them 
feel listened to. (can 
I link to placebo 
effect from time and 
likeable doctors?) 
This may be as 
ffective as the T3 link 
to Peter Taylor, we 
cannot study the 
placebo or othr 
healing efects if 
medicine is unable 
to give time, and 
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discussion 
about T3 
Clear about 
own views 
(do not 
endorse 
T3/ndt based 
on evidence) 
and concern 
for safety. 
Base on own 
knowledge 
and 
judgement 
(mr: pick up 
on a sense of 
personal 
responsibility; 
worry in 
some who 
rely on the 
evidence/gui
delines - link 
to 
consultancy)  
 I think it's a 
process of 
trying to 
impart good 
quality 
information 
about the 
condition and 
its treatment 
and to explain 
to them what 
you know  my 
strategy is 
and offer 
them what I 
can offer 
them be clear  
 
I think in 
principle the 
more 
knowledge 
the better. I 
think it 
empowers 
people to 
know and 
understand so 
I'm always 
giving them 
time trying to 
explain and 
sort of 
educate as 
much as I can. 
Um (...)I think 
there are 
some risks in 
doing that if 
you take it to 
the extreme. 
Sometimes 
people are 
fixated 
about  about 
Sympathy, 
empathy, 
awareness of 
struggle to get to 
be seen 
Being supportive 
and non 
confrontational 
Listening, 
explaining 
Keeping the ‘door 
open’ (link to 
biological causes 
 
Try to discuss 
stressful life 
events: encourage 
them to work on 
that as well as the 
biological side 
(expectation): not 
enough time for 
holistic approach 
Patients do not 
want to engage in 
psychosocial 
aspects (want to 
focus on biological 
side). Link to 
interview 1; 
reluctance of 
patients (not well 
appreciated by 
patients)  
Education, scans, 
images 
Open 
collaboration 
enables 
disclosure, talk 
about risk 
 
An 
acknowledgment 
of listening is very 
important. 
Listening to all 
aspects and not 
belittling small 
ones yes Listening 
support is 
definitely helpful. 
More specific than 
that, I don't think I 
can narrow it 
down. Im tempted 
to just say to the 
patient, "For 
whatever you feel 
gives you more 
energy, so long as 
it's not going to be 
harmful, I would 
strongly be 
supportive of." 
Some people, they 
do a little bit of 
breathing 
Agreement at the 
start (or never 
ending process)  
Manage 
expectations 
Collaborate  
Goal setting (3 
month trial or 
never ending 
process) 
Listening, 
validation 
Not ‘quick fix as GP 
Scaffolding; 
building up a 
picture of the 
illness with the 
patient 
(explanation, 
education, 
empathy) so do 
not build a brick 
wall.  
Level of care and 
understanding 
Empassioned 
conversation; 
listening to what 
they are saying; 
explaining that ‘t3 
might not be the 
answer to all your 
problems’  
Educate about 
literature/RCT, 
unknown risks 
(combination 
treatment); open 
patients minds, 
hormones, how 
the body works, 
history of T4/T3 
Lifestyle, caffeine 
sleep (vitamin 
deficiencies) 
All takes time 
Trust (in research 
and doctor) rather 
than online blog 
 
drugs are too har to 
source and keep). 
This will add to the 
success of 
alternative and self 
sourced medicines 
and errode the 
effectiveness of 
medicine). Drs 
viewtheir role as 
safety and authority 
figures but find it 
hard to compete 
against those who 
want to profit from 
patients(sometimes 
rogue).   
 
Gap; need for 
professionals to look 
at lifestyle 
interventions. Need 
for GP support for 
patients with 
‘medically 
unexplained 
symptoms’ t reduce 
referrals to hospital 
(revolving door)  
 
Need for GP 
education to 
understand impact 
of non-thyroid 
illness upon thyroid 
function test.  
 
Biopsychosocial 
approach needed 
(he calls it 
addressing somatic 
symptoms from life); 
lifestyle approach to 
health needed. 
However, many 
patients have their 
minds made up and 
focus on the thyroid 
only (fed by online 
info and difficulties 
at GP level).  
 
I don't have any 
graphical slides that 
I routinely use, but I 
often draw a thyroid 
gland on a piece of 
paper, and I draw 
pituitary, gland and I 
explain the feedback 
mechanism and how 
to interpret the 
function test, but 
there isn't a specific 
additional tool that I 
use. 
 
There isn't really 
any dedicated 
psychological 
support. 
 
Self managing dose 
can make things 
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the tests and 
one really 
difficult thing 
to it to 
transmit the 
thing to 
people is the 
significance of 
tiny changes, 
the um, er 
error  in the 
measurement
s that is 
inherent. 
Sometimes 
they can over 
interpret the 
kind of data 
that comes in. 
But  
I think that's 
okay. It's a 
process. 
When I was a 
medical 
student, I did 
the same and 
you know 
with 
experience, 
you start to 
understand it 
better and to 
you know 
have a better 
insight into 
what it 
means. I think 
it is 
counterprodu
ctive to to 
prevent 
people from 
from going 
into this area. 
If that's what 
they want, if 
they want 
access to 
their results 
and you want 
them to 
understand 
them, then 
you've got to 
help them. I 
think that can 
turn and be a 
positive 
experience 
for them and 
and I think 
the 
empowermen
t is an 
important 
part of it but 
exercise. I'm not 
sure that's a big 
thing. A few 
people engaging 
in other 
complementary 
therapies. Some 
people try 
meditation or 
mindfulness. I 
don't think I can 
identify one 
specific one. My 
rough shot at it is 
it is a more 
holistic listening 
and supportive 
approach. 
I think the answer 
is partial in the 
sense that what 
people think they 
benefit from is 
listening and an 
explanation and 
keeping the door 
open that there 
may be a 
biological 
explanation. 
Basically, that 
actually relaxes 
people a little bit 
to consider other 
things because it's 
like, "If you think 
I'm mad, I'm not 
going to have a 
conversation with 
you," but if I give 
them the 
legitimacy which I 
think is legitimate, 
that there may be 
a biological reason 
why they're not 
feeling well. That 
helps me engage 
more with other 
aspects. It gives 
me a bit more of a 
mandate todiscuss 
those things. 
  
more complicated.  
 
I think there 
certainly is a degree 
of self-management 
like there is in any 
condition really and 
lifestyle is part of 
that. It's different 
from something like 
diabetes where you 
may have to self 
manage the dose 
that you gave. I 
think dose in a in a 
lot of these 
patients, they 
manage the doses 
themselves 
depending on how 
they feel, and that, 
if anything, makes it 
more difficult for us 
to assess what their 
status is because 
we're not actually 
really sure what 
they've been taking 
and how to 
interpret their 
results just in light 
of that. 
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again this is a 
general 
principle in 
medicine. 
Empowermen
t is fine, but I 
think if  
 
you've got to 
actually 
engage the 
patients in 
the process of 
trying to 
answer this 
question 
Interview 7g Interview 8h Interview 9i Interview 10j Interview 11k Interview 12l 
Time enables 
patients to 
build a 
rapport and 
develop trust 
 
 think that's 
the huge gap 
what we have 
not only just 
with thyroid 
even with 
patients with 
any chronic 
conditions, 
diabetes as 
well. They 
should have 
that support 
actually, 
psychological 
support is 
Communication 
skill: Difficult 
doctor patient 
communication 
when patients 
have pre-fixed 
beliefs 
 
Difficult 
conversation 
when science has 
‘gaps’ (intra-
cellular/tissue 
hypothyroidism); 
believes this is a 
valid point but 
‘we’ve got no way 
of measuring that’ 
Information, 
education, 
understanding and 
trust and the key. 
Getting patients to 
understand and 
follow guidelines. 
All else is 
irrelevant and 
outside of clinician 
skill base. 
 
Patients need to 
be confident that 
you are an expert 
in the field. Time 
and 
communication 
skills underpin the 
process of building 
understanding and 
adherence. 
Time, trust, 
communication, 
convince patients 
you are acting in 
their best interest; 
able to increase 
patient satisfaction 
even when you 
cannot give the 
patient the answer. 
Take pride in 
explaining to 
patients.   
 
Trust in 
relationships make 
unexplained 
symptoms easier to 
hear  
It's really important 
that they trust and 
believe that you  
Psychosocial 
interventions: fear of 
bias on patient 
reported outcome 
measures due to 
wanting to keep the 
treatment.  Problems 
with treatment skew 
results.  
 
Educate about risk; 
informed consent 
 
often they're very well 
informed patients. It 
tends to be a feature 
of patients and how I 
get that they're well 
informed. 
You're starting with a 
discussion where 
they've already got a  
A lot of these 
patients, they 
complain of weight 
gain or difficulties 
maintaining weight. 
I know it sounds 
rather blunt, but 
generally, weight 
management comes 
down to a healthy 
diet and regular 
exercise, and I know 
that's much easier 
said than done link 
to BTF leaflet 
https://www.btf-
thyroid.org/thyroid-
and-weight-the-
science 
However, also link 
to persistent 
symptoms (could be  
 
 
Summaries/notes: 
 
• Referrals to non-endocrine support not always well received by patients (depression, CFS 
seen as cause of symptoms). Focus on finding/fixing cause rather than maintaining health 
& wellbeing (not seen as in clinician role; don’t have will to change); distrust of doctors 
and the system  
• Supportive care works best when embedded in practice 
• Interview 9i Making causal relationships between psychological symptoms and thyroid 
hormone status is impossible. (link this Watt et al, 200– not trying to establish cause)  
• Referral to non-endocrine support is particularly difficult for those who do not endorse 
personalised trials (‘heartsink’; stuck, revolving door) – especially when try to ‘diagnose ‘ 
I’m not an expert but compared to other who knows cfs criteria) 
• Patients may have tried an extensive list of lifestyle related changes to feel better already 
(felt by those open to trials)  
• For some, combination therapy restores ability to engage in healthy lifestyle behaviours- 
Key to rule out other conditions first 
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• For those who do not feel better on time limited trials, ‘other’ interventions seem more 
agreeable (however, cost, lack of experience and safety concerns – even in those with 
experience) as co aspects of health rather than alternative treatment for hypothyroidism 
• Combination therapy to be a last resort due to issues with safety (some more relaxed with 
it; patients will stop if does not suit but cost makes this a problem). Some believe in the 
placebo effect (targeted trials required). To be structured and not adhoc (interview 4; also 
find interview 5; we used to do it on an ad hoc basis) – link to guidelines written by Dayan 
(no-one mentioned these), clear, boundaried, time limited (SMART goals – Dayan’s 
guidelines help this)  
• Embedded Interventions (even interview 1 says works well when embedded in practice) : 
Create a table and put in ‘integrative approach vs medical model’; ‘psychosocial support 
within role vs psychosocial support not part of role or not enough time’ and 
collaborative approach vs authoritarian approach; … list them all but split into 2; 2 clear 
camps (one endorses integrative approaches, emotional support, personalised trials, open 
door approach; managing expectations, collaboration (vs collusion), scaffolding, links to 
more positive feel and patient reaction), one less open to these approaches, more 
inclined to refer externally for depression/CBT/CFS) due to feelings towards combination 
therapy.   
• Providing knowledge and education (but not as passive recipients); need to engage them 
to find out what they want (1a)  
• Empowerment as a burden on patients, patient choice undermining 
knowledge/experience of doctor as ‘expert’, worry about safety (personal responsibility 
of clinician)   
• 11k (issues with PROMS) – patients Psychosocial interventions: fear of bias on patient 
reported outcome measures due to wanting to keep the treatment.  Problems with 
treatment skew results. However; proms are good for working (problems with 
FS/ME/IAPT – recovery used as definition; whereas its about using everything we  have to 
help you feel batter)  - feel better and living well not necessarily recovery ; use cancer 
example.  
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Appendix I: Grouping codes to generate candidate themes 
 
Endocrinologists views about hypothyroidism and its management: 
 
● General attitude towards condition (1) 
● Expectations/ Anticipated Changes to treatment (1) 
● Anticipated changes to treatment (add to attitude towards condition?) (1) 
● Trust/belief in scientific literature (1) 
● Lack of funding and research  
● Situation skews results 
● Safety (Commercialisation of healthcare; medicalisation of life)   
 
 
Endocrinologists views about hypothyroid patients 
 
● Heterogeneity of thyroid subgroups (2) includes Unexplained illness; somatisation; 
biological/non-biological cause  
● Reasons for persistent symptoms (2)  
● Managing patient expectations (Thyroid might not be cause/T3 might not be the answer 
to all problems, (lack of definitive tests and personalised trials halts patients deciding for 
themselves)  
● Cause of patient stress/distress (role of medicine in this) (2), leads on to psychosocial 
interventions section 
 
Endocrinologists views about their role and self-identity as a doctor: 
 
● How Endocrinologists feel (3) 
● Experiences/competency of doctor (3) 
● Personal belief-based approaches to practice (3) 
● Open Vs closed door medicine / support for patient choice (3) Openness to trial 
personalised medicines (due to current research, patient expectations, from GP and  
online influences, knowledge and confidence of doctors) 
●  Link two above to training requirements (some use psychosocial skills others think its not 
in their skill set) (3) 
● Role of doctor (Group of patients with vague symptoms being ‘fobbed off’  / failed (lack of 
time at GP level) or conned (bad doctors/social media) (3) Safety 
● Self/social identity as doctor (collaborate vs collude with patients) provide expertise, 
safety. (3) 
● Safety minefield (non human ration, rogue doctors (and other professionals/self sourcing) 
, patients influenced, marketing/commercialism/ fear of responsibility, unlicensed, 
unclear research and guidelines, personal capability, opportunity and motivation and 
responsibility, patient strong voice and personalised approach; lipservice to patient at the 
center). (3) 
● Engaging in changed practice (sees results), need to have a will to change practice (3) 
● Trust In doctor and patient (empowerment) (doctors are trained to have interpretive 
power but patients, social media and GP practices/CCGs are all trying to take this role; 
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trust in training, expertise and knowledge of safety); trust as key psychosocial 
intervention?  (2/3/4) 
 
Endocrinologists views about non endocrine interventions: 
 
● Psychosocial interventions (4) 
● Trust 
● Expectations (4) 
● Referrals (charity dietician, GP, supportive care, lifestyle) (4) 
● Need for a multidisciplinary approach? (4) 
● Communication theory; persuade patients you are acting in their best interests (but 
problems in doing this; role of media, misinformation, ambiguous guidelines, problems 
with evidence base); its the way that you do it (time, trust)  (4) 
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Appendix J: Developing candidate themes 
 
Candidate theme 1: Endocrinologists views about hypothyroidism and its management 
 
 
 
 
 
 
 
                                                                       Scientific ‘unknowns’  
                            An ‘unnecessary battleground’   
 
Heterogeneity amongst hypothyroid subgroups                                                                              
 
 
 
Subtheme 1:  An unnecessary battleground has been created 
• Hypothyroidism is mostly straightforward to detect and manage in the majority of patients, 
but difficulties are recognised to persist (differences in perception of group size are 
reported) 
• Socio-political factors (unregulated cost of medicine) have eroded both doctors’ and 
patients’ sense of control: An unnecessary battleground has been created.  
 
Sub theme 2: Heterogeneity amongst hypothyroid subgroups  
• Different subgroups of patients with hypothyroidism exist/ Biological 
Psychological/sociological factors 
• Patients with autoimmune thyroid disease have additional symptom burden due to 
inflammation/cytokines and should be monitored for additional autoimmune symptoms. 
This group requires a low treatment threshold for thyroid hormone replacement therapy 
(thyroid hormone therapy is less likely to alleviate autoimmune symptoms)  
• Patients treated for thyroid cancer are likely to experience higher levels of symptom 
burden and psychosocial distress (e.g. rapid onset and treatment) and may struggle to 
adjust to T4 only therapy at lower doses after T3 and/or TSH suppression treatment. Over 
replacement may lead to psychological symptoms.   
• Patients with no thyroid may be different to those with partial thyroid see 3 (link to female 
one; people feel ok for a while then do not)  
• Individual differences may exist in response to treatment. People may have diagnosable 
hypothyroidism (not subclinical) and persistent hypothyroid symptoms (gaps in science, 
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‘we do not know’ tissue level and lack of biomarkers). Targeted trials are required for this 
group (but need to manage expectation) and to improve research quality. Difficult to 
separate this group and those in over diagnosed category). 
• Some patients may have other overlooked problems not related to the thyroid (now 
includes reasons for persistent symptoms) 
• Hypothyroidism requires lifelong monitoring and adjustment which can be sub optimally 
managed (or micromanaged) in primary care/ Patients sub optimally treated in primary 
care may improve with optimal treatment (NICE guidelines should support this; link to 
Dew study) 
• Hypothyroidism symptoms are ambiguous and can lead to overdiagnosis and treatment/ 
Another group of patients with ‘medically unexplained symptoms’/ difficult to diagnose 
symptoms warrants more attention and support (at GP level; GPs often over diagnose as 
hypothyroid as a convenient hook for symptoms)… link to managing expectations; NHS 
embarrassing secret (can be exploited by the ‘wellness industry).  
• Subjective norms (created from patient online communities) may impact upon on 
patient’s beliefs and motivation to comply with treatment / Difficult to study the 2 groups 
above if started on alternative therapies outside of NHS and without baseline data … need 
not to be dismissed by the NHS; keep open mind. Safer to work with them.  
• Many reasons for persistent symptoms exist which need time to rule out before 
combination therapy should be started (list these, send to Endos?).  
 
Subtheme 3: Scientific ‘unknowns’ exist  
• Methodological limitations, guideline omissions, a lack of diagnostic biomarkers and 
regulated body-identical treatment preparations (T3/ndt), and prohibitive treatment 
costs are yet to be resolved)   
• Up to 14 RCTs have explored different available treatments for replacing thyroid 
hormones  
• Current studies are of weak quality (population-level studies/lack of targeted studies on 
appropriate population and incorrect dosing of treatments) 
• New research is required with carefully targeted populations and accurate treatment 
dosing 
• Without funding for improved research, no forward movement will occur (CCG power) 
• Guidelines are tools, not rules 
• Guidelines require specialist interpretive power 
• New UK NICE guidelines give a ‘nod’ to patient with persistent symptoms and have ‘left 
the door open’ for personalised trials,  
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• A lack of guidance continues for administering personalised treatments (barrier for 
improved health outcomes) – link to Dayan study 
• New UK NICE guidelines should reduce referrals to secondary care by optimising thyroid 
hormone replacement in primary care (guiding GPs) 
• A lack of quality biomarkers or hypothyroidism (e.g. at tissue level) perpetuates the 
‘ambiguity’ of symptoms 
• Development of a synthetic long-lasting T3 preparation which mimics the body may 
address Endocrinologists’ safety concerns 
• The current price of treatment is prohibitive to personalised trials; and research and 
development and perpetuates the battleground  
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Appendix K: Writing to develop overarching themes (example excerpt)   
 
Additional Theme 1: Research/clinical and Socio-political contexts  
 
Subtheme 1: Research and clinical context: ‘Scientific ‘unknowns’ exist’  
Participants described methodological limitations, a lack of diagnostic biomarkers and regulated 
body-identical thyroid hormone replacement preparations (T3/NTD) as scientific ‘unknowns’, 
compounded by prohibitive treatment costs and chronic underfunding to further knowledge and 
practice.  In their accounts, they described that up to 14 RCTs have explored different available 
treatments for replacing thyroid hormones:  
 
Doctor A:  “ I'm not convinced by the arguments that the way that we replace thyroid hormones is 
suboptimal and the other ways of doing it will be better. I derive this opinion largely from the 
numerous randomised controlled trials looking at combined treatment with alone levothyroxine 
treatment, which have shown absolutely no difference I, I one  has to accept  that maybe there is a 
tiny, tiny sort of subgroup of people um by no means, is this anywhere like the 15%, but a really 
really subgroup that truly have a biological problem” 
Doctor N: “ We need to bear in mind that all the clinical trials haven't found the benefit, if you say. 
for the most, people can say that the randomised control trials and analyses have basically been 
negative for combination treatment. 
Doctor O: “ Certainly, there's not much good quality information that adding T3 to T4 and T3 to T4 
treatment really makes a difference for most people.” 
Doctor P: “ there have been trials of people given higher doses of Levothyroxine or given T3, 
and if you look at these trials, at how they conduct a trial, then they usually show that 
there's no benefit at all of additional therapy” 
Doctor I: “I don't think there is adequate evidence or any evidence really to show benefits in 
prospective studies. The studies that I have seen and looked at in some detail suggest either 
no benefit or they are completely inconclusive and then the other thing is, although there's 
no data on potential side effects, that's something that concerns me, based on extensive 
studies in the basic science literature using animals” Doctor Q: “ So, if thyroxine works well, 
just as well as T3 and we have all these experience and safety data on thyroxine, why not 
leave trying T3 and then make T3 the exception for those who do not clearly benefit” 
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Some participants, however, highlighted that the available studies to date are of weak quality 
(population-level studies and a lack of targeted trials with the appropriate patient population and 
incorrect dosing of treatments were identified as key flaws). These participants advocated for 
additional funding for new research with carefully targeted populations and accurate treatment 
dosing: 
Doctor G: “Currently, that's where we are lacking. We do not have enough, well-designed studies, 
or the studies that have enough power to say that uh the additional treatments like T3 or NDT is 
useful." 
Doctor Q: “We've come some way and the kind of work we are doing is to actually see whether there 
is any link between things like genotype and wellbeing on thyroxine. If there's such a link. That would 
be the group in which we would need to do a randomised controlled trial. 
At population level is quite hit and miss. You could have people who have lots of other problems 
and you're just giving them T3 it won’t work for them. You've got to try and find those patients 
who would have a physiological reason not to utilize T3, not to utilize T4, not to metabolize T4. 
That's hopefully what we'll achieve” 
Doctor K: “The only sort of significant randomized control trial states there was no difference 
between T4 and the combination. Although with some trends towards some improvements 
perhaps in things like with combination therapy. The problem was it was a patient population who 
were fine on T4 alone. I don't think any of us would be advocating treating people with T4 alone-- 
I'm sorry, moving people who are fine on T4 alone to combination therapy. I think there is a need 
for a properly sized, randomized controlled trial combination treatment targeting those people 
who are still symptomatic on T4 alone, I think that will be very helpful.” 
Doctor C: “I think what they do show is that for the average hypothyroid patients T4 and T3 
doesn't work but what we haven't got so far is the trial in this subset of patients. I'm not aware of 
any trials that have been conducted specifically in people who are unhappy with adequately with 
Levothyroxine. I don't think that exists. Secondly, I don't think we've got a trial in prospective trials 
rather than a subgroup trial in people with a specific Deiodinase polymorphism. There might be 
some truth in there that there might be a group of patients in which T3 might be beneficial but the 
problem at this point is we don't know who” 
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Appendix L: Supporting information from systematic review 
1. PICO table 
 
PICO Included Excluded 
Population Adults over 16 years including 
pregnant women. 
 
Diagnosed with thyroid diseases. 
Babies and children 
Patients with thyroid cancer. 
Patients with ‘healthy’ status or with 
‘other’ chronic illnesses (e.g. diabetes), 
tested for changes in thyroid function 
(e.g. in exercise studies) 
Studies conducted on animals.  
Interventions Psychological or social (including 
lifestyle) interventions. 
Single or multi-faceted 
interventions (including with 
biomedical primary but also with 
clear psychosocial outcomes) 
All study designs (RCTs and non-
RCTs) 
Diet and nutritional interventions 
(including supplements). 
Interventions to change behaviour of 
medical professionals. 
Physical outcomes but no link to 
psychosocial impact (e.g. specific aspects 
of cardiovascular health).  
Non-intervention studies. 
Comparison All comparisons included (standard 
care, non-psychosocial 
comparisons), as well as studies 
with no control groups.  
 
Outcome All psychosocial outcomes. Quality 
of life and/or wellbeing.  
Definition widened to include 
coping and perceived fatigue. 
Outcomes assessed by quantitative 
outcome measures and by 
qualitative patient reports.  
Psychosocial outcomes resulting from 
pharmacological or surgical therapy. 
 
Outcomes for other participant groups 
(e.g. carers, health professionals) 
Other All years of included journals.  
Studies with any length of follow up 
(including no follow up). 
Published and unpublished 
materials were considered for 
review.  
 
Non-English language papers 
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3: Information sources, databases and other sources searched 
 
The following databases were searched. No date restrictions were applied and at this stage, no 
language restrictions were applied.  
   
1. CINHAL searched Nov 2016, search strategy developed and re-run January 2017 (2,411 
results, 48 selected) 
2. Medline searched December 2016, search strategy developed and re-run January 2017 
(3039 results, 67 selected) 
3. Psychinfo, Psycharticles, AMED searched together through EBESCO host January, 2017 
(2577 results, 34 results selected)  
4. Web of Science searched January, 2017 (2,741 results, 57 results selected) 
5. Cochrane Library searched January, 2017 (42 results, 4 selected) 
6. Science Direct searched January, 2017 (3,346 results, 14 selected) 
7. The Cochrane Register of Controlled Trials (CENTRAL) searched January, 2017 (57 results, 
4 selected) 
8. Open Grey searched January, 2017 (1017 results, 6 selected) 
9. ZETOC hand searched (12 results) 
10. Google and google scholar were searched 
11. Mail outs from internet peer and patient support groups were monitored for posted 
articles. 
12. References from a number of popular self-help books were searched (and mail-outs from 
blogs joined).  
13. Local information was obtained during a meeting with a member of the Bristol Clinical 
Commissioning group, and researchers contacted for information about current research 
in the area.  
14. A meeting was held with a local specialist professor to discuss up to date publications. 
15. Publishers from three universities were contacted about their work. 
16. The British Thyroid Foundation were involved and were asked for relevant information 
and publication updates.  
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4:  Search strategy 
The search strategy for this review was adapted from a similar published review (Walklet et al, 
2016) examining whether psychosocial interventions improve quality of life and wellbeing in adults 
with neuromuscular disorders.  This paper was identified, and the author contacted for discussion. 
For the present review, the terms ‘multidisciplinary’, ‘nutritional’, ‘exercise’ and ‘pacing’ were also 
added to further capture behaviour change  interventions. 
Core search strategy: 
 
1. ( thyroid OR thyro* OR hyperthyro* OR hypothyro* or Graves or goiter OR T4 or TSH) : in any 
field 
 
2. AND (psychosocial OR psychological OR biopsychosocial OR social OR "social support" OR 
"support group*" OR psychoeducation OR "peer support" OR counsel#ing OR "psychological 
therap*" OR psychotherapy OR psychodynamic OR "cognitive behavio#r*" OR cognitive OR 
behavio#r* OR CBT OR "self manag*" OR "self care" OR mindfulness OR "acceptance and 
commitment therapy" OR “telephone support” OR “nutritional support” OR supplementation OR 
diet OR exercise OR pacing OR “integrative team” OR “multidisciplinary team” OR “multidisciplinary 
education” OR placebo OR “functional approach” OR “functional medicine” OR “communication” 
OR EFT OR EMDR OR “trauma therapy” OR “motivational interviewing” OR “family therapy” Or 
“training” OR online OR skills ): in any field 
3. AND ( “quality of life” OR "well being" OR "well-being" OR "wellbeing" OR "life satisfaction" OR 
"mental health" OR "psychological stress" OR anxiety OR depression OR pain OR fatigue OR 
inflammation OR adjustment OR "social participation" OR "positive psychology" OR "psychological 
adjustment" OR coping OR Cop* OR “body image” ): in any field 
Science direct changed to; 
 
1. (thyroid OR hyperthyroidism OR hyperthyroid OR hypothyroid or hypothyroidism OR Graves or 
goiter OR T4 or TSH ) : in any field 
 
2. AND (psychosocial OR psychological OR biopsychosocial OR social OR "social support" OR 
"support group*" OR psychoeducation OR "peer support" OR counselling OR "psychological 
therapy" OR therapies OR psychotherapy OR psychodynamic OR "cognitive behaviour*" OR 
cognitive OR behaviour* OR CBT OR "self manage" OR management OR "self care" OR mindfulness 
OR "acceptance and commitment therapy" OR “telephone support” OR “nutritional support” OR 
supplementation OR diet OR exercise OR pacing OR “integrative team” OR “multidisciplinary team” 
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OR “multidisciplinary education” OR placebo OR “functional approach” OR “functional medicine” 
OR “communication” OR EFT OR EMDR OR “trauma therapy” OR “motivational interviewing” OR 
“family therapy” Or “training” OR online OR skills ): in any field 
3. AND (  “quality of life” OR "well being" OR "well-being" OR "wellbeing" OR "life satisfaction" OR 
"mental health" OR "psychological stress" OR anxiety OR depression OR pain OR fatigue OR 
inflammation OR adjustment OR "social participation" OR "positive psychology" OR "psychological 
adjustment" OR coping OR “body image”  ): in any field 
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Appendix M: Poster presentation of findings 
 
